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ABSTRACT
Hebert and Carruthers (1992) showed that the human erythrocyte glucose
transporter is an allosteric complex of four GLUT1 proteins whose structure and substrate
binding properties are stabilized by reductant-sensitive noncovalent subunit interactions.
The GLUT1 tetramer dissociates into dimers upon exposure to reductant but subunits are
not associated via disulfide bridges. Each subunit of SDS-denatured tetrameric GLUT1
exposes only two thiols while reduced denatured GLUT1 exposes all six sulfhydryl
groups. They hypothesized that glucose transporter oligomeric structure and cooperative
catalytic function resulted from noncovalent subunit interactions promoted or stabilized
by intramolecular disulfide bridges. These interactions give rise to an antiparallel
arrangement of substrate binding sites within the transporter complex.
In the present studies, we tested aspects of this model. Specifically, we wanted 1)
to understand why the native, noncovalent, homotetrameric GLUT1 complex is sensitive
to reductant, 2) to determine whether the tetramer is more catalytically efficient than the
dimer in situ and 3) to test the hypothesis that it is the antiparallel arrangement of
substrate binding sites between subunits that provides the transporter with its catalytic
advantage. We used biochemical and molecular biological approaches to isolate specific
determinants of transporter oligomeric structure and/or transport function in purified
isolated transporter preparations, in intact red cells and in CHO cells. We have also
examined the hypothesis that net sugar transport in the human erythrocyte is rate limited
by reduced cytosolic diffusion of sugars and/or by reversible sugar association with
intracellular macromolecules.
Our findings support the hypothesis that each subunit of the parental glucose
transporter contains a single intramolecular disulfide bridge located between cysteine
residues 347 and 421. This disulfide seems to be necessary for GLUT1 tetramerization.
Our findings suggest that GLUT1 N-terminal residues 1 through 199 provide contact
surfaces for subunit dimerization but are insufficient for subunit tetramerization. Our
studies also show that in situ disulfide disruption by cell impermeant reductants results in
the loss of cooperative subunit interactions and a 3 to 15-fold reduction in the transport
efficiency of the transporter. We further find that in situ GLUTI is susceptible to exofacial
proteolysis. Exofacial trypsin cleavage eliminates cooperativity between subunits but does
not affect transporter oligomeric structure or transport activity. Thus catalytic efficiency
does not derive directly from cooperative interactions between substrate binding sites on
adjacent subunits. We have confirmed that 30MG transport in human erythrocytes is a
diffusion limited process. We find that steady-state sugar uptake in red cells and K562
cells measures two processes - sugar translocation and intracellular sugar binding. We
propose a model for native GLUTI structure and function.
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Chapter I
Introduction: Literature Review
All cells express a variety of integral , plasma membrane proteins that catalyze
transmembrane solute fluxes. These proteins are called transporters and typically catalyze
cellular uptake or effux of nucleosides , carbohydrates, amino acids, cations or anions.
Solutes enter the cell via three independent mechanisms: 1) slow, bidirectional transbi-
layer diffusion (simple diffusion); 2) rapid, protein-mediated, bidirectional, facilitated dif-
fusion (passive transport); and 3) rapid, active, protein-mediated transport (active
transport) (Stein 1986). Since these transporters provide the cell' s metabolic machinery
with its necessary substrates , it is easy to understand why transporters are essential for life.
However, the mechanism of protein-mediated transmembrane solute transport remains one
of the fundamental enigmas of contemporary cell biology.
We are interested in unraveling this process and have chosen the glucose trans-
porter as our prototypical model for study. Sugars are strongly hydrophilic molecules and
their diffusion into the cell is effectively blocked by the hydrophobic plasma membrane.
The transport of glucose across the plasma membrane of most cells occurs via a rapid, pro-
tein-mediated, bidirectional, facilitated diffusion mechanism called uniport. The proteins
responsible for this are known as glucose transporters. Net glucose transport is always
from a high to low sugar concentration. This and the lack of obligatory coupling to the
symport or cotransport of cations distinguishes glucose uniport from active glucose trans-
port or glucose/cationsymport. The pharmacology of glucose uniport inhibition differs
significantly from that of active glucose transport (Carruthers 1990). Unlike active glucose
transport mechanisms , faciltated diffusion of glucose is inhibited by the fungal metabolite
cytochalasin B.
Six distinct isoforms of glucose transporters have been identified by biochemical
and recombinant DNA techniques and are named GLUTI through GLUT7. GLUTI
(Mueckler et. al. 1985) is also called the erythrocyte/HEP G2 type transporter and is found
in almost all tissues including the brain and fibroblasts. GLUT2 , or liver type transporter
(Thorens et. al. 1988) is found in the B-cells of the pancreas , hepatocytes , intestine and
kidney. GLUT3 (Kayano et. aI. , 1988) is found mainly in the brain of most species but is
more widely distributed in humans. GLUT4 , the insulin-sensitive transporter (Fukumoto
et. al. 1989, James et. al. 1989 , Kaestner et. a11989, Birnbaum 1989 , Charron et. al. 1989),
is found in muscle and adipose tissue. GLUT5 (Kayano et. al. 1990) is found largely in the
jejunum and may mediate intestinal absorbtion of fructose rather than glucose (Burant et.
al. 1992). GLUT7 (Waddell et. al. 1992), the hepatic microsomal glucose transporter, is
thought to mediate glucose transport across the endoplasmic reticulum. GLUT6 is a psue-
do gene that was identified by a homology screening approach (Kayano et. al. 1990). It is
not expressed at the protein level.
We have chosen the GLUTI isoform for our studies on membrane transport.
GLUTI is the best studied isoform for a number of reasons of which the most important is
its availability. LUTI is found in high abundance (5% of total membrane proteins) in
human red cell membranes. Erythrocytes are easily obtainable and thus provide a good
model system for in situ studies. In addition , GLUTI is easily purified from erythrocytes
(yields of up to 20 mg from one unit of blood) and is thus well suited for in vitro studies.
GLUTI exhibits nearly ubiquitous tissue distribution. The highest expression lev-
els are at the blood/brain barrier but GLUTI is abundantly expressed in all blood-tissue
barriers (Gould and Holman 1993 , Mueckler 1994). The regulation of GLUTI expression
has been extensively studied in cultured cells. GLUTI expression levels are increased by:
butyrate (Takano et al. 1988), cAMP (Hiraki et al. 1989), fibroblast growth factor (Hiraki
et al. 1988), growth hormone (Tai et al. 1990), hypoxia (Loike et al. 1992), insulin (Tordj-
man et al. 1989), insulin-like growth factor I (Maher et al. 1989), oncogenes (Birnbaum et
al. 1987, Flier et aL 1987), phorbol esters (Hiraki et al. 1988), platelet-derived growth fac-
tor (Rollns et al. 1988), serum (Hiraki et al. 1988), sulfonylureas (Tordjman et al. 1989),
thyroid hormone (Weinstein et al. 1990), transforming growth factor-B (Kitagawa et al.
1991), tumor necrosis factor a (Stephens et al. 1992) and vanadate (Mountjoy and Flier
1990). Glucose causes a reduction in GLUTI expression levels (Walker et al. 1988,
Walker et aL 1989 , Tordjman et aI. 1990, Wertheimer et al. 1991), Acute hypoxia has also
been shown to activate glucose transport without altering GLUT 1 expression (Diamond
and Carruthers 1993).
Glucose transporters are also part of a much larger superfamily. Homologous
transporters have been found in algae (Sauer and Tanner 1989), cyanobacteria (Zhang et.
al. 1989), Escherichia coli (Maiden et. al. 1988), plants (Sauer et. aL 1990), protozoa
(Cairns et. al. 1989, Bringaud and Baltz 1992), yeast (Celenza et. al. 1988 , Szkutnicka et.
al. 1989) and in Zymomonas mobils (Barnell et. al. 1990).
There are a number of structural features which are common to the glucose trans-
porter isoforms. The primary structures of human GLUTI-5 exhibit 39-65% sequence
identity and 50-76% sequence similarity in pairwise comparison (Bell et al. 1990).
The secondary structure of GLUT 1 is predicted (by hydropathy analysis of the pri-
mary structure; Mueckler et. aL 1985) to contain twelve transmembrane helices (Fig. 1).
Scanning hydrophobic moment analysis (Eisenberg, 1984), however, suggests only ten
transmembrane domains (Carruthers, unpublished). Using anti-peptide antibodies , Fish-
barg et al. (1993) suggest that GLUTI forms a beta barrel and that the number of trans-
membrane domains may not be twelve. The N- and C-termini and a large middle loop are
located in the cytoplasm. This has been confirmed using anti-peptide antibodies and by
analysis of protease susceptibility (Cairns et aL 1987, Davies et al. 1987 , Haspel et al.
1988). Spectroscopic studies suggest that purified GLUTI is greater than 80% helical
(Chin et al. 1986, Alvarez et al. 1987) and that more than 80% of the polypeptide chain is
accessible to solvent (Alvarez et aL 1987). Since a larger portion of intramembranous pro-
tein is accessible to bulk solvent, the presence of a water filled pore or channel is possible.
There are two conserved motifs between the Nand C terminal halves of the transporters.
There is an RXGRR motif between helices 2 and 3 in the N-terminus and between helices
8 and 9 in the C-terminus (Maiden et al. 1987). Another conserved motif is EXXXXXXR
found between helices 4-5 and 10-11 in the Nand C termini respectively (Gould and Hol-
man 1993). Thus it is possible that the two-domain , twelve membrane spanning helical
transporter structure may have arisen from gene duplication of an ancestral six transmem-
brane-spanning helical protein. It has been hypothesized that GLUTI contains one or
Figure 1. Proposed 2D topology of GL UTI
A proposed topographical map of GLUTI generated by hydropathy analysis (Mueckler et
al. 1985) and optimized by the method of Jones et al. 1994. Amino acids are indicated by
their one letter codes. Putative transmembrane domains are shaded. The location of the
cysteine residues are denoted by dark circles. GLUTI is heterogeneously glycosylated at
asparagine-45.
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more intra-molecular disulfide bonds (Hebert and Carruthers 1992).
There is no information about the tertiary structure of glucose transporters. It has
proven to be extremely difficult to grow high quality protein crystals of membrane pro-
teins for x-ray crystallographic studies. Recent data from Reithmeier s group (Wang et al.
1994) have provided a fascinating view of the three-dimensional map of the human eryth-
rocyte anion exchanger (Band 3). Band 3 is a membrane protein with eight to fourteen pre-
dicted transmembrane helices (Reithmeier 1993). Band 3 exists as dimers and tetramers in
the membrane and anion exchange occurs by a ping pong mechanism. Band3 , like
GLUTl , may stil be functional as a monomer in vitro. Using electron microscopy and
image reconstruction , the three dimensional inap of two dimensional crystals of Band 3
has been determined at 20 A resolution. The 3D map reveals a dimer (Fig. 2) which forms
a U-shaped structure. The structure is open at the top and at the sides. The monomers are
in close contact at the base which is thick and is believed to span the bilayer. The exofacial
domains form a canyon. Biochemical data suggest that the protrusions are dynamic. The
canyon is a wide space that narrows down and converges into a depression centered
between the subunits at the top of the base. The depression may form a channel.
There is a growing body of biophysical evidence concerning the quaternary struc-
ture of the glucose transporter. GLUTI has been proposed to be a tetramer (Cuppoletti et
al. 1981 , Jung et aL 1980) or a dimer (Jarvis et al. 1986) by radiation inactivation studies.
Freeze-fracture electron microscopy of reconstituted GLUTI suggest it is a dimer (Hinke
et al. 1979). A number of hydrodynamic studies have suggested that the transporter is a
monomer (Rampal et al. 1986), a monomer or a dimer (Zoccoli et al. 1978) and a dimer
Figure 2. 3D map of the dimeric transport domain of Band 3 protein.
Perspective View. The bulky basal domain is probably embedded in the lipid
bilayer, indicated by the two blue planes which are separated by 35 A. The longest dim en-
sion of the basal domain is - 110 A. Based on the available biochemical data, it is sug-
gested that the protrusions on the upper side of the basal domain are on the cytosolic side
of the membrane and that the smooth surface on the lower side is exofacial. The two
domains on the cytosolic side form two sides of a canyon that leads to a depression which
is probably the entrance to a pore. Striped areas represent cuts through the map above the
putative membrane surface which form protein-protein contacts in the crystals.
Top View. Shows the open canyon on the cytoplasmic side. The two sides of the
canyon narrow down on the surface of the basal domain. The lower part of the protein
thought to be embedded in the membrane appears blue. The bar represents 20 A.
This figure is adapted from Wang et al. 1994.
Figure 2
(Masher and Lundahl (1987). These studies were all performed on purified, detergent-sol-
ubilized, reduced glucose transporter. Hebert and Carruthers (1992) showed via hydrody-
namic studies and by using conformation-specific antibodies that the reduced transporter
is a dimer while the non-reduced purified carrier exists as a tetramer. Furthermore , they
showed that the red cell-resident carrier is a tetramer. Supporting evidence for GLUTI oli-
gomerization has been obtained using co-immunoprecipitation techniques in 3T3-Ll adi-
pocytes (Pessino et al. 1991). These studies show that GLUTI forms homo-oligomers.
GLUTI fails to oligomerize with GLUT4 in the same cell.
A number of additional features of GLUTI have been revealed by site-directed
mutagenesis studies. There are six tryptophan residues in GLUT1. All have been mutated.
Trp388 and Trp412 show impaired glucose transport activity in CHO cells (Katagiri et al.
1991) and in Xenopus oocytes (Garcia et al. 1992). CCB photolabellng is also decreased
(Inukai et al. 1994). Mutations at Trp48 , Trp65, Trp186 and Trp363 had no effect on glu-
cose transport. A Gln282-+Leu mutation has been shown to markedly reduce binding of
exofacial ligands (ATB-BMPA and ethylidene- glucose) with little effect on glucose
transport or CCB binding (Hashiramoto et aL 1992). Mutations at Asn288 and Asn317
have no effect (Hashiramoto et al. 1992), Mutation at Asn415 decreases transport function
(Ishihara et al. 1991). It has been suggested that mutagenesis of Tyr293-+Leu locks the
transporter in an outward facing conformation (Mori et al. 1994). Substitution of Tyr292 is
without effect (Mori et al. 1994). The role of Pro385 appears to be dependant on the sub-
stituted side chain. Pro385-+ Ile appear to lock the transporter in an inward facing confor-
mation whereas Pr0385-+Gly is without effect (Tamori et al. 1994). ProI87-+His
Pro205-+Phe, Pro383-+Ala/Gln, Pr0385-+Ala/Gln and Pro387-+Ala/Gln are without
effect in Xenopus oocytes (Wellner et aI. 1995) but Prol96-+Arg shows a reduced trans-
port capacity. Mutagenesis of cysteines is reported to have no effect on glucose transport
in the Xenopus expression system (Wellner et aI. 1992 , Wellner et aI. 1994). Substitution
of leucine or asparagine for Gln161 markedly reduced 2DOG uptake in Xenopus oocytes
(Mueckler et al. 1994). Mutations at Asn100 and Gln200 were without effect (Mueckler et
aI. 1994).
The analysis of the transport function of the mutants is complicated by the system
used to express the mutants. GLUTI has been expressed in a number of cell types includ-
ing CHO cells (Zottola et aI. 1995, Harrison et al. 1990a, Asano et al. 1989), 3T3-Ll cells
(Harrison et al. 1990b, Gould et aI. 1989), COS cells (Schurman et al. 1992), Xenopus
oocytes (Burant & Bell 1992 , Gould et aI. 1991 , Gould & Lienhard 1989), Sf9 cells (Yi et
aI. 1992) and in transgenic mice (Marshall et al. 1993 , Ren et al. 1993). It is difficult to
study transport kinetics in systems which contain an endogenous glucose transporter since
it wil contribute to transport. In addition , non-mammalian systems may lack required cel-
lular machinery for proper assembly or regulation of expressed proteins.
A large body of data is available for analysis of potential mechanisms of erythrocyte
glucose transport. The facilitated diffusion of sugars across cell membranes is usually
attributed (Bell et aI., 1993, Mueckler, 1993) to a protein-mediated , uniport (transport)
mechanism called the simple carrier. According to this model (Fig. 3), transport is a
sequential (iso-uni ping pong) process in which the transporter (E) cycles between sugar
import (E2) and sugar export (El) states (Lieb & Stein, 1974 , Widdas, 1952). While this
Figure 3. Proposed mechanisms of glucose translocation by GLUTI
One-site carrier. This is a schematic representation of the one-site, or simple carrier
mechanism. In the absence of sugar, the carrier E can exist in one of two conformations.
E2 presents a sugar influx site for extracellular sugar. Extracellular glucose binds to E2 to
form E2S2 which undergoes a conformational change to form EIS1. Glucose is now
exposed to the cytosol and dissociates leaving El which re-isomerizes to E2 for an addi-
tional round of influx. El and E2 are mutually exclusive. Dimeric GLUTI is proposed to
exist as two independent one-site carriers.
Two-site carrier. This is a schematic representation of the two-site (iso) carrier. In the
absence of sugar, the carrier exists in one of two conformations, E or F. Both conforma-
tions present influx and effux sites to glucose simultaneously. E and F are arranged in an
antiparallel manner. When E isomerizes to the sugar binding sites are rearranged in a
coupled , antiparallel fashion. In this model , unlike the simple carrier, the carrier can exist
as a ternary complex of extracellular sugar:carrier:intracellular sugar. The two site model
could represent a dimer of simple carriers in which the sugar binding sites of each mono-
mer are always arranged in an antiparallel manner. Isomerization of one monomer forces
the antiparallel isomerization of the second binding, site. Tetrameric GLUTI is proposed to
exist as two two-site carriers.
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model quantitatively predicts the steady-state sugar transport of some cells, it was
recognized by Miler in 1968 (Miler, 1968) that key aspects of erythrocyte sugar transport
are incompatible with this mechanism. This promoted systematic analyses of red cell sugar
transport in which a number of groups ultimately rejected the simple carrier mechanism for
erythrocyte hexose transport (Baker & Naftalin, 1979 , Eilam & Stein , 1972 , Ginsburg &
Stein , 1975, Hankin et aI. , 1972 , Holman, 1980, Holman et aI. , 1981 , Lieb , 1982 , Lieb &
Stein, 1974, Naftalin & Holman, 1977, Stein, 1986). This conclusion stimulated
unfavorable criticism and led others to re-examine earlier studies and subsequently to
conclude that the simple carrier mechanism is an adequate description for erythrocyte sugar
transport (Lowe & Walmsley, 1986 , Wheeler, 1986, Wheeler & Whelan, 1988).
These later studies examine steady-state, unrestrained sugar transport in red cells.
It had been recognized for some time, however (Baker & Widdas, 1973, Baker 
Carruthers, 1981 , Krupka & Deves, 1981), and later proven theoretically (Carruthers,
1991) that such analyses often lack the sensitivity to distinguish various transport
mechanisms. For example, theory shows that when cellular steady-state sugar transport is
consistent with the simple carrier mechanism , it is always compatible by default with a
diametric transport mechanism called the simultaneous (Fig. 3) or two-site carrier
(Carruthers, 1991). This carrier, unlie the simple carrier , can bind sugars at import and
export sites simultaneously (Baker & Widdas, 1973). The only acceptable conclusion these
later studies allow is that steady-state red cell sugar transport could be mediated by both
simple- and simultaneous-carrier mechanisms.
More sensitive tests of carrier mechanisms examine sugar hetero-exchange (Miler
1968) or inhibitions of sugar transport produced by the simultaneous presence of reversible
competitive inhibitors of sugar import and export (Krupka & Deves, 1981). The results of
these analyses are either consistent with simple and simultaneous-carrier models (Krupka
& Deves, 1981) or support rejection of the simple carrier (Carruthers & Helgerson, 1991
Helgerson & Carruthers, 1989, Miler, 1968 , Naftalin & Rist, 1994, Naftalin et aI., 1985).
A single analysis of pre-steady-state sugar transport by red cells has been reported (Lowe
& Walmsley, 1987) and the results are incompatible with the simple carrier mechanism
(Naftalin , 1988).
A plausible, physical explanation for the complex kinetic behavior of the
transporter was suggested when the erythrocyte sugar transporter was found to be an
allosteric, oligomeric complex of four GLUT 1 proteins (Hebert & Carruthers 1991 , Hebert
& Carruthers 1992). This complex is stabilized by noncovalent subunit interactions but
dissociates into GLUTI dimers upon exposure to reductant. GLUTI dimers function as
prototypical simple carriers in which each subunit contributes a single transport unit which
functions independently of its neighbor (Appleman & Lienhard 1989 , Hebert & Carruthers
1992). The parental transporter consists of 4 such subunits whose behavior in the mature
complex is hypothesized (Hebert & Carruthers, 1992) to be constrained by subunit
interactions. Cooperative interactions are suggested to produce a pseudo-D2 symmetry in
import and export site orientation within the transporter complex. When one subunit
presents an import site, the adjacent subunit must expose an export site and vice versa. 
this way, the parental transporter always exposes two sugar import and two sugar export
sites although at any instant, the individual subunits contributing specific sites vary.
According to this hypothesis, subunits of the parental transporter complex can now
bypass rate-limiting steps in the ping-pong transport cycle and are thus more efficient
catalytically than their dimeric counterparts. This hypothesis is supported indirectly by
analyses of the catalytic turnover of dimeric GLUTI (Appleman & Lienhard, 1989) and
parental transporter (Lowe & Walmsley, 1986) at lO C which show that dimeric GLUTI
is some lO-fold more less active than the parental transporter (Hebert & Carruthers, 1992).
This hypothesis has been questioned by Burant and Bell (1992) who conclude that
sugar transporters exist functionally as monomeric species in the plasma membrane,
However, the conclusion of Burant and Bell was based upon two indirect observations and
five untested central assumptions. The observations are: 1) Co-expression of GLUTI and
GLUT3 in Xenopus oocytes results in expression of two kinetically distinct components of
sugar uptake; 2) Co-expression of wild-type GLUT3 and a mutagenized (dysfunctional)
GLUT3 does not inhibit wild-type GLUT3 function. The untested assumptions were: 1)
Post-translational processing of glucose transport proteins is identical in Amphibia and
Mammalia; 2) Glucose transporter isoforms and mutants share identical spatial and
temporal processing kinetics (i.e. the proteins can oligomerize prior to insertion at the
plasma membrane) and/or, 3) Sugar transporters constantly dissociate and reoligomerize at
the plasma membrane; 4) Subunits of oligomeric transporters are functionall coupled at
all times; 5) Transporter isoforms can form heterocomplexes.
Recent findings invalidate the first 2 assumptions. In contrast to CHO cells (Pessino
et aI. , 1991), GLUTI and GLUTlIGLUT4 chimeras do not physically associate in Xenopus
oocytes where the kinetics of isoform and mutant transporter processmg can differ
dramatically (Hresko et aI., 1994). Earlier studies from this laboratory (Hebert &
Carruthers, 1991 , Hebert & Carruthers , 1992) demonstrate that the third assumption is
invalid in erythrocytes and CHO cells. A number of studies argue against obligate
functional coupling between transporter subunits and thus refute the 4th assumption. For
example, dimeric GLUTI consists of structurally coupled but functionally independent
GLUTI proteins (Hebert & Carruthers, 1991 , Hebert & Carruthers, 1992). Expression of
dysfunctional GLUTI mutants by CHO cells can be without effect on parental GLUTI
function (Tamori et aI. , 1994) or can inhibit parental GLUTI functions (Mori et aI., 1994)
- the effect is mutant-specific. The 5th assumption is refuted by earlier studies showing that
GLUTI and GLUT4 do not form heterocomplexes (Pessino et aI. , 1991).
In the body of work presented in this thesis, we test aspects of the model
hypothesized by Hebert and Carruthers (1992). Specifically, we want 1) to understand why
the native, noncovalent, homotetrameric GLUTI complex is sensitive to reductant, 2) to
determine whether the tetramer is more catalytically efficient than the dimer in situ, and 3)
to test the hypothesis that it is the antiparallel arrangement of substrate binding sites
between subunits that provides the transporter with its catalytic advantage. We used
biochemical and molecular biological approaches to isolate specific determinants of
transporter oligomeric structure and/or transport function in purified isolated transporter
preparations, in intact red cells and in CHO cells. We have also examined the hypothesis
that net sugar transport in the human erythrocyte is rate limited by reduced cytosolic
diffusion of sugars and/or by reversible sugar association with intracellular
macromolecules.
Our findings support the hypothesis that each subunit of the parental glucose
transporter contains a single intramolecular disulfide bridge between cysteine residues
347 and 421. This disulfide seems to be necessary for GLUTI tetramerization. Our
findings suggest that GLUTI N-terminal residues 1 through 199 provide contact surfaces
for subunit dimerization but are insufficient for subunit tetramerization. Our studies also
show that in situ disulfide disruption by cell impermeant reductants results in the loss of
cooperative subunit interactions and a 3 to 15-fold reduction the intrinsic efficiency of the
transporter. We also find that erythrocyte-resident GLUTI is susceptible to exofacial
proteolysis. Exofacial trypsin cleavage eliminates cooperativity between subunits but does
not affect transporter oligomeric structure or transport activity. Thus catalytic efficiency
does not derive directly from cooperative interactions between substrate binding sites on
adjacent subunits. We have confirmed that 30MG transport in human erythrocytes is a
diffusion limited process. We find that steady-state sugar uptake in red cells and K562
cells measures two processes - sugar translocation and intracellular sugar binding, We
propose a model for native GLUT 1 structure and function.
Chapter 
Materials and Methods
Materials
HJ-Cytochalasin B
, (
HJ- Methyl- Glucose, e CJ- DeoxY- glucose, ( CJ-
Iodoacetic acid and rI lJ-protein A were purchased from New England Nuclear. Rabbit
antisera raised against a synthetic carboxyl-terminal peptide of GLUT 1 (intracellular
residues 480-492; C-Ab) were obtained from East Acres Biologicals. Anti-GLUT 1
antisera reacting exclusively with extracellular epitopes of GLUTI (d-Ab) were prepared
as described previously (Harrison et aI., 1990a). Fluorescein and rhodamine-conjugated
secondary antibodies were purchased from Calbiochem. Recently expired human blood
was obtained from the University of Massachusetts Medical Center Blood Bank. Reagents
were purchased from Sigma Chemicals. Restriction enzymes were purchased from New
England Biolabs. Fetal Bovine Serum was purchased from UBI. Sculptor was purchased
from Amersham Life Science Inc. , and DOTAP from Boehringer Mannheim. Media
trypsin, antibiotics and G418 were purchased from Gibco. CHO- , K562 cells and
pRSVneo are from American Type Tissue Culture, Endoproteinase glu- (V8),
endoproteinase lys-C (V9) and sequence-grade trypsin were obtained from Boehringer-
Mannheim. Staphylococcus aureus toxin (type 616392) was purchased from
Calbiochem.
Solutions
Saline consisted of 150 mM NaCI , 5 mM TrisHCI , 0.2 mM EDTA, pH 7.4. Lysis
medium contained 10 mM TrisHCI , 2 mM EDTA, pH 7.4. Stop solution consisted of 150
mM NaCI , 10 11 cytochalasin B , 100 11 Phloretin and 10 11 HgCl2 at ice temperature.
Tris medium consisted of 50 mM TrisHCI, 0.2 mM EGT A, pH 7.4. Alaline wash
medium contained 2 mM EGTA adjusted to pH 12.0 using NaOH. Cytochalasin stock
solutions were made in dimethylsulfoxide. Phloretin stock solutions were made in ethanol.
Carrier concentrations in cytochalasin and phloretin-containing solutions were never
greater than 0, 1%. Size exclusion-HPLC column buffer and sucrose gradient medium
consisted of 150 mM NaCI , 5 mM MOPS, 20 mM cholic acid :t 10 mM dithiothreitol
1 % SDS , pH 7.
Tissue culture
CHO-Kl cells were maintained in F12 medium supplemented with 10% FBS, 100
U/mL penicilin , and 100 Jlg/mL streptomycin in a 37 C humidified 5% C02 incubator.
K562 cells were maintained in RPMI- 1640 medium supplemented with 10% FBS, 100 U/
mL penicilin , 100 Jlg/mL streptomycin and 20 mM L-glutamine in a 37 C humidified 5%
C02 incubator. K562 cells were induced to synthesize hemoglobin by addition of 100 
hemin (Charnay & Maniatis, 1983).
Muta enesis of GLUTI cDNA
A 1.7 kbp BstYI fragment of the human GLUTI cDNA derived from pLENGT
(Harrison et al.1990a) was subcloned into the BamHI cloning sites of M13mpl9 (M13-
GTl) and pGEM3Z (pGEM3Z-GTl). Oligonucleotide-directed point mutations were
introduced by the modified phosphorothioate method of Eckstein (Nakamaye & Eckstein
1986) using the Sculptor in vitro mutagenesis system. Each of the six cysteines in GLUTI
were mutagenized individually to serine using the following primers:
Amino Acid Primer
C133S CATCGGTGTGTACAGCGGCCTG- 3'
C201 S CTGCTGCAGAGCATCGTGCTGCCC- 3'
C207 S GCCCTTCAGCCCCGAGAG-
C347S ATGGCGGGTAGTGCCATACTCATG-
C421S 5 ' GTGGGCATGAGCTTCCAGTATGTG- 3 ,
C429S GAGCAACTGTCTGGTCCC-
where the underlined nuc1eotides are the codon targeted for mutagenesis. The nucleotide
substitution is shown in boldface. Mutants were selected by sequencing M13 clones across
the following fragments which have unique restriction sites to facilitate subcloning:
Amino Acid Fra ment
C133S 244 bp Hpa II Apa I
C201S, C207S 303 bp Apa IIBst E2
C347S 294 bp Bst E2/Nhe I
C421S, C429S 461 bp Nhe I/BamHI
The fragment was excised from M13-GTl , sub cloned into pGEM3Z-GTI and resequenced
across these restriction sites to verify the ligation region and the introduced mutation.
Finally, wild-type and mutant cDNAs were subcloned into the pCMV5 expression vector
(Anderson et aI., 1989).
Stable Ex ression of Wild T e and Mutant GLUTlcDNAs in CHO-Kl Cells.
Subconfluent CHO-Kl cells were co-transfected with GLUT 1 cDNA and
pRSVneo using the cationic lipid transfection reagent DOTAP (Leventis & Silvius
, 1990).
The transfected cells were grown in F12 media containing 250 Ilg/mL G418. G418-
resistant cells were ring-cloned and expanded (Freshney, 1994). Clones expressing wild-
type or mutant glucose transporters were identified by immunofluorescence and by
Western blot analysis of total cellular membranes prepared as described previously
(Harrison et aI., 1990a) and blotted using C-Ab. CHO-cell plasma membranes and low
density microsomal membranes were isolated by homogenization and sucrose-cushion
centrifugation exactly as described by Harrison et aI.
, 1990b).
Red cells and red cell hosts
Red cell ghosts were prepared from washed, intact red cells as described by Helg-
erson et al. (1989). Human red cells were collected from recently expired
, whole human
blood (University of Massachusetts Medical Center Blood Bank) by suspension in ice-cold
saline (25 volumes of saline: 1 volume whole blood) followed by centrifugation at 1100 x
g for 5 minutes. The supernatant fluid and buffy coat were aspirated and the red cell pellet
resuspended in saline. This wash/centrifugation procedure was repeated until the superna-
tant fluid was clear and the red cell pellet lacked any discernible buffy coat (normally 3 to
4 cycles). The washed red cells were then resuspended in 100 volumes of saline and al-
lowed to rest at room temperature for 1 hr. to deplete intracellular D-glucose, D-glucose-
depleted cells were harvested by centrifugation to a final hematocrit of 80-90%,
Red cell ghosts were depleted of peripheral membrane proteins by a single wash
(Carruthers, 1986a) in 5 volumes of alkaline wash medium (4 oC, 20 min). Membranes were
1.'1
collected by centrifugation (14 000 x g for 5 min at 4 C) and resuspended in 10 volumes of
Tris medium. These membranes were subjected to three additional wash/centrifugation
:)F-
cycles in Tris medium, adjusted to 4 mg membrane protein per mL and stored at -
When ghosts were resealed in media containing high concentrations of glycerol
the same concentration of glycerol was included in washing media to prevent subsequent
hypotonic lysis.
Glucose Trans ort Protein
GLUTI plus endogenous lipid were purified from human erythrocytes as described
by Hebert and Carruthers (1992) or , in the presence of DTT as described by Cairns et al.
(1984). The glucose transporter was purified from outdated human blood (Baldwin et. al.
1982 , Cairns et. al. 1984). All of the following operations were performed at 4 C. Red
blood cells are obtained by washing one unit of blood three times with ice-cold 150 mM
KCI, 0.2 mM EDTA adjusted to pH 7.4 using Tris base. The red cells are pelleted by
centrifugation at 27,000 x g for 20 minutes and the buffy coat (white cells) and serum
removed by aspiration. Erythrocyte membranes (ghosts) are prepared from washed red
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blood cells by the method of Steck & Kant (1974). Red blood cells are lysed in 40 volumes
of ice-cold lysis medium containing 10 mM Tris- HCl, 4 mM EDT A adjusted to pH 8.0 with
Tris base. The membranes are pelleted by centrifugation at 27,000 x g for 20 minutes. The
pellet is resuspended in lysis medium and pelleted again. This process is repeated
approximately seven times to remove all the cytosolic hemoglobin or until the membranes
appear white. Protein concentration of the membranes is determined by the Pierce BCA
assay using bovine serum albumin as the standard. The protein content of the membrane
pellet is adjusted to 4 mg/mL with 50 mM Tris-HCI adjusted to pH 7.4 with Tris base.
Peripheral membrane proteins are stripped from the membranes by alkaline extraction.
Five volumes of 2 mM EDTA, 15.4 mM NaOH, pH 12.0 are added to the 4 mg/mL
membrane fraction and the suspension is incubated for 10 minutes without agitation. The
membranes lacking peripheral proteins (stripped ghosts) are pelleted at 27 000 x g for 20
minutes. The pH of the membrane fraction is restored by washing three times with 50 mM
Tris-HCI pH 7.4 The protein concentration of the membrane fraction is adjusted to 2 mg/
mL with 50 mM Tris-HCI pH 7.4. Integral membrane proteins are released from the
stripped membranes by solubilization in 46 mM octylglucoside while rotating for 30
minutes. The detergent solubilized membrane fraction is ultracentrifuged at 100 000 x g
for 60 minutes in a Beckman Ti 50. 1 rotor and the resulting pellet is discarded. The
supernatant is adjusted to 25 mM NaCl. A sample (60 mL) of supernatant is applied to a
column (2.5 cm x 8.0 cm) of DEAE-cellulose (Whatman DE-52) equilibrated with 34 mM
octylglucoside , 25 mM NaCI , 50 mM Tris- HCI adjusted to pH 7.4 with Tris base. The flow
rate was adjusted such that the supernatant is in contact with the column for 45 minutes.
The immediate flow through is collected and subsequently up to one and a half volumes
(90 mL) of the added supernatant volume. The transporter is largely hydrophobic and
contains very few charged residues at pH 7.4, thus is not retarded by the anion exchange
column. Other integral membrane proteins liberated from the membrane by octylglucoside
solubilization (anion transporter) are more extensively charged and therefore bind to the
column. The flow-through material containing GLUTI and red cell lipid is dialyzed two
times against 6 liters of 50 mM Tris-HCI, 2 mM EDT A, pH 7.4 to remove more than 99% Ih.
of the detergent. This results in a glucose transporter preparation in which the protein is
inserted into its native lipid bilayer. The preparation is characterized by SDS-PAGE
(Lamell , 1970) and protein assay. Routinely 20 mg of 95% purified glucose transporter
as assayed by SDS-PAGE, is obtained from one unit of blood, The main contaminants
observed are the nucleoside transporter (0:2%) and band 7 (0:4%, see Fig. 4), an Rh antigen
thought to be involved in erythrocyte membrane integrity (Cherif-Zahar et. al. 1990).
GLUT 1 +DTT is prepared by adding 10 mM DTT during the alkaline treatment of ghosts
and to all other steps that follow.
ELISA
ELISA and competition ELISA were performed using C- and/or Ab by a modifi-
cation of the method of Sogin and Hinke as described by Hebert and Carruthers (1992).
ELISA were performed using C-Ab or dAb. Rabbit and sheep Ab has been characterized
and found to react with an epitope presented on the exofacial portion of the protein (Harri-
son et. al. 1990) whereas C-Ab reacts with the COOH terminus of the protein located on
the cytosolic portion of the transporter. The protein is adsorbed to a 96 well microtiter
plate in 60 mM NaC03, pH 9.6 for 1-16 hours at 37 C. The wells are each washed three
times with phosphate buffer (20 mM sodium phosphate, 145 mM NaCI, 0,05% Tween-
pH 7.5) and then incubated with a 2 500-fold dilution of the respective antisera in phos-
phate buffer for 90 minutes at 37 C. The reporter molecule employed to detect rabbit IgG
binding to carrier was goat anti-rabbit IgG-peroxidase conjugate (Sigma, 1O,000-fold dilu-
tion). Bio-Rad peroxidase substrate kits were employed. Substrate development was ar-
rested after the necessary time using 1 % oxalic acid and product determined by detecting
absorbance at 410 nm using a Dynatech MR-700 plate reader. Nonspecific IgG binding
was determined by processing wells lacking glucose transport protein.
In some cases, a modified ELISA was also employed omitting the detergent
(Tween-20) to avoid potential denaturation of carrier. Bovine serum albumin (1 % BSA)
was used in place of Tween-20 to reduce nonspecific adsorption of IgGs to wells. In ad-
dition , after absorption of the transporter to the micro titer plate 200 mL of 1 % BSA in car-
bonate buffer is applied to the wells and incubated for 1 hour at 37 C. The plate is then
processed as described above,
Nondenaturin chromato of GLUTI
Size exclusion chromatography-HPLC studies of GLUT I-containing, cholate-sol-
ubilized membranes were performed using a Toso Haas TSK-Gel G4000 SWXL column
as described previously (Hebert & Carruthers, 1992). Briefly, the column was pre-equil-
brated with 150 mM NaCI , 5 mM Mops, pH 7,2 containing 20 mM cholic acid:tlO mM
DTT using a Waters HPLC system and developed at a flow rate of 0.3 mLlmin.
The column was calibrated using Pharmacia low and high molecular weight protein
gel filtration calibration kits. The calibration is: 10g(Stokes Radius in nm) = 1.551 -
1.801 *Kav (R2 = 0.9714).
Samples were solubilized in elution buffer containing 50 mM cholic acid :t1O mM
DTT for 1 hr at room temperature. The 200 000 x g (1 hr) supernatant containing cholate-
solubilized proteins was added to the column and fractions were collected at 1 minute in-
tervals, Fractions were assayed by ELISA.
tochalasin B bindin studies
Equilibrium , D-glucose (400 mM)-inhibitable ( HJ-Cytochalasin B binding to
purified GLUTI was determined as described previously (Hebert & Carruthers, 1992).
Equilibrium cytochalasin B binding to red cells and red cell ghosts was measured as
described in (Helgerson & Carruthers, 1987), Cytochalasin D (10 IJ) was included in
equilbrium cytochalasin B binding experiments to inhibit saturable cytochalasin B binding
to non glucose transporter sites (Jung & Rampal, 1977). DTT-containing cytochalasin B
solutions were made freshly for each experiment since it was observed that prolonged
exposure (;: 24 hr) of cytochalasin B to DTT at - C resulted in the irreversible loss of
cytochalasin B binding to both nonreduced and reduced GLUT1.
Determination of GLUT 1 free sulfh l and disulfide content
Reduced and nonreduced , purified GLUTI (each at approximately 100 g/mL in 1
mL and exhaustively dialyzed to remove traces of DTT) were denatured in 0.5% SDS in 50
mM TrisHCI , 3 mM EDTA, pH 8.0 for 30 min. The solubilzed protein was collected as
supernatant by centrifugation (100 000 x g for 1 hr at 4 C and quantitated. The free
sulfhydryl contents of reduced and nonreduced GLUTI were determined by using Ellman
reagent (Rao & Scarborough, 1990). The reaction was initiated by addition of 100 
freshly prepared 10 mM 5 5' - dithiobis(2-nitrobenzoic acid) (DTN). The course of the
reaction at room temperature was recorded as the increase in absorbance at 412 nm.
GLUTI disulfide content was measured by the 2-nitro- thiosulfobenzoate (NTSB) assay
in which disulfides are cleaved by sulfitolysis and the resulting free sulfhydryls quantitated
(Rao & Scarborough, 1990). An extinction coefficient of 13,600 M- l cm l at 412 nm for 2-
nitro- thiobenzoic acid (NTB) was used to quantitate both reactions. All NTSB assays
included the parallel , internal controls of porcine insulin (3 disulfides per molecule) and
oxidized glutathione (1 disulfide per molecule).
The NTSB assay allows us to determine if the inaccessible cysteines in nonreduced
SDS denatured GLUTI are present as mixed disulfides (e.g. GLUTl-glutathione disulfide)
or as internal disulfides. After the disulfide bonds are cleaved by sulfitolysis , the type of
disulfide is identified by the following reactions:
Internal Cysteine Disulfide
R + S032- +- R- S03- + RS-
RS- + NTSB -+ RSS03 - + NTB
1 mol NTB:2 mol SH
Mixed Disulfide
G + S032- ++ R- S03- + GS-
GS- + NTSB -+ GSS03 - + NTB
1 mol NTB:l mol internal S
Thus for each internal disulfide bond and for each free sulfhydryl , one molecule of NTB is
generated.
GLUTI alk lation/ roteol sis
The procedure of Rao and Scarborough (1990) was used to label either all cysteine
residues or free cysteine residues of GLUTI purified in the absence of DTT. Briefly,
GLUTI (1 mg/mL) was unfolded in SDS, reduced (or not reduced) and alkylated using 0.
mM e CJ-iodoacetic acid (incubation was in 0.2 M Tris-HCI, 2 mM EDT A, 1 % SDS, pH
3 for 25 min at room temperature in the dark). Alylation was terminated by addition of
2-mercaptoethanol (0.5%; 64 mM) and free label was removed by extensive dialysis.
Labelled GLUTI was electrophoresed on a preparative urea-acrylamide gel in the dark.
This gel consisted of9M urea , 11 % acrylamide, 375 mM Tris-HCI , pH 8. 8, and 0.2% SDS.
Samples were solubilzed in an equal volume of sample buffer and electrophoresed at 3W
constant power. Gels were rinsed for 20 min in deionized water to remove urea then
vacuum dried. Dried gels were exposed overnight to X-ray film to locate the radiolabelled
GLUT 1.
' - , - - - .._
Peptide mapping of labelled GLUTI peptides was performed either as described
previously (Carruthers and Helgerson, 1989) or with the following modifications. Pieces of
dried gel (5 x 8 mm) were excised from the preparative gel and inserted into wells of a
stacking gel containing sample buffer and 8 g V8 protease. The dried gel piece was
allowed to soak up the buffer and running buffer was then used to cover the well. Samples
were electrophoresed into the stackig gel and the power was interrupted for one hour to
allow proteolytic digestion of GLUT 1. Power was resumed and the peptides were allowed
to separate in the 18% gel. Electrophoresis was performed in the dark. Peptides were then
transferred to Immobilon-P membrane fiters for immunoblot analysis or for staining with
Coomassie Briliant Blue R and subsequent sequence analysis. When peptides were
isolated in this manner for N-terminal sequence analysis, acrylamide gels were pre-run and
were electrophoresed in the presence of ImM thioglycolate. Parallel lanes were also run for
visualization of alkylated peptides by autoradiography.
Immunofluorescence microsco of cells
For red blood cells, circular coverslips were washed in 70% ethanol, 1 % HCI for 1
, oven-dried, immersed in a 10% solution of polylysine for 5 minutes then air-dried
overnight. Washed erythrocytes (10 , 50% hematocrit) were pipetted onto polylysine-
coated coverslips positioned above 5 mL saline in 50 mL Falcon tubes. These tubes were
then centrifuged at 1100 x g for 5 min and unattached cells were removed by addition and
subsequent aspiration of saline (20 mL). Two additional saline washes were made then the
erythrocyte-coated coverslips were transferred to 6 well tissue culture dishes for
immunohistochemical processing.
Antibody binding to cells was measured in cells that were either unfixed or fixed
and permeabilized. Fixation was for 15 min in saline containing 4% paraformaldehyde
followed by 2 washes in saline containing 1 % fetal bovine serum. Fixed cells were
permeabilzed by 15 min incubation at room temperature in saline containing 0.05% Triton
100 and 1 % FBS followed by 4 washes in saline containing 1% FBS. Fixed and unfixed
cells were then incubated for 60 min in saline containing 1% FBS plus C-Ab (1:5000
dilution of crude serum) and/or plus Ab 
(1:5000 dilution of crude serum). Cells were
washed 3 times in FBS saline then incubated for 30 min with rhodamine-conjugated goat
anti-rabbit (anti-CAb) IgGs (4 I-g/mL) or with fluorescein-conjugated rabbit anti-sheep iJ'f1
(anti- Ab) IgGs (4 I-g/mL). In experiments where both C- Ab and Ab binding were
measured simultaneously, cells were subsequently exposed to rhodamine-conjugated goat
anti-rabbit (anti-CAb) IgGs followed by washing and exposure to fluorescein-conjugated
rabbit anti-sheep (anti- Ab) IgGs. Cells were then washed 3 times in saline , the coverslips
mounted on a slide with 2.5% DABCO (Sigma Chemicals), 90% glycerol and the slides
sealed with clear nail polish.
Erythrocyte anion transporters were labelled exofacially using fluorescein
isothiocyanate as described by (Matayoshi & Jovin , 1991 , Sato et aI. , 1985). These cells
were then attached to polylysine coated coverslips for subsequent fluorescence
microscopy. In some experiments, red cells were not attached to coverslips but were
processed in dilute solution and mounted later for immunofluorescence microscopy.
CHO cell lines were plated directly onto sterile coverslips in 6-well plates 48 hours
prior to processing. Cells were washed three times with PBS and fixed for 15 min at room
temperature with 2% paraformaldehyde in PBS with or without preincubation in 5mM
DTT for 15 min at room temperature. Concentrations of paraformaldehyde above 2%
permeabilized the cells. Subsequent washes were done with PBS plus 1% FBS. Mter
fixing, cells were solubilzed with 0.05% Triton X- 100 for 15 min at room temperature.
Fixed, solubilized cells were then incubated for 1 hour at room temperature with PBS
containing 1% FBS , rabbit C-Ab (1:5000 dilution of crude serum), and/or sheep d-
(1:5000 dilution of crude serum). The cells were washed and incubated for 30 min at room
temperature in PBS containing 1% FBS, goat anti-rabbit IgG-Rhodamine (4 /lg/mL
dilution) and then for 30 min at room temperature in PBS containing 1 % FBS, rabbit anti-
sheep IgG-FITC (4 /lg/mL). The coverslips were washed extensively, mounted in 90%
glycerol , 2,5% DABCO and sealed with clear nail polish.
Samples were visualized by fluorescence microscopy using a Nikon Diaphot 200
microscope with a Nikon Apo 60/1.4 oil immersion lens. Images were digitized with 14-bit
resolution using a thermoelectric ally cooled CCD camera (Photometrics Ltd. , Tuscon , AZ)
and stored on magnetic media for subsequent analysis.
Reconstitution of GLUT1.
GLUTI was purified from human erythrocyte membranes in the absence of reduc-
tant (Hebert & Carruthers, 1992) and was reconstituted into egg phosphatidylcholine large
unilammelar vesicles (diameter z 2 as judged by phase contrast microscopy) by cholate
dialysis (Hebert & Carruthers, 1991 , Zeidel et aI., 1992). Equilibrium ligand (sugar or cy-
tochalasin B) binding to reconstituted GLUTI proteoliposomes was measured by monitor-
ing ligand-induced quenching of GLUTI intrinsic tryptophan fluorescence (Hebert &
Carruthers, 1992), GLUTI-mediated D-glucose uptake by reconstituted proteoliposomes
was measured by light scattering analysis of sugar transport-induced changes in proteoli-
posomal volume (Carruthers & Melchior, 1983, Carruthers & Melchior, 1984a, Carruthers
& Melchior, 1984b). The orientation of GLUTI in reconstituted, sealed proteoliposomes 101.,
was determined by use of antibodies that react with endofacial (C-Ab) or exofacial (d-Ab)
epitopes of erythrocyte GLUTI as described previously (Zeidel et aI. , 1992), Our results
(63% right side out: 37% inside out) are consistent with previous demonstrations of random
GLUTI orientation upon reconstitution (Baldwin et aI., 1980, Carruthers & Melchior
1984a, Zeidel et aI., 1992),
Proteol sis of GLUT1.
Packed red cells (0.5 mL) were suspended in saline to a final volume of 1.5 mL.
Samples were warmed to 37 C for 10 min. and to this mixture , either saline or trypsin (final
concentration 1 mg/mL) was added. Cell slurries were mixed by end over end rotation
and incubated at 37 C for 30 min. Reactions were terminated by addition of 12 mL saline
containing 0.2 mM PMSF. Cells were collected by centrifugation, resuspended in PMSF-
saline then stored on ice until use.
Immunoblot anal sis of GLUT 1.
Membranes were collected by centrifugation and resuspended in 50 mM Tris-HCI
pH 7.4, Proteins were resolved on either 10% or 15% gels as described previously (Laem-
mli , 1970), transferred to Immobilon P membrane filters, and subjected to Western analysis
using C-Ab and ( 125!J-protein A as reporter molecules. Filters were dried and exposed to
Kodak XAR-5 film at - C for 2 to 48 hours using a DuPont Cronex Lightning Plus in-
tensifying screen. Resulting autoradiograms were quantitated by densitometry using a Hoe-
fer GS300 Transmittance/Reflectance Scanning Densitometer in combination with the GS-
370 Data System (Apple Macintosh Version). Peaks were integrated and expressed as a
percentage of total transmittance.
Photolabelln GLUTI using r.3H tochalasin B.
Red cells were preincubated in saline containing (3HJ-cytochalasin B (3,71J, 50
Ci) plus 10 IJ cytochalasin D :t D- or L-glucose (200 mM) for 20 minutes on ice. The
suspension was irradiated at 300 nm for 0.5 min. in a Rayonett Photoreactor. Cells were
collected by centrifugation and washed by resuspension in 10 volumes of saline. The cen-
trifugation/wash cycle was repeated twice.
tochalasin B bindin to er throc te membranes.
Equilbrium (3HJ-Cytochalasin B binding measurements were as described by Hel-
gerson and Carruthers (1987), The cytocrit of the final suspension of ghosts in (3HJ-cy-
tochalasin B solution was 33%. Initial studies of maltose-inhibition of cytochalasin B
binding to intact cells used Sigma plant-biology grade sucrose as the osmotic substitute or
control for extracellular maltose. This source, however, was discovered to be significantly
contaminated with D-glucose - a GLUTI substrate that acts as a competitive inhibitor of
exofacial maltose binding to GLUTI and, following its transport into the cell, as a compet-
itive inhibitor of cytochalasin B binding to GLUT1. Subsequent experiments used Sigma
Sucrose ACS grade. In experiments where cytochalasin B binding was measured in the
presence of DTT, solutions were made daily.
uantitation of antibod bindin to trypsinized red cell GLUT1.
Two methods were used: immunofluorescence microscopy and direct binding mea-
surements using 1251-Protein A as the reporter molecule (Harrison et aI. , 1990, Diamond
& Carruthers, 1993), Ab IgGs were also affinity purified using 500 
g purified GLUTI
that was additionally gel-purified by reducing, SDS PAGE and subsequently transferred to
immobilon. That region of the blot containing intact GLUTI (Mr(app) 45 - 68 kDa) was
excised, blocked using 3% gelatin then incubated with 
Ab for 2 hr at room temperature
as per Western blotting protocols (Harrison et aI. , 1990, Diamond & Carruthers , 1993). The
membrane was washed, and IgGs eluted using 100 mM glycine (pH 2.5, 10 min incuba-
tion). The buffer was removed, neutralized using one-tenth volume 1 M Tris (pH 8,0) and
dialyzed overnight against 100 volumes of saline. This was used for subsequent binding
studies using 1251-protein A or ELISA. Our measurements show that 87:t 4% ((208,721:t
9276) cpm versus (240,778 :t 1655) cpm) of the red cell binding activity in 5 Il of 
serum is recovered following Ab purification using denatured, reduced , intact GLUT 1 as
the affinity matrix. ELISA indicates superimposable 
Ab and d-Ab-IgG titration curves
when the concentration of recovered material is adjusted for dilution during purification,
For immunofluorescence microscopy, cells were first attached to polylysine-coated
coverslips. Circular coverslips were washed in 70% ethanol, 1 % HCI for 1 hr , oven-dried
immersed in a 10% solution of polylysine for 5 minutes then air-dried overnight. Washed
erythrocytes were exposed to saline:t trypsin (0.5 mg/mL) for 30 min at 37 C then washed
free of trypsin. These cells (10 , 50% Ht) were pipetted onto polylysine-coated cover-
slips positioned above 5 mL saline in 50 mL Falcon tubes. These tubes were then centri-
fuged at 1100 x g for 5 min and unattached cells were removed by addition and subsequent
aspiration of saline (20 mL). Two additional saline washes were made then the erythrocyte-
coated coverslips were transferred to six well tissue culture dishes for immunohistochemi-
cal processing,
Cover slips with attached control and trypsin-treated cells were exposed to saline :t
2 mM dithiothreitol (pH 7.4) for 30 min at 37 C. At this time, cells were fixed by addition
of 4% paraformaldehyde (15 min) then washed twice in saline. Fixed cells were permeabi-
lized by 15 min incubation in saline containing 0.05% Triton X- 100 and 1 % fetal bovine
serum (FBS) followed by 4 washes in saline containing 1 % FBS. Cells were incubated for
60 min in saline containing 1 % FBS and either C-Ab (1:5000 dilution of crude serum) or
Ab (1:5000 dilution of crude serum), washed 3 times in FBS saline then incubated for 30
min with fluorescein-conjugated goat-anti rabbit IgGs (4/lg/mL). Coverslips were washed
3 times in saline, mounted on a slide with 2.5% DABCO (Sigma Chemicals), 90% glycerol
and the slides sealed with clear nail polish.
Samples were visualized by fluorescence microscopy using a Nikon Diaphot 200
microscope with a Nikon Apo 60/1.4 oil immersion lens. Images were digitized with 24 bit
resolution using a thermoelectric ally cooled CCD camera (Photometrics Ltd., Tuscon , AZ)
and stored on magnetic media for subsequent analysis.
0-meth lucose u take b throc tes.
Zero-trans 3- Methyl- Glucose uptake and efflux was measured as described
previously (Helgerson et aI., 1989). Briefly, sugar-free red cells (at ice temperature) were
exposed to 5 volumes of saline (ice temperature) containing variable (30MGJ and fixed
((3HJ-30MGJ. Uptake was permitted to proceed for selected time points then 50 volumes
(relative to cell volume) of stopper solution were added to the cell suspension. Cells were
sedimented by centrifugation (14 000 x g for 15 sec at 4 C, washed twice in stopper
collected by centrifugation (14 000 x g for 15 sec at 4 C and extracted in 1 mL 3%
perchloric acid. The acid extract was centrifuged (14 000 x g for 15 sec at 4 C and duplicate
samples of the clear supernatant fluid were counted. Zero-time uptake points were prepared
by addition of stopper to cells prior to addition of medium containing sugar and radiolabeI.
Cells were immediately processed. Radioactivity associated with cells at zero-time was
subtracted from the activity associated with cells following the uptake period. All uptakes
were normalized to equilibrium uptake where cells were exposed to sugar medium at 37
for 30 min. prior to addition of stopper. This procedure limits the experimental 30MG
space of the cells to 10% or lower. CHO ce1l2-deoxy- glucose uptake was measured at
, in 24-well dishes using 100 IJ 2-deoxy- glucose as described previously
(Harrison et aI., 1990a). Protein-mediated sugar uptake is defined as total sugar uptake less
uptake measured in the presence of saturating levels (50 IJ) of cytochalasin B , a
noncompetitive inhibitor of uptake.
0-methyl- glucose exit from erythrocytes was measured as described by
Helgerson and Carruthers (1989). Briefly, cells (500 of 30% Ht) are loaded with 0. 1 mM
0-methyl- glucose for 30 minutes at 37 C. Then ( HJ-30MG (10 IlCi/mL) is added to
the suspension. Cells are incubated for an additional 20 minutes then sedimented by
centrifugation. The cells are washed three times in 100 volumes of ice-cold saline. Then
sugar exit is initiated by injecting the cells (10 ) into 500 saline. At various times (0,
10, 30, 60 and 120 seconds), 1 mL of ice-cold stopper solution is added and the cells are
processed as for uptake determination. Equilbrium exit is determined by allowing exit to
proceed for 40 minutes at 37
Time course of net 3-0-meth lucose u take b throc tes and K562 cells
0-methyl- glucose uptake was measured as described previously (Carruthers
et aI., 1989). K562 cells are not adherent and may thus be manipulated like erythrocytes.
Sugar-free cells (at ice temperature) were exposed to 5 volumes of saline (ice temperature)
containing 50 IJ 30MG plus eHJ-30MG. Uptake was permitted to proceed over
intervals as short as 5 sec to intervals as long as 3 hr then 50 volumes (relative to cell
volume) of stopper solution were added to the cell suspension. Cells were sedimented by
centrifugation , washed once in stopper, collected by centrifugation and extracted in 1 mL
3% perchloric acid. The acid extract was centrifuged and duplicate samples of the clear
supernatant fluid were counted. Zero-time uptake points were prepared by addition of
stopper to cells prior to addition of medium containing sugar and radiolabel. Cells were
immediately processed. Radioactivity associated with cells at zero-time was subtracted
from the activity associated with cells following the uptake period. All uptakes were
normalized to equilbrium uptake where cells were exposed to sugar medium at 37 C for
30 min. prior to addition of stopper. Uptake assays were performed using solutions and
tubes pre-equilbrated to 4 C and were carried out in a thermostatically cooled block.
In experiments where red cells were permeabilized using a-toxin , it is impossible
to wash cells following sugar uptake without rapid loss of intracellular sugar. Here, sugar
uptake was measured as the disappearance of sugar from the incubation medium. Cells
(permeabilzed or non permeabilized) were resuspended at zero-time to a final hematocrit
of 50% in saline containing 50 IJ ( HJ-30MG. Cells were sedimented at specific
intervals by rapid centrifugation and samples (10 ) of the supernatant counted. Parallel
experiments were also made using ( CJ- glucose (a nontransported sugar).
uilibrium exchan e 3-0-meth lucose u take b throc tes
In these experiments, intracellular (30MGJ = extracellular (30MGJ and the rate of
cellular equilibration with extracellular tracer radiolabelled 30MG is monitored. The
uptake assay is otherwise identical to net sugar uptake measurements. Cells were pre-
equilbrated with varying (30MGJ (0 to 100 mM) by incubation in 10 volumes of
equilbration medium for 1 hr at 37 C. Cells were collected by centrifugation
resuspended in 1 volume ice-cold equilibration medium and, following equilibration to
C, uptake was initiated' by addition of labelled 30MG. Stopper contained sucrose at a
concentration identical to intracellular (30MGJ,
Calculation of net u take rate constants
All constants were computed by direct curve-fitting procedures using nonlinear
regression of untransformed data. The software package used was KaleidaGraph 3.
(Synergy Software, Reading PA). For radiolabelled sugar uptake , all data were fitted to the
equation:
cpm cpm cpmi 1 - ki) cpmi 1 - (eqn 1)
where cpmt and cpmo are the counts associated with the cells at times t and zero-time
respectively, cpm 1 and cpm2 are equilbrium counts associated with cell compartments 
and 2 respectively and kl and k2 are first order rate constants describing the rate of
equilibration of compartments 1 and 2 respectively. Where only a single cellular
compartment for sugar penetration was presented, this analysis provides unique solutions
for cpml and cpm2 but computes statistically indistinguishable solutions to kl and k2' In
experiments where multiple cellular compartments are apparent, increasing the number of
cellular compartments to 3 or greater does not statistically improve the quality of the
computed fit.
For sugar exit experiments, all data were fitted to the equation:
k t -k t
cpm cpm cpml e 1 cpm2e 2 (eqn 2)
where cpmt and cpme are the counts associated with the cells at times t and equilibrium
respectively, cpm 1 and cpm2 are equilibrium counts associated with cell compartments 
and 2 respectively and k 1 and k2 are first order rate constants describing the rate of loss of
sugar from compartments 1 and 2 respectively. In the exit experiments reported here, only
a single cellular compartment is apparent since the rate constants kl and k2 are
indistinguishable.
Calculation of trans ort and li and bindin
g p
arameters
V max and Km(app) for 30MG uptake were computed by direct, nonlinear regres-
sion analysis of the concentration dependence of 30MG uptake assuming Michaelis-Ment-
en kinetics. Kd(app) and Bmax for ligand (cytochalasin Band D-glucose) binding to
GLUTI were computed in a similar manner. Here, however, we modeled the data assuming
two saturable components of ligand binding. When the computed Kd(app) for binding to
the first saturable component was statistically indistinguishable from Kd(app) for binding
to the second saturable component, we concluded that binding was described by a single
saturable process. Otherwise, we concluded the assumption of multicomponent saturable
binding is correct. In these instances , addition of a third or fourth saturable component to
the analysis did not statistically improve the computed fit. The software package used was
KaleidaGraph 3.0 (Synergy Software, Reading P A).
Anal tical Procedures
Protein was determined by the Pierce BCA procedure (Brown et aI., 1989). SDS-
slab (10 or 18%) PAGE of membrane proteins and GLUTI were as described previously
(Carruthers & Helgerson , 1989). Immuno- (Western) blotting of proteins using d- or C-
was as described in (Harrison et aI. , 1990a). Immune serum (d-Ab) specific (1251J-protein
A binding to erythrocyte membranes was determined as described previously (Harrison et
aI., 1990a). Amino acid and N-terminal sequence analysis of immobilon membrane-bound
peptides was performed by Dr. John Leszyk , Director of the Core Laboratory for Protein
Chemistry at the Worcester Foundation for Experimental Biology, Shrewsbury, MA.
Densitometric analysis of autoradiograms was carried out using either a Hoefer GS300
Transmittance/Reflectance Scanning Densitometer in combination with the GS-370 Data
System (Apple Macintosh Version) or by using the software package NI Image (v 1.5,
National Institutes of Health) to analyze autoradiograms digitized at 8-bit resolution.
Chapter III
Molecular Determinants of GLUTl Structure
Why is the native, noncovalent, homotetrameric GLUTl complex sensitive to reductants?
The molecular interactions that stabilize tetrameric GLUTI are only partly
understood. Exposure to reductant causes tetrameric GLUTI to dissociate into GLUTI
dimers but subunits of tetrameric GLUT 1 are not attached via disulfide bridges (Hebert and
Carruthers , 1992), Each subunit of SDS-denatured tetrameric GLUTI exposes only 2 thiols
(Hebert & Carruthers, 1992) while reduced denatured GLUTI exposes all 6 sulfhydryl
groups (Baldwin et aI. , 1982 , Hebert & Carruthers, 1992). This suggests that glucose
transporter oligomeric structure and cooperative catalytic function result from noncovalent
interactions promoted or stabilized by intramolecular disulfide bridges.
We have used both biochemical and molecular biological approaches to test this
hypothesis. We have confirmed the results reported by Hebert and Carruthers (1992) with
Ellman s reagent. We further show that assays of subunit disulfide bridge content suggest
that two inaccessible sulfydryl groups form an internal disulfide bridge. Differential
alkylation/peptide mapping/N-terminal sequence analyses show that a GLUTI carboxyl-
terminal peptide (residues 232 to 492) contains 3 inaccessible sulfhydryl groups and that
an N-terminal GLUTI peptide (residues 147 to 261/299) contains 2 accessible thiols, The
carboxyl-terminal peptide most likely contains the intramolecular disulfide bridge since
neither its yield nor electrophoretic mobility are altered by addition of reductant. Each
GLUTI cysteine was changed to serine by oligonucleotide-directed, in vitro mutagenesis.
The resulting transport proteins were expressed in CHO cells and screened 
immunofluorescence microscopy for their abilty to expose tetrameric-GLUTI specific
epitopes. Serine substitution at cysteine residues 133 , 201 , 207 and 429 does not inhibit
exposure of tetrameric-GLUTI specific epitopes. Serine substitution at cysteines 347 or
421 prevents exposure of tetrameric-GLUTI specific epitopes. Hydrodynamic analysis of
GLUTlIGLUT4 chimeras expressed in and subsequently solubilzed from CHO cells
indicates that GLUT 1 residues 1 to 199 promote chimera dimerization and permit GLUTlI
chimera hetero-tetramerization. This GLUTI N-terminal domain is insufficient for chimera
tetramerization which additionally requires GLUTI residues 200 to 463.
We conclude from these studies that each subunit of the glucose transporter
contains an extracellular disulfide bridge (cys347 and cys421) that stabilizes transporter
oligomeric structure. The N-terminal half of the transporter (residues 1 to 199) contains
motif(s) which promote transporter dimerization.
Results
GLUTI sulfh l chemistr
The purified GLUTI preparation contains red cell lipid (Hebert and Carruthers,
1991), GLUTI (MrCapp) = 55K; Fig. 4 lanes 2 and 3) and red cell Band 7 or RhD protein
rCapp) = 33K, peptide of Fig. 4 , lanes 2 and 3). Amino acid composition analyses of
these proteins following electrophoretic transfer to immobilon membranes indicates that
the molar ratio of GLUT 1 : Band 7 present in the GLUTI preparation is 1: 0.04. This is
consistent with our frequent but qualitative observation that GLUT 1 is stained very poorly
by Coomassie,
SDS-unfolded , nonreduced, purified GLUTI exposes 2 thiol groups per GLUTI
monomer (Table I) and is resolved as a monomer during nonreducing SDS PAGE (Fig. 4
lanes 2 and 3). Reduced GLUTI exposes 6 sulfhydryl groups per GLUTI monomer (Table
I). Because the deduced cysteine-content of GLUTI is 6 residues per polypeptide
(Mueckler et aI., 1985), this raises the possibility each GLUTI molecule contains as many
as two intramolecular disulfide bridges. We assayed nonreduced GLUTI disulfide content
by using the 2-nitro- thiosulfobenzoate (NTSB) assay in which disulfides are cleaved by
sulfitolysis and the resulting free sulfhydryls are quantitated by measuring the release of
nitro- thiobenzoate (Rao & Scarborough , 1990). Sulfitolysis of SDS-unfolded tetrameric
GLUTI disulfides reveals an additional 3 moles of reactive sulfhydryl groups per mole of
GLUTI (Table I).
Table I summarizes the results of three types of alkylation strategies in which free
sulfhydryls, inaccessible sulfhydryls and all sulfhydryl groups are labelled using ( CJ-
iodoacetic acid. Inaccessible sulfhydryl groups are revealed by first alkylating nonreduced
GLUTI with unlabeled (( 12CJ-) iodoacetic acid then GLUTI is reduced and alkylated
using ( CJ-iodoacetic acid. Reduced GLUTI incorporates almost three times more e CJ-
iodoacetic acid than does non-reduced GLUT1. Differential alkylation of unavailable sulf-
/; .
,'i! "
Figure 4. Analysis of tryptic fragments of differentially alkylated GLUTI.
Molecular weight markers are shown in Lane 1, These are (in order of decreasing molecular
weight): 106.5, 80 49. , 32.5, 27.5 and 18.5 kDa. Coomassie-stained protein is shown in
lanes 2 and 3. Peptides with intact C-termini (C-Ab-reactive peptides) are shown in lanes
1'-
4 and 5. e CJ-iodoacetic acid-labelled peptides are shown in lanes 6 through 9. Lanes 8
and 9 are sections of single lane gels used to purify peptides for N-terminal sequence
analysis. In lanes 2 - 5, nonreduced, tetrameric GLUT 1 was subjected to reducing (DTT+)
or nonreducing (DTT-) SDSPAGE. In lanes 6, 7 , 8 & 9, nonreduced GLUTI was either
reduced (DTT+) or nonreduced (DTT-) prior to alkylation and reducing SDS PAGE.
Peptide is Band 7 or RhD (see Results). The identity of peptide is shown in Table I.
Figure 4
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hydryl groups in nonreduced GLUTI results in almost 2-fold greater ( CJ-iodoacetic acid
labellng relative to ( CJ-iodoacetic acid labellng of available sites. Since these data and
quantitati of GLUTI sulfhydryls using Ellman s reagent show that GLUTI exposes all
six potential thiols following exposure to reductant, the results of the NTSB assay are
consistent with the view that each GLUTI molecule contains one intra-molecular disulfide
bridge and either two mixed disulfides or two free thiols that are exposed only upon
reduction of the internal disulfide bridge.
One GLUTI cysteine residue occurs within a proposed cytosolic GLUTI domain
four lie in proposed transmembrane domains and the remaining residue is predicted to
contact the interstitium (Mueckler et aI., 1985), To determine which GLUTI cysteines are
inaccessible in tetrameric GLUTl , we subjected alkylated GLUTI to proteolysis and N-
terminal sequence analysis. Reduced and nonreduced GLUTI were alkylated, mildly
trypsinized and the resulting peptides separated by SDS- 
PAGE under reducing or non-
reducing conditions. Total peptides were detected by staining, alkylated peptides were
detected by autoradiography and peptides containing an intact C- terminus were detected by
immunoblot analysis using anti-GLUT 1 carboxyl-terminal peptide antiserum (C-Ab).
Peptides detected by all three criteria were subjected to N-terminal sequence analysis.
Figure 4 (lanes 6, 7) shows that reduced intact GLUT 1 is alkylated 4-fold more heavily than
is nonreduced intact GLUT 1. Lanes 6 , 7, 8 and 9 of the same figure also show that a peptide
of appMr 25 kDa (peptide b) is heavily labelled by iodoacetic acid when the transporter is
reduced prior to alkylation and proteolysis. This peptide cross-reacts with C-Ab and neither
its mobility nor yield are affected significantly by omission of reductant during
Table I: Sulfhydryl Chemistry of GLUT 1 
Mol ( CJ- NTSB
iodoacetic Mol-
acid
assay.
incorporated SH per
Mol
mol NTB
per mol
GLUT 1 per mol
protein or GLUTI
peptide
TETRAMERIC GLUTI nonreduced 1.8 :t 0, 2:t 8:t
reduced 6.4:t 0. 7:t
0.4
CJ-
alky lated 8 :t 0.
then
reduced
( 12CJ- 1 :t 0.
alkylated
Peptide N-terminal sequence &
deduced residues
b GTADVTHDLQEMKEE (233-492) nonreduced 0.2
b GTADVTHDLQEMKEE (233-492) reduced
c VSPTALRGALGT (147-298) nonreduced 1.7
d SRQMMREKKV (248-358) nonreduced c( 0.
d KAGVQQPVYA (300-425) nonreduced c( 0,
d VGPGPIPWFI (381-492) nonreduced c( 0.
d LFSQGPRPAA (394-492) nonreduced c( 0,
DIMERIC GLUTI reduced 2 :t
Table I Notes:
GLUTI free sulfhydryl content was assayed using Ellman s reagent.
GLUTI disulfides were cleaved sulfitolysis and the exposed thiol groups quantitated
using NTSB.
( 12CJ-alkylated protein was treated with cold (unlabeled) iodoacetic acid prior to treatment
with ( CJ-iodoacetic acid. Alylation results summarize 4 separate experiments.
Peptides identified as c and d are those indicated in Figure 4. Assays of GLUTI
sulfhydryl content and disulfide bond content were made in duplicate on at least 3 separate
occaSIOns.
I' I
electrophoresis.
Quantitation of label incorporation indicates that the 25 kDa peptide incorporates
99 and 8 pmol iodoacetic acid per g peptide when labelled after or before reduction
respectively, By contrast, GLUTI incorporates 117 and 33 pmol iodoacetic acid per 
GLUTI when labelled after or before reduction respectively. N-terminal sequence analysis
by Edman degradation indicates that the N-terminus of the 25 kDa peptide is:
233GTADVTHDLQEMKEE247
Since this peptide also contains an intact C-terminus, this allows a peptide
assignment of GLUTI residues 233-(480-492). The last 13 residues are less certain since
1M!
the polyclonal , GLUTI C-terminal peptide antiserum is raised against GLUTI residues
:f:!I,
, 1,,1"
i'II'
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480-492 and may not bind to all 13 residues. Assuming all 13 C-terminal residues are
present, this peptide has a deduced molecular weight of 28,705 Daltons. Iodoacetic acid
incorporation into this peptide is thus 2.8 and 0.2 mol per mol reduced and nonreduced
ill
,ll
peptide respectively.
The other low molecular weight protein present in the GLUTI preparation (peptide
a of Fig 4) has a computed molecular weight of 33 kDa. This peptide does not react with
Ab and is labelled only very weaky by iodoacetic acid. The N-terminal sequence
derived for this peptide is SSKYPRSVRR which corresponds to N-terminal residues 2-
of RhD , a component of Band 7 protein in human erythrocytes (Arce et aI., 1993),
Nonreduced, alkylated GLUTI was also subjected to urea gel electrophoresis.
Intact GLUT 1 was identified by immunoblot analysis, excised from the gel and subjected
!II'
:1:i1
11'
II'
to Cleland mapping using V8 protease. Peptides were transferred to immobilon and
subjected to N-terminal sequence analysis. Fig. 5 (lanes 2 and 6) shows that a peptide of
rapp 15 kDa (peptide c) is significantly alkylated. The N-terminal sequence of this
fragment is
147 VSPTALRGALGT 156'
Quantitation of iodoacetic acid incorporation indicates 113 pmol reactive thiols per
Ilg peptide. Figure 5 (lanes 2, 4 and 6) also shows that a peptide(s) of Mrapp 11.6 kDa
(peptide d) cross-reacts with C-Ab on immunoblot analysis but is not alkylated appreciably.
Sequence analysis indicates that this region of the blot contains as many as 4 peptides with
terminal sequence:
248SRQMMREKKV 257
300KAGVQQPVY A309
381 VGPGPIPWFI390
394LFSQGPRP AA403
Each of these peptides falls within the C-terminal domain of tetrameric GLUTl
(residues 233-492) that lacks accessible thiol groups. If two of these peptides were to
contain an intact GLUTI C-terminus (i.e. GLUTI peptides 381-492 and 394-492) they
would be characterized by predicted M of 12.3 kDa and 11 kDa respectively and could
account for C-Ab binding to this region of the blot.
Figure 5. V8 peptideMmapping of urea-gel electrophoresis purified, alkylated tet-
rameric GLUTI.
Lanes 1 & 2 show Coomassie stained protein, Lanes 3 & 4 show peptides containing
intact C-termini as judged by immunoblot analysis using anti-GLUT 1 carboxyl terminal
peptide antiserum (C-Ab). Lanes 5 & 6 are 2-week autoradiographic exposures of alky-
lated GLUTI and show e CJ-iodoacetic acid incorporation. Lane 7 shows the mobilty of
molecular weight markers. These are (in order of decreasing molecular weight): 139,
86. 47. 33.3, 26,6, 20.4, 16. , 14.4 2 kDa). Exposure to (+) or omission of (-) V8
protease (8 g) is indicated above the lanes. Peptides c and were subjected to N-terminal
sequence analysis. Their identities are shown in Table I.
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Muta enesis of GLUT 1 c steines
GLUTI cysteines were mutagenized to serines by oligonucleotide-directed in vitro
mutagenesis. The resulting cDNAs were subcloned into pCMV5 expression vectors for
CHO cell transfection, CHO cells were chosen for GLUTI expression because sugar
transport by both CHO cells and erythrocytes is inhibited by extracellular reductant (see
Chapter IV). This suggests that erythrocytes and CHO cells process GLUTI in a similar
fashion.
Clonal cell lines expressing GLUTI wild-type and cysteine mutants were screened
for extent of GLUTI overexpression by immunoblot analysis and by immunofluorescence
microscopy. Two antisera were used. Ab binds to exofacial epitopes of native , tetrameric
GLUTI but fails to react with dimeric GLUTI (Hebert & Carruthers, 1992) while C-
binds to the intracellular C-termini of both tetrameric and dimeric GLUTI (Hebert &
Carruthers, 1992).
Immunoblot analyses of CHO cell total membranes using C-Ab indicate that clonal
cells express wild-type or mutant glucose transporter at levels 2 to 4-fold greater than
levels of GLUTI expression in parental CHO-Kl cells (Table II). CHO cell total
membranes were also sub fractionated into plasma membrane and low density microsomal
membrane fractions. In two separate experiments where all GLUTI cysteine mutants were
examined , the ratio of plasma membrane GLUTI content (protein detected by immunoblot
analysis of 100 Ilg membrane total protein) to low density microsomal membrane GLUTI
content (1:0.5) was unaltered (see Fig. 6) by mutagenesis of GLUTI cysteine residues to
serines, This suggests that cellular processing of GLUTI is unaffected by serine
Figure 6. Immunoblot Analysis of CHO Clones
Immunoblot analysis (using C-Ab as primary antiserum) of cell membranes (100
/-g total protein) from CHO cell clones, The top panel shows the total membrane fraction.
The middle panel shows the plasma membrane fraction. The bottom panel shows the low
density microsome membrane fraction. The blots are: wild-type expresser (WT, lane 1),
GLUTI cysteine mutants C133S, C201S, C207S, C347S, C421S and C429S (lanes 2 to 7
respectively) and CHO-Kl cells (lane 8). Lane 9 contains 250 ng purified GLUT1. Lanes
10 and 11 show results of a second similar experiment using CHO-Kl cells.
The nomenclature used to describe the membrane fractions is used to maintain
consistency with previously published literature in the glucose transporter field. In con-
temporary cell biology literature, the total membrane fraction is called the crude mem-
brane fraction. The low density microsomal fraction is analogous to what is now referred
to as light microsomes, or golgi-enriched membrane fractions. The nomenclature for the
plasma membrane fraction has not changed.
Figure 6
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Total GLUTI expression was also quantitated by digital imaging fluorescence
substitution of cysteine.
microscopy (DIFM) using C-Ab. Since C-Ab does not bind to intact cells (see Fig. 7), this
requires that fixed cells are first permeabilized by using either nonionic detergent (e.
05% Triton X- 100) or by using paraformaldehyde levels in excess of 2% (weight:vol)
during fixation. Immunofluorescence quantitation was by three methods. Total, specific
immunofluorescence from the field was quantitated and divided by the number of cells in
the field. In the second approach , specific immunofluorescence of individual cells was
quantitated and averaged over a large number of cells. These methods can suffer from depth
of field phenon:ena (see below) so a third approach was used in which specific
immunofluorescence within patches of flattened cellular extensions was measured. The
results of all three approaches are in close agreement. The C-Ab immunofluorescence data
of Table II are computed using the specific, cellular immunofluorescence approach and are
not significantly different (2-tailed paired t-test) from the results of immunoblot analyses
using C-Ab (Table II).
The depth of field phenomenon is ilustrated by the fluorescence micrographs of the
C347S mutant in Figure 8. For one cell in the field of view, both C- Ab and Ab staining
patterns suggest an unusual , local sequestration of immunoreactive protein. The second cell
in the same field does not show this behavior. In fact, this local fluorescence intensity is a
cell shape phenomenon. In this hot spot, the value for the z-axis is large (reflecting cell
magnitude of the z-plane (Agard et aI. , 1989). Total cellular fluorescence is relatively
morphology) and the intensity light collected from a given area of x y-pixels reflects the
I::;" i!:
Figure 7. Immunofluorescence ofCHO cells.
Parental, CHO-Kl cells were fixed using 2% paraformaldehyde (A through D), then
exposed to 0 (A, B) or 0.05% Triton-X 100 (C, D). Cells were stained using rabbit Ab 
C) which is used to quantitate tetrameric GLUTI or C-Ab (B , D) which quantitates total
GLUTI and developed using fluorescein-conjugated goat anti-rabbit IgGs. Cells were
visualized by digital imaging microscopy.
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Figure 8. Immunofluorescence of CHO cell clones
Cells were fixed, permeabilized and stained for Ab and C- Ab reactive epitopes. Sheep 
Ab and rabbit C-Ab were used to simultaneously stain cells for both epitopes. Fluorescein-
and rhodamine-conjugated secondary antibodies were used. Results are shown for parental
CHO-Kl cells (CHO), for a wild-type GLUTI overexpresser (CWT) and for cysteine
mutants 133 , 201, 207, 347, 421 and 429 (C133S through C429S). For display purposes,
the full range of fluorescence intensities associated with all images acquired using a given
primary antiserum is compressed to a scale of 0 to 255 (8 bit resolution). This aids visual
comparison of the range of staining intensities obtained with different cells but using one
antiserum. For example, CWT express d-Ab-reactive epitopes at levels 3-fold greater than
do CHO-Kl parental. The actual (measured) range of fluorescence intensities in this
experiment is 0 to 4753 (arbitrary units) for Ab binding images and 0 to 2953 for C-
binding images.
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Table II: GLUTI Expression In CHO Cells
Immunoblot Immunofluorescence Microscopy
Cell type d- Abb Abb Ab/C-
CHO-
CWT 3.4 :: 0. 8 :t 1.3 7 :t 0. 1.3 :t 0. 1 (0.4)
C133S 2.4 :t 0.2 9:t 4. 0:t 2.2 1.3 :t 0. 2 (0.
C201S 9 :t 0.2 5.4 :t 1.7 6 :: 0. 1.4:t 0.3 (1.2)
C207S 3 :t 0. 1 :: 3. 5.4 :t 2.4 1.2 :: 0. 1 (0.
C347S 8 :t 0.4 e,fO,9:t 0. 9 :t 1.6 gO.3 :t 0. 1 (0.4)
C421S 1 :t 0. e,f0.9:t 0. 5:t 1.4 gO.3 :t 0. 1 (0.4)
C429S 9 :: 0.4 3 :t 2. 6 :t 1.0 1.3 :t 0.2 (0.
GT3 3 :t 0. 0:t 1.0 2 :: 1.8 1.2 :t 0. 2 (0.
GLUTI- 5 :t 1.6 0 :t 0. 3.4 :t 1.1 (3.
jGLUTln- 1.9 :t 0. 8 :t 0. 1 :t 1.5 (4.
Notes
lntact GLUTI was quantitated by immunoblot analysis of 100 g CHO cell membrane
protein using C-Ab as primary antiserum and e lJ-protein A as the reporter molecule.
Resulting autoradiograms were quantitated by densitometry.
bd-Ab and C-Ab binding to fixed permeabilized CHO cells was measured simultaneously
by digital imaging fluorescence microscopy using fluorescein-conjugated rabbit-anti-sheep
IgGs as the reporter molecule for Ab binding and rhodamine-conjugated goat anti-rabbit
IgGs as the reporter molecule for C-Ab binding.
The ratio of cellular Ab binding (fluorescein fluorescence): C-Ab binding (rhodamine
fluorescence) was computed for each cell analyzed. The numbers in parentheses indicate
the range of results.
All results are expressed relative to those obtained with CHO- Kl parental cells within the
same experiment. The following summarizes unadjusted data for CHO-Kl cells,
Immunoblot analysis, (59 701 :t 10 121) arbitrary units per 100 g membrane protein; 
Ab binding, (3.2:t 0.37) x 106 arbitrary fluorescence units per cell; C-Ab binding, (1.06:t
19) x 106 arbitrary fluorescence units per cell; d: C ratio, (3. 19:t 0.20): 1.
All results are significantly greater than those obtained with control, CHO-Kl cells (p 
05; 1 tailed paired t test) with the exception ofein which these results are not significantly
different from control and gin which the result is significantly lower than control (po: 0.005;
tailed paired t test).
No significant statistical differences exist across columns 1 through 3 with the exception of
in which this result is significantly less (po: 0.05; 1 tailed paired t test) than those obtained
by immunoblot or immunofluorescence analysis using C-Ab and hin which this result is
significantly greater (po: 0.05; 1 tailed paired t test) than that obtained by
immunofluorescence analysis using C-Ab.
GT3 cells are CHO cell line that expresses GLUTI at very high levels (Harrison et aI.
1990a).
hmmunoblot data for GLUTI-4C and GLUTln-4 are taken from Pes sino et al. (1991).
Results are shown as mean :t SEM of 3 or more separate determinations.
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constant. This phenomenon was observed infrequently in all clonal cell lines and was most
common when cells were characterized by a rounded morphology.
Since transfected CHO cells express GLUTlcys mutants, we next determined
whether these cells also expose increased levels of tetrameric GLUTI-specific (d-
binding) epitopes. These data were collected from the same cells that were analyzed for
GLUTI expression levels by C- Ab fluorescence. This is possible because these cells were
dual labeled for both C-Ab and d-Ab-reactive epitopes. Cells were fixed, permeabilzed
and exposed to sheep Ab and rabbit C-Ab. C-Ab binding was detected by using
rhodamine-conjugated goat anti-rabbit IgGs. The cells were washed and Ab binding was
detected by using fluorescein-conjugated rabbit anti-sheep IgGs. As with quantitation of C-
Ab binding, Ab binding was quantitated using the specific individual cellular
immunofluorescence approach. In three separate experiments, we also stained cells
separately for Ab and for C-Ab binding and obtained results indistinguishable from those
obtained by the simultaneous staining procedure.
The data we collected are expressed in two ways. Specific (d-Ab or C-Ab) cellular
immunofluorescence is expressed relative to that measured in CHO- Kl parental cells. For
example, Table II shows that the C429S GLUTI mutant expresses Ab and C-Ab reactive
sites at levels 5.3 and 3. fold greater respectively than do CHO-Kl cells. Figure 8 shows
typical immunofluorescence micrographs where C429S GLUTI expressing CHO cells
show approximately 4-fold greater Ab and C-Ab staining than do CHO-Kl cells.
The ratio of Ab: Ab staining in a given cell for a given experiment is also
computed and is expressed relative to this same ratio in CHO-Kl cells. This facilitates
comparison of GLUTlcysteine mutant Ab and C-Ab binding properties with those of
GLUTI in a cell (CHO-Kl) where almost all GLUTI forms a homotetratrameric structure
(e. g. see Hebert and Carruthers, 1992 and see Fig. 10). The ratio Ab: Ab binding is not,
however , a direct measure of the absolute ratio of cellular tetrameric GLUTl: total cellular
GLUT1. The Ab: Ab binding ratio also provides an internal control for individual
experiments. Thus, while variations in levels of cellular expression of GLUT 1 and GLUTI
cysteine mutants exist between experiments and are evident from standard errors computed
in columns 1 , 2 and 3 of Table the ratio of cellular Ab: Ab binding sites (for 
binding competent GLUTl) is much less variable because this ratio is independent of
GLUTI expression level (see Fig. 9).
The results (summarized in Fig. 8 and Table II) show that serine substitution at
cysteine 347 or 421 significantly reduces GLUTI exposure of tetrameric-GLUTI-specific
epitopes. Some variation between experiments is observed and ranges for Ab: 
binding ratios are provided in Table II.
Mapping Oligomerization Domains
It was previously shown (Pes sino et aL 1991) that specific immunoprecipitation of
GLUTI-GLUT4 chimeras expressed in CHO cells by using anti-GLUT4 antiserum results
in co-immunoprecipitation of endogenous GLUTI protein. The transporter chimeras used
in these studies were GLUTI-4c (GLUTI resides 1 to 463 plus the 30 C-terminal residues
of GLUT4) and GLUTln-4 (GLUTI resides 1 to 199 plus the 294 C-terminal residues of
GLUT4). Since co-immunoprecipitation of 3T3Ll adipocyte GLUT4 and GLUTI is not
Figure 9. Ab vs. Ab '
CHO- , CWT and GT3 cells were analyzed for GLUTI expression by immunoblot anal-
ysis and by immunofluorescence analysis of Ab binding. Results are expressed as rela-
tive Ab binding versus relative C-Ab binding. All results are expressed relative to
binding observed with CHO-Kl cells. The straight line drawn through the points was com-
puted by the method of least squares and corresponds to: relative Ab binding = 0.7 + III!;
99 relative C-Ab binding (R=0.944).
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Relative C-Ab binding (immunob1ot)
observed under the same conditions, Pessino et al. (1991) concluded that GLUTI-specific
domains mediate GLUTlIchimera associations.
We have now determined the hydrodynamic radius of glucose transporter-
containing micelles solubilized from these cells. Our analyses (Fig. 10) indicate that
parental GLUTl , wtGLUTl , GLUTI-4c and 25% of expressed GLUTln-4 co-resolve with
authentic tetrameric GLUTI upon size exclusion chromatography. The majority of
GLUTln- , however, co-resolves with authentic dimeric GLUT1.
Figure 10. Hydrodynamic size analysis of GLUTI/GLUT4 chimeras.
Cell membranes from Parental CHO cells (.) and from CHO cells expressing Wild Type
GLUTI (0), GLUTln-4 (0) or GLUTI-4c (8) (Pessino et aI. , 1991) were solubilized in
cholate and applied to a size exclusion column as in (Hebert and Carruthers, 1992).
Chimeras and GLUTI were detected by ELISA using anti-GLUT4- or anti-GLUTI-
terminal peptide antisera respectively. Authentic tetrameric (V) and dimeric (T) GLUTI
are also shown. Relative (GLUTIJ content (ordinate) is expressed versus elution time
(abscissa).
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Discussion
A substantial body of direct, biophysical evidence supports the hypothesis that
GLUTI exists as an oligomeric complex (Hebert & Carruthers, 1991 , Hebert & Carruthers
1992 , Jarvis et aI. , 1986, Jung et aI., 1980, Pessino et aI. , 1991 , Sogin & Hinkle, 1978,
Zoccoli et aI. , 1978). The present study was formulated to answer the question: Why is the
quaternary structure of the glucose transporter sensitive to reductant if it is stabilzed
primarily through noncovalent subunit interactions? Our findings support the hypothesis
that each subunit (GLUTI protein) of the parental glucose transporter contains a single
intramolecular disulfide bridge between cysteine residues 347 and 421. This disulfide
seems to be necessary for GLUTI tetramerization. Our findings suggest that GLUTI N-
terminal residues 1 through 199 provide contact surfaces for subunit dimerization but are
insufficient for subunit tetramerization,
Quantitation of GLUTI disulfide content first requires sulfitolysis of disulfides
followed by quantitation of exposed thiols by the NTSB assay (Rao & Scarborough, 1990).
Disulfide cleavage by sulfitolysis produces one S-sulfonated cysteine and reveals a free
thiol group on the remaining cysteine. The assay for an internal disulfide thus yields 1 mol
NTB per 2 mol internal cysteine while that for a mixed disulfide yields 1 mol NT per mol
internal cysteine. Our assay detects 4. 8 :t 0.3 mol NT which, since parental GLUTI
exposes 2 sulfhydryl groups without prior reduction, indicates that sulfitolysis reveals an
additional 3 mol reactive sites. This result strongly suggests that GLUT 1 contains 1 internal
disulfide and either 2 mixed disulfides or 2 free sulfhydryl groups that are revealed only
when the disulfide bridge is broken, It is unlikely that the "missing" thiol is inaccessible
due to covalent modification by other species since DTT reveals this group. It is unlikely
that sulfitolysis is incomplete since excess (lO OOO-fold) sodium sulfite was used and
GLUTI (which was unfolded in SDS) is quantitatively alkylated under similar conditions.
terminal sequence and immunoblot analyses of rI c- J-iodoacetic acid labelled
GLUTI peptides indicates that a C-terminal peptide containing GLUTI residues 233
through 492 contains 3 of the 4 inaccessible sulfhydryl groups of each parental GLUTI
subunit while a peptide containing GLUTI residues 147 to 260/299 contains both reactive
thiols, The conditions used here for GLUTI alkylation do not favor alkylation of other
functional groups (Gurd, and quantitation of presumed GLUT 1972)
carboxymethylcysteine content is in agreement with GLUTI sulfhydryl content as
measured using Ellman s reagent. It is unlikely, therefore, that these quantitative estimates
are seriously flawed. The mobility of the GLUTI C-terminal fragment is unaffected by
omission of reductant during electrophoresis. If the peptide were to remain disulfide-linked
to the smallest possible GLUT 1 tryptic fragments containing either cysteine 133 (residues
184 to 212) or cysteines 201 and 207 (residues 127:153), its molecular weight would
increase by 3308 or by 2925 Daltons respectively. No mobility shift is detected even though
molecular weight markers of the same range of molecular weight but differing by only 5000
Daltons are clearly separated.
May has shown that GLUTI cysteine 429 can be alkylated by cell impermeant
maleimides (May, 1988, May et aI., 1990). However , alkylation is not quantitative and
ranges between 2 to 14 mol% incorporation (May et aI., 1990), This is consistent with our
estimates of molar incorporation of iodoacetic acid into the carboxyl-terminal GLUTI
peptide (20 mol%). In independent studies using a Xenopus oocyte expression system
Wellner and colleagues (Wellner et aI., 1992, Wellner et aI., 1994) have demonstrated that
GLUTI cysteine 429 is required for exofacial pCMBS inhibition of sugar transport but
suggest that mutagenesis of individual cysteine residues is without effect on sugar uptake
by GLUTI expressed in Xenopus oocytes. These studies do not permit direct comparison
of the catalytic activities of the various GLUTI cysteine mutants in Xenopus oocytes since
cell surface GLUTI content was not quantitated and transport was measured at only one or
two sugar concentrations. However, if GLUT I-cysteine mutants are not inhibited, this
suggests either: 1) The cysteine-hypothesis is incorrect or, 2) GLUTI does not fold
normally in oocytes. Recent experiments from this laboratory show (Fig. 11) that GLUTI
expressed in oocytes is capable of transporting sugars but neither binds Ab nor is
inhibited by dithiothreitoI. This strongly suggests that the structural and functional
phenotype of oocyte-expressed GLUTI differs fundamentally from that of human
erythrocyte and CHO cell GLUT1. Oocyte-expressed GLUTI may resemble dimeric
GLUTI - an in vitro, low affinity form of the erythrocyte sugar transporter (Hebert and
Carruthers , 1992). This would explain the troubling observation that oocyte-expressed
GLUTI binds sugars with 5 to lO-fold lower affinity than does erythroid GLUTI (Burant
& Bell , 1992).
In the studies reported here, immunoblot and immunohistochemistry analyses of
parental and transfected CHO cell GLUTI content show that wild-type GLUTI and
Figure 11. GL UTI expression in Xenopus oocytes.
Capped mRNA was synthesized using the Ambion Megascript Kit. 
Xenopus oocytes were
injected each with 25 ng (0.5 Ilg/mL in H20) and maintained in ND96 media +2.5 mM
pyruvate and gentamicin (50 Ilg/mL) for 3 days. 30MG uptake at 22 C and 100 IJ was
measured over 1 minute. Oocytes were exposed to ND96 media :t50 IJ CCB , 2 mM DTT
or 2 mM GSSG for 30 minutes prior to processing for sugar influx or antibody binding.
Sugar influx measurements represent SEM of 5 oocytes, Uninjected oocytes take up
30MG at a rate of =22:t2 fmol/oocyte/min. Oocyte immunofluorescence was performed
as described for erythrocytes. Antibody binding is normalized to fluorescence intensity per
sq cm oocyte surface area.
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GLUTI cysteine mutants are expressed at levels 2 to 5 fold greater than is endogenous
GLUT1. We selected the highest overexpressers for analysis of GLUTI oligomeric
structure. The least ambiguous method for determining the oligomeric state of CHO cell
GLUTI would be to perform hydrodynamic size analyses on purified, solubilized GLUT1.
This method requires additional quantitation of micellular lipid and detergent content and
suffers from the potential for purification-associated perturbations in transporter
quaternary structure (see Hebert & Carruthers, 1992), An alternative approach is to perform
hydrodynamic size analyses of GLUTI solubilzed directly from CHO cell membranes.
This approach, although useful, is not definitive since the protein, detergent and lipid
contents of the solubilzed GLUTI-containing micelles is uncertain, The strategy we
adopted was to quantitate binding of an anti-tetrameric GLUTI antiserum (d-Ab) to CHO
cell GLUTI and to contrast this binding with that of an antiserum (C-Ab) that shows no
detectable sensitivity to GLUTI quaternary structure (Hebert & Carruthers , 1992).
We have previously demonstrated that Ab does not cross-react with dimeric
GLUTI but binds with high affinity to tetrameric GLUTI (Hebert & Carruthers, 1992) and
to SDS- denatured, reduced GLUTI (Harrison et aI., 1990a). We have demonstrated that 
Ab binding to CHO cells is directly proportional to CHO-cell GLUTI expression over a
20- fold range (Harrison et aI. , 1990a) and that Ab binds at an exofacial site(s) on the
transporter (Harrison et aI. , 1990a). We have further shown that reversible dissociation of
tetrameric GLUTI into dimeric GLUTI is associated with the reversible loss of 
binding to GLUTI (Hebert & Carruthers, 1992). We have also shown that affinity
purification of Ab using reduced, SDS-unfolded GLUTI results in quantitative recovery
of binding activity to intact cells (Chapter V and Coderre et aI., 1995). Together these data
suggest that GLUTI contains specific epitopes that are exposed in tetrameric GLUTI but
not in the GLUTI dimer. Thus the ability of Ab to bind to GLUTI reflects the
accessibility of these epitopes. It is possible that Ab reactive epitopes could be
sequestered or exposed in the absence of any change in transporter oligomeric structure.
This has not been observed experimentally (Chapter V and Coderre et aI. , 1995, Hebert &
Carruthers, 1992).
Our results show that serine substitution at cysteines 347 and 421 significantly
reduces Ab binding to GLUT1. The magnitude of this effect suggests that remaining 
Ab binding is accounted for by binding to parental GLUT1. While these results do not
discount the possibility that serine substitution at cysteine 347 and 421 induces subtle
conformational changes that mask the Ab epitopes, they are consistent with the view that
these cysteine residues are important for GLUTI oligomeric structure. When reviewed in
the context of the peptide mapping/alkylation studies, these finding strongly suggest that
the internal , GLUTI disulfide bridge, if extant, is formed between residues 347 and 421.
Hydrodynamic analyses using GLUTI/GLUT4 chimeras indicate that GLUTI
residues 463-492 make a negligible (isoform-specific) contribution to GLUTI oligomeric
structure. This is consistent with the observation that anti-GLUT 1 carboxyl terminal
peptide antiserum (C-Ab) binding to GLUTI is insensitive to GLUTI oligomeric structure,
A portion (25%) of the expressed GLUTln-4 chimera (GLUTI residues 1 through 199 plus
GLUT4 residues 216 to 509) does resolve as a tetramer. Specific immunoprecipitation of
GLUTln-4 from CHO cells using anti-GLUT4 carboxyl terminal peptide antiserum
quantitatively precipitates parental GLUTI (Pessino et aI., 1991). Almost all parental
GLUTI from GLUTln-4 chimera-expressing cells co-resolves with authentic tetrameric
GLUT1. However , most of the chimera co-resolves with authentic dimeric GLUT1. While
our studies cannot rule out the possibility that GLUTln-4-containing micelles contain
molecular species other than lipid, detergent, GLUTln-4 and GLUTl , these data are
consistent with the hypothesis that GLUTln-4 /wild-type GLUTI complexes are
heterotetramers while the remaining GLUTln-4 forms only homodimeric structures. If
correct, this would mean that wild-type GLUTI is dominant positive over GLUTln-4 with
regard to transporter oligomeric structure,
These data further suggest that the GLUTI N-terminal half provides dimerization
motifs/contact surfaces while the carboxyl-terminal half contains the tetramerization motif
(cys 347 and 421) and contact surfaces. These contact surfaces for tetramerization
presumably also include domains that are well conserved in GLUTI and GLUT4 carboxyl-
terminal halves. GLUTI residues 200 - 463 and GLUT4 residues 216 - 479 share 78%
sequence homology.
Chapter IV
Effect of Reductant on in situ GLUTl
Structure and Function
Is the GLUTl tetramer more catalytically active than the dimer in situ?
In earlier studies, Hebert and Carruthers (1992) hypothesized that tetrameric
GLUTI is a more efficient transporter than its reduced , dimeric counterpart. Their
hypothesis was based on indirect in vitro studies. Here, we test the hypothesis in situ. 
test the effect of reductants on erythrocyte and CHO cell structure and function.
Extracellular reductants (dithiothreitol , B-mercaptoethanol or glutathione) reduce
erythrocyte 3-0-methyl- D-glucose uptake by up to 15-fold. This noncompetitive inhibition
of sugar uptake is reversed by the cell-impermeant, oxidized glutathione. Reductant is
without effect on sugar exit from erythrocytes. Dithiothreitol doubles the cytochalasin B
binding capacity of erythrocyte-resident glucose transporter, abolishes allosteric
interactions between substrate binding sites on adjacent subunits and occludes tetrameric-
GLUTI specific GLUTI epitopes in situ. CHO cell-resident GLUTI structure and
transport function are similarly affected by extracellular reductant.
Results
GLUTI structure, GLUTI-mediated sugar transport and ligand binding in intact red cells
GLUTI-mediated 3-0MG uptake by human erythrocytes is inhibited 3 to 15-fold
by dithiothreitol , 2-mercaptoethanol and by reduced glutathione preincubation at 37
(Fig. 12) while oxidized glutathione stimulates red cell sugar import (Fig. 12). The
inhibitory action of dithiothreitol is noncompetitive (Table III) and is half-maximal at 0.
:t 0. 1 mM (SEM of 4 experiments). This effect is exerted at the exofacial surface of the cell
membrane since glutathione and oxidized glutathione are cell impermeable (Kondo et aI.,
1989, Srivastava & Beutler, 1969). Removal of extracellular DTT from 2 mM DTT-Ioaded
ghosts results in reversal of transport inhibition but does not deplete ghosts of intracellular
reductant as judged by quantitation of the release of DTNB-reactive species upon addition
of Triton X-100. 3-0MG exit is unchanged in DTT-exposed cells shown in parallel
experiments to have reduced sugar uptake (n = 3).
Cytochalasin B binding to red cells and to resealed , hemoglobin-depleted red cell
ghosts is affected by DTT in two ways. 1) Sugar-inhibitable cytochalasin B binding
capacity is increased 2.4-fold following red cell incubation with 2 mM DTT (Table III), 2)
The kinetics of maltose-inhibition of cytochalasin B binding are converted from negative-
allosteric inhibition to simple , linear competitive inhibition (Fig. 13).
Although exposure to reductant rapidly and reversibly modifies glucose transporter
function and ligand binding in intact red cells, it is difficult to know whether transporter
structure is affected at the same time. To address this question, we fixed red cells that were
preincubated at 37 C in the presence or absence of 2 mM DTT. These cells were attached
to polylysine coated coverslips prior to exposure to medium and fixative. The fixed cells
were permeabilzed , washed free of reductant and stained separately for either tetrameric
GLUTI-specific epitopes (using Ab) or for total GLUTI (using C-Ab) and resulting
staining intensities visualized and quantitated using digital imaging fluorescence
microscopy (Fig. 14). While C-Ab binding is unaffected by cellular exposure to reductant,
Ab binding is reduced 3.5 :t O, fold by prior cell exposure to 2 mM DTT. Similar
experiments were carried out using CHO cells but here cells were dual stained for d- and
Ab reactive epitopes. CHO cells (growing on coverslips) were exposed to saline or to
saline plus 2 mM DTT, fixed, washed free of DTT and permeabilized prior to staining. The
CHO cell d- and C-Ab binding images shown in Figure 14 (e.g. panels e and f) were
obtained simultaneously from the same field. DTT inhibits Ab binding to CHO cells by
76%. As with red cells, C-Ab binding is unaffected by prior DTT exposure.
In parallel experiments, 2 mM DTT inhibits 2-deoxy- glucose net uptake at 22
by 2-fold in parental CHO-Kl cells and in CHO cells overexpressing GLUTI (CWT cells;
Table III). 2DOG phosphorylation is rate-limiting for net uptake in these experiments (t1l2
for CHO cell uptake of the nonmetabolized sugar 30MG (100 11) at C is 40 sec). While
we cannot rule out the possibility that DTT affects the 2DOG phosphorylation step and not
transport, this appears unlikely since the redox state of cytosol in viable cells is reducing in
the absence of exogenous reductant (Gilbert, 1982).
Figure 12. 30MG uptake by RBCs :t reductant.
CCB-inhibitable30MG uptake (66 11 sugar, 4 C) by erythrocytes (RBCs) in the presence
or absence of 2 mM extracellular reductants (glutathione (GSH), dithiothreitol (DTT) and
B-mercaptoethanol (BME)) and by erythrocyte ghosts (ghosts) containing (e.g. DTTi) or
lacking 2 mM reductant and exposed to 2 mM extracellular reductants (e.g. DTT ) or 2 mM
oxidized glutathione (GSSG), Results represent the mean :t SEM of at least 4 separate
experiments made in triplicate.
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Figure 13. Effect of DTT on maltose-inhibition of CCB binding in RBCs.
Effect of 2 mM DTT-treatment of red cells on maltose-inhibition of cytochalasin B
binding. Ordinate: (cytochalasin Bhreel(cytochalasin BJbound' Abscissa: (maltoseJ in mM.
The curves drawn through the data points are best fit curves and were computed by
nonlinear regrssion assuming that control cells (filed symbols) display negative
heterotropic cooperativity between maltose and cytochalasin B binding sites (Helgerson
and Carruthers , 1987, also see Fig. 19) with Ko for maltose binding of 3.6:t 0. 1 mM , K for
CCB binding of 90 :t 12 nM and a negative cooperativity factor, a, of 2. 1 :t 0. 1. The line
drawn through the DTT data (open symbols) assumes simple competitive inhibition
between cytochalasin B and maltose binding sites with Ko for maltose binding of 32.5 :t
5.4 mM and Ki for CCB binding of 90 :t 6 nM. These data summarize 7 separate
experiments. Each data point represents mean :t SEM of 7 separate measurements made in
quadruplicate.
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Figure 14. Immunoflu9rescence of RBCs and CHO cells :tDTT.
Images show red cells (RBC , panels a - d) and CHO cells (panels e - h) fixed in the presence
(c, d, g, h) or absence (a, b, e, f) of 2 mM DTT. Cells were then washed and stained for 
Ab (a, c , e, g) and/or C-Ab (b, d, f, h) reactive epitopes. Red cells were not stained
simultaneously for Ab and C-Ab binding sites. Thus cells in panel a are not identical to
those in panel b but are from the same population of cells and were processed in parallel to
cells in a. CHO cells were dual stained for Ab (panels e, g) and C-Ab (panels f, h) reactive
epitopes, Thus images shown in panels e and f show Ab and C-Ab binding associated
fluorescence respectively from the same cells. Exposure to DTT prior to fixation inhibits
Ab binding by as much as 4-fold. As with Figure 8 and for display purposes only, the full
range of fluorescence intensities associated with all images acquired using a given primary
antiserum and cell type is compressed to a scale of 0 to 255 (8 bit resolution). The actual
(measured) range of fluorescence intensities in these experiments are: panels a & c, 0 to
3164 (arbitrary units); panels b & d, 0 to 4281; panels e & g, 0 to 3729; panels f & h, 0 to
1462. These results are typical of three separate experiments.
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Table Ill: Effect of Reductant on GLUTI Function
Parameter Control DTT
V max 276 :t 28 138 :t 32
m(app) 11 :t 0. 18 :t 0.
max
128 :t 16 315 :t 22
d(app) 91 :t 8 137:t 16
CHO-KI cells 167:t 11 77 :t 4
CWT cells 275:t 14 131 :t 9
Table ITI Notes:
v max is the maximum velocity ( 01l cell water per min) and Km(app) the Michaelis
constant (mM) for 3-0-methyl- glucose uptake by control and DTT (2 mM) -treated
erythrocytes at 4 C. Results represent the mean :t SEM of 3 separate experiments made in
triplicate.
max and Kd(app) represent maximum binding capacity (thousands of sites per cell) and
dissociation constant (nM) for equilbrium cytochalasin B binding to erythrocytes. Results
represent the mean :t SEM of 5 separate experiments made in triplicate.
CHO-KI and CWT cell experiments measure cytochalasin B (20 IJ) inhibitable 2DOG
uptake ( ol sugar per L cell water per minute) by parental and GLUTl-transfected CHO
cells at 100 IJ sugar and 22 C. Results are shown as mean :t SEM of 3 separate
experiments measured in quintuplicate. The water (30MG) space of a single CHO cell is
98 pL. CHO-Kl cell and CWT ce1l2DOG uptake in the presence of 20 IJ cytochalasin
Bare 53 and 46IJIL cell water per min respectively.
Discussion
Hebert & Carruthers (1992) previously hypothesized that tetrameric GLUTI is a
more efficient transporter than its reduced, dimeric counterpart. This hypothesis is based
on kinetic analyses of red cell resident (tetrameric) GLUTI and reduced, purified GLUTI
(Appleman & Lienhard, 1989, Lowe & Walmsley, 1986) that show that the catalytic
turnover of purified dimeric GLUTI at lO C is significantly lower than that of red cell-
resident GLUTI at the same temperature. Specifically, dimer-mediated net uptake and net
exit are 2-fold and 8-fold slower respectively than that mediated by native GLUT1. While
omission of a number of extrinsic environmental factors can be offered for the catalytic
deficit of reduced purified GLUTl , a kinetic rationale for this behavior is provided by the
observation that exchange transport (sugar uptake coupled to sugar exit) by dimeric and
native GLUTI are indistinguishable. This indicates that sugar-promoted translocation steps
are largely insensitive to transporter oligomeric structure. It is the sugar-independent
transporter conformational changes (relaxation steps) inferred to be sensitive to transporter
oligomeric structure. The slowest steps catalyzed by dimeric GLUTI are relaxation steps
(El f- E2) which, at lO occur almost 100-fold more slowly than do the sugar
translocation steps (E.S 1 f- E.S2) (Appleman & Lienhard , 1989). If the transporter could
bypass relaxation steps, transport would be stimulated dramatically. In principle, this is
what tetrameric GLUTI (a simultaneous carrier) should achieve since the simultaneous
carrier couples sugar import and regeneration of import sites into a single step.
This study tested this hypothesis by exposing erythrocyte-resident GLUTI to
reductant. This reduces the intramolecular disulfide bridge of each subunit causing the
transporter to dissociate into dimers. 
In this way the catalytic and ligand binding properties
of the dimer and tetramer can be contrasted directly. Tetrameric GLUTI dissociation into
dimers should be accompanied by a loss of 
Ab binding to red cells. C-Ab binding to
permeabilzed cells, however , should be unchanged since this antiserum recognizes an
epitope whose availability is insensitive to GLUTI oligomeric structure. Our results show
that red cell-fixation in the presence of reductant significantly reduces the availability of
the d-Ab-specific epitope(s) while C-Ab binding is unchanged. Assuming the loss of 
binding reflects GLUTI dissociation into dimers, the cooperativity hypothesis predicts that
the ligand binding and sugar transport properties of the cells wil be modified dramatically.
Transporter conversion from a simultaneous carrier (tetramer) to a simple carrier
(dimer) wil impact cytochalasin B binding to GLUTI in two ways. GLUTI cytochalasin
B binding capacity wil be doubled and inhibition of cytochalasin B binding to GLUTI by
extracellular maltose wil be transformed from complex allosteric inhibition to simple
competitive inhibition. Increased cytochalasin B binding is expected because only half of
the subunits in tetrameric GLUT 1 can present an export (cytochalasin B binding) site at any
instant. When tetrameric GLUTI dissociates into dimers, subunits are released from this
constraint and now isomerize independently of their neighbor. Thus each subunit now
presents an export site and therefore binds cytochalasin B independently of its neighbor.
This prediction was satisfied experimentally.
Inhibitions of ligand binding to tetrameric GLUTI may be competitive or allosteric
depending on the sites of action. For example, inhibition of extracellular maltose binding
by extracellular D-gluGose would be competitive because both ligands compete for the
import site (an E2 subunit conformation). Similarly, inhibition of cytochalasin B binding
by intracellular D-glucose would be competitive since cytochalasin B binds at or close to
the sugar export site (an El subunit conformation). Extracellular maltose-inhibition of
cytochalasin B binding to tetrameric GLUTl , however, requires negative cooperative
interactions between subunits. Thus maltose binding to an E2 subunit wil affect
cytochalasin B binding to an El subunit only if the occupancy state of the E2 subunit is
communicated to adjacent El subunits and vice versa, In dimeric GLUTI each subunit
functions independently of its neighbor as an El or E2 conformation. Cytochalasin B
binding to El wil competitively inhibit maltose binding to E2 and vice versa. Our
experiments demonstrate that dithiothreitol converts maltose inhibition of cytochalasin B
binding from negative allosteric inhibition to simple competitive inhibition.
0-methyl- glucose uptake is noncompetitively inhibited following red cell
exposure to reductant. The extent of import inhibition ranges from 3 to 16-fold and is
rapidly reversed upon removal of extracellular reductant. Transport inhibition increases in
the order dithiothreitol .( B-mercaptoethanol .( reduced glutathione. Transport inhibition
is not observed in resealed erythrocyte ghosts that contain 2 mM DTT but are washed free
of extracellular reductant. These findings indicate that the site of action is most liely
extracellular and that inhibition is unrelated to the closed ring structure of oxidized
dithiothreitoL
An unexpected result is the failure of reductant to inhibit erythrocyte sugar efflux.
This suggests a number of possibilties: 1) The cooperativity hypothesis is incorrect; 2)
purified reduced GLUTI is unable to mimic faithfully the catalytic properties of
erythrocyte-resident, reductant-exposed GLUTl; 3) The observed kinetics of erythrocyte
sugar exit do not reflect the intrinsic catalytic properties of the transporter. Ample evidence
supports the latter two possibilities. The absence ofnucleotides (AMP, ADP, ATP) impacts
the behavior of purified GLUTI since the transporter is also a nucleotide binding protein
(Carruthers & Helgerson , 1989 , Helgerson et aI., 1989) whose catalytic turnover and ligand
binding properties are radically altered in the presence of nucleotide (Carruthers, 1986a
Carruthers, 1986b, Carruthers & Helgerson , 1989, Carruthers & Melchior , 1983 , Helgerson
et aI., 1989 , Jacquez, 1983). In addition , kinetic analysis suggests that intracellular sugar is
distributed between free and bound compartments (Helgerson & Carruthers , 1989, Naftalin
et aI., 1985 , Nishimura et aI. , 1993). The observable kinetics of transport (which assume
that all intracellular sugar is free) are, therefore, unlikely to accurately reflect the intrinsic
behavior of the transporter.
Other studies in our lab support rejection of the cooperativity hypothesis. We have
found (Chapter V and Coderre et al. 1995) that exofacial proteolysis of GLUT 1 abolishes
cooperativity in ligand binding to GLUTI but fails to impact GLUTI oligomeric structure
or sugar transport function. This suggests therefore, that rapid substrate translocation by
parental (tetrameric) GLUTI results from subunit interactions distinct from those that
promote cooperative ligand binding. This wil be explored in detail in the next chapter.
Chapter V
Effect of Trypsin on in situ GLUTI
Structure and Function
How does the hypothesized antiparallel arrangement of substrate binding sites between
subunits influence catalytic activity?
In the course of these studies , we observed that human red cell-resident GLUTI is
proteolytic ally cleaved by extracellular trypsin. Initially, this result was unexpected since
trypsin is known to inhibit GLUTI-mediated sugar transport only when present inside the
red cell (Baldwin et aI., 1980, Can-uthers & Melchior, 1983 , Masaik & LeFevre, 1977)
where it acts to proteolytically cleave GLUTI (Cairns et aI., 1987, Holman & Rees , 1987
Mueckler et aI. , 1985). While the effect of exofacial trypsin on GLUTI-covalent structure
is unreported, immunoblot analyses show that the rat adipocyte glucose transport protein
GLUT4 is digested by exofacial trypsin (Czech & Buxton, 1993). GLUTI and GLUT4
share 67% sequence identity and similar (proposed) membrane topographies in which both
transporters are suggested to expose extracellular tryptic cleavage sites (Fukumoto et aI.
1989). It is not surprising, therefore, that GLUTI is also cleaved by exofacial trypsin, The
functional resistance of GLUTI to exofacial trypsin indicates, therefore , that GLUTI-me-
diated sugar transport is unaffected by exofacial GLUTI proteolysis.
Closer examination reveals that exofacial GLUTI proteolysis uncouples coopera-
tive interactions between substrate binding sites on adjacent subunits without causing sub-
unit dissociation or inhibition of sugar transport. Extracellular reductant, however, causes
tetrameric GLUTI dissociation, transport inhibition and the loss of cooperative ligand
binding to GLUT1. This suggests that the higher catalytic turnover of tetrameric GLUTI
does not derive from functional cooperativity between ligand binding sites as originally
proposed (Hebert & Carruthers , 1992) but rather, from other aspects of subunit interactions
within the tetrameric transporter complex.
Results
Effects of tr sin on GLUTI covalent structure.
Intact erythrocytes were treated with several proteases including: thrombin , en-
doproteinase glu-C, endoproteinase lys-C and trypsin. These proteases show high specific-
ity for arginine, glutamic acid, lysine and arginine/lysine residues, respectively. Only
extracellular trypsin (Fig. 15A, lane 1) cleaves erythrocyte-resident GLUT1. Identical re-
sults were obtained using three different batches of TPCK-trypsin and four batches of se-
quence-grade trypsin and the effects of trypsin are blocked by soy bean trypsin inhibitor
(10: 1 inhibitor to trypsin ratio by mass; n = 2). Tryptic cleavage generates a 25, 100 Dalton
GLUTI C-terminal fragment as judged by immunoblot analysis using GLUTI C-terminal
peptide anti-serum (C-Ab). Since intact GLUTI is also found under these conditions, the
possibilty exists that either some erythrocytes are leaky and thus allow endofacial tryptic
cleavage of GLUT 1 , or that sub optimal conditions were used for exofacial tryptic diges-
C I
Figure 15. Tryptic digestion of erythrocyte GLUT 
Western blot analysis of human erythrocyte membranes using anti-GLUT 1 C-ter-
minal antiserum. Intact erythrocytes (5 x 109 cells) in 1 mL saline were exposed to 200 /-g
trypsin (lane 1), thrombin (lane 2), V8 (lane 3) or V9 (lane 4) for 30 min. at 37 C. Cells
were collected, washed, lysed and membrane proteins resolved on 15% acrylamide gels,
Western blot analysis of human erythrocyte membranes using anti-GLUT 1 C-ter-
minal antiserum. Intact erythrocytes (1 x 1010 cells) were incubated in saline (lane 1), or in
2 mL saline containing 100 /-g trypsin (lane 2) or trypsin and 100 IJ cytochalasin B (lane
3) at 37 C for 1 hr. Cell membrane proteins resolved on 10% acrylamide gels. In lanes 4
and 5, unsealed erythrocyte ghosts (4 mg membrane protein in 2 mL saline) were incubated
with (lane 5) or without (lane 4) 100/-g trypsin for 15 min.
Coomassie stained gel (10% acrylamide) of reconstituted GLUTI proteoliposomes
(20 /-g GLUTI in 10 mg egg phosphatidy1choline) exposed to 100 Il saline (lane 1) or to
100 Il saline containing 5 /-g trypsin (lane 2) at 37 C for 30 min.
The mobility of pre-stained molecular weight markers are indicated in A, Band C.
Figure 15
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tion.
In contrast to its effects on GLUTI in intact red cells, tryptic digestion of unsealed
erythrocyte membranes results in the complete loss of immuno-detectable glucose trans-
porter (Fig. 15B , lane 5), Because peptide maps obtained from intact cells and unsealed
ghosts differ significantly, these results strongly suggest that exofacial trypsin acts at an ex-
tracellular GLUTI site in intact red cells. Maximum tryptic cleavage of erythrocyte resi-
dent GLUTI is obtained within 30 to 40 minutes of exposure to trypsin (Fig 16, A and B).
Cleavage appears to occur at least two sites. At early times, a low abundance 38 kDa C-
terminal GLUTI fragment is just detectable ( 8% total immunoreactive protein as judged
by densitometric analysis). This fragment is lost upon longer exposure to trypsin, Maximal
GLUTI digestion is produced at a trypsin to membrane protein ratio of approximately
1: 100 (3 j.g trypsin per 5 x 108 cells; Fig. 16C). At higher trypsin concentrations, the de-
pendence of rate of proteolysis upon trypsin level becomes nonlinear. This may result from
trypsin autodigestion. Exofacial tryptic digestion of red cell-resident GLUTI is unaffected
by the presence of 2 mM DTT (pH 7.4; n = 3).
Effects of trypsin on GLUTI oligomeric structure.
We were curious to understand whether disruption of the GLUTI backbone affects
GLUTI oligomeric structure. GLUTI is known to exist as a GLUT 1 homotetramer in the
erythrocyte membrane (Hebert & Carruthers , 1991 , 1992). We examined the effects of ex-
ofacial tryptic cleavage on GLUTI oligomeric structure by monitoring the binding of 
to intact red cells. Ab is an epitope-specific antiserum that binds with high affinity to tet-
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Figure 16. Kinetics of GLUTI Digestion by Extracellular Trypsin.
Erythrocytes (5.5 x 109 cells/ml) were digested with 0.3 mg/ml trypsin in HEPES-
saline for 0, 2 , 5, 10, 20, 30 , 45 and 60 minutes (lanes 1 through 8 respectively) at 37
Erythrocytes were washed and lysed. Membrane proteins were electrophoresed on 15%
polyacrylamide gels, subjected to Western blot analysis using anti-GLUT 1 C-terminal an-
tiserum and immunoreactive proteins visualized by autoradiography.
The intensities of immunoreactive proteins revealed by autoradiography were
quantitated by scanning densitometry. Ordinate: percent of total immunoreactive protein
present. Abscissa: time in minutes. Three populations of immunoreactive proteins were
quantitated (see arrows in panel A): intact GLUTI (8), a 38 kDa peptide (0) and a 25 kDa
peptide (V). Curves drawn through the points were computed by fourth order Runge-Kutta
numerical integration assuming GLUTI is initially proteolyzed to release a 38 kDa C- ter-
minal peptide which is subsequently cleaved to produce a 25 kDa C-terminal peptide. The
computed best fit first order rate constants for assumed first and second cleavage reactions
are (0. 1 and 0.75 min-1 respectively).
Concentration dependence of GLUTI proteolysis by exofacial trypsin. Erythro-
cytes were digested (as in A) for 30 minutes at varying (trypsin). Erythrocyte membranes
were collected and membrane proteins processed as in Figure llA. The extent of GLUTI
proteolysis was quantitated as in IIB. Ordinate: rate of GLUTI proteolysis (percent per
min.). Abscissa: trypsin: erythrocyte membrane protein ratio by mass. The curve drawn
through the points was drawn by eye and has no theoretical significance.
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rameric GLUTI but fails to bind to dimeric GLUTI (Hebert & Carruthers , 1992). 
binding to intact cells (212 987:t 2166 cpm per 2 x 108 cells; n = 3) is unaffected by prior
erythrocyte exposure to exofacial trypsin (191 789 :t 2427 cpm per 2 x 108 cells; n = 3).
This confirms that epitopes exposed in tetrameric GLUTI but not in dimeric GLUTI re-
main accessible in the trypsin-treated transporter and strongly suggests that transporter oli-
gomeric structure is preserved under conditions where the polypeptide backbone of each
subunit is broken. Quantitative immunofluorescence digital imaging fluorescence micros-
copy (Fig. 17) confirms this result and further shows that exposure of red cells to 2 mM
DTT for 30 min at 37 C prior to fixation reduces AB binding to control and trypsin-treat-
ed red cells by 80% and 70% respectively. C-Ab binding to permeabilized control and
trypsinized cells is not inhibited by DTT.
We further examined the oligomeric structure of GLUTI by using non denaturing
size exclusion chromatography to determine the hydrodynamic radius of GLUTI-contain-
ing micelles solubilized from erythrocyte membranes. The Stokes radius of C-Ab-reactive,
protein-containing cholic acid/lipid micelles solubilized from red cell membranes (8 :t 0.
nm; 11 = 3) is not affected by cellular exposure to trypsin (1 mg/mL for 40 min) prior to de-
tergent solubilization (Fig. 18). However, red cell-exposure to DTT (2 mM for 30 min at
C) prior to cholate-solubilization reduces the Stokes radius of cholic acid/lipid/GLUT 
micelles from 8 to 5. 1 :t 0.3 nm (n = 3), Cholic acid-solubilized , purified tetrameric and
dimeric GLUTI are characterized by Stokes radii of 7. 8 :t 0. 2 and 6.0:t 0.2 nID respectively
(Hebert & Carruthers , 1992).
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Figure 17. Effects of Trypsin and Reductant on 
Ab and C-A b Binding to Red Cell
GLUTI
Antibody binding to permeabilized erythrocytes was quantitated by digital imaging fluo-
rescence microscopy. Cells were preincubated for 30 min at 37 C with 0.5 mg/mL trypsin
(c, d, g, h) or saline (a, b, e, f) then att(ched to coverslips where they were exposed to
saline (a, c, e, g) or to 2 mM DTT (b, d, f, h) for 30 min at 37 C prior to fixation and per-
meabilization. Ab binding was measured in a, b, c and d. C-Ab binding was measured in
e, f, g and h. The bar chart to the right of the images quantitates cellular fluorescence (rel-
ative to cells in a) in arbitrary units, Results are shown as mean :t SEM (n= 4) and are
shown for Ab (black bars) and for C-Ab (gray bars). This experiment was repeated three
times with quantitatively similar results on each occasion.
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Figure 18. Hydrodynamic Size Analysis of In Situ GLUTI.
Erythrocytes were exposed to saline (8), trypsin (V;0.5 mg/mL) or dithiothreitol (0; 2
mM) for 30 min at 37 C (see Fig. 17). Cells were collected by centrifugation , washed in
saline, then solubilized in 150 mM NaCI, 4 mM MOPS, 80 mM cholic acid, pH 7.0. The
suspension was centrifuged at 45,000 x g for 30 minutes , then 100 !l of the clear superna-
tant was applied to a TSK-Gel G4000 SWXL size exclusion column which was developed
in the same buffer at a flow rate of 0.3 mL/min. The column was equilibrated using Phar-
macia standards and is characterized by: log Stokes radius (nm) = 1.551 - 0.0649 (Rf - V),
where V is the void of the column (23.03 min. ) Correlation coefficient2 = 0.971. The elu-
tion times of some of these standards and the Stoke s radius of these standards (nm) are
indicated by the arrows. This chart summarizes 3 analyses.
Figure 18
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Effects of trypsin on transporter photolabelling by cytochalasin B
GLUTI present in intact and trypsinized red cells was photolabelled using (3HJ-cy-
tochalasin B and the labeled species resolved by SDS-PAGE. Sub-optimal conditions of
proteolysis were used in order to aid comparison of ligand binding to intact and 25 kDa
GLUTI peptides within the same membrane. With trypsinized red cells, most of the incor-
porated label migrates with low molecular weight species that co-localize with the C- ter-
minal peptide fragment (Fig. 19A). This region of the gel contains a greater percentage of
photolabel if labeling is performed before trypsinization of red cells rather than after
trypsinization (Fig, 19A). The extent of GLUTI proteolysis is also increased by photola-
bellng (but not by UV irradiation per se) prior to proteolysis (see inset of Fig. 19 A). The
presence of 50 IJ cytochalasin B during red cell exposure to trypsin does not alter the ex-
tent of GLUT 1 proteolysis (Fig. 15B , lanes 2 and 3). It is possible , therefore , that cytocha-
lasin B cross-linkng (but not cytochalasin binding per se) promotes exofacial tryptic
digestion of GLUTI but that proteolysis does not prevent ligand binding to the 25 kDa tryp-
tic fragment.
Cytochalasin B binding to the 25 kDa tryptic fragment appears to be increased rel-
ative to binding to intact GLUT1. When normalized for the amount of immunodetectable
GLUTI C-terminal peptide (Fig. 19A, inset) and corrected for the small amount of endog-
enous GLUTI proteolysis detected in control cells (Fig. 19A), cytochalasin B photoincor-
poration into the 25 kDa peptide is 4 :t 1.3 fold greater if labeling is performed after
proteolysis rather than before trypsinization (n = 3). Label incorporation per unit 25 kDa
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Figure 19. Effect of Trypsin on GLUTI-mediated Ligand Binding.
Erythrocytes were photolabelled using 3H-cytochalasin B either before (V) or after
(0) exposure to 50 j.g/mL trypsin for 30 min. at 37 C. Control (trypsin-
free) cells are also
shown (8). Erythrocytes were washed, lysed and membrane proteins were electrophoresed
on 10% gels. Gels were stained with Coomassie Brillant Blue, destained and gel lanes
sliced into 2 mm aliquots, Each gel slice was digested with 10% H2
02 at 56 C overnight
and then analyzed by liquid scintilation counting. Ordinate, percentage of total (3HJ-
CCB
incorporated per gellane; abscissa, gel slice. The inset shows the densitometric quantitatio
of an autoradiogram of a parallel Western blot analysis of these membranes using anti-
GLUTI C-terminal antiserum. DPM 
(3HJ-cytochalasin B incorporated per lane are: con-
trol, 5453; labelled before trypsin, 6439; labelled after trypsin, 8683.
Effect of trypsin on cytochalasin B binding to membranes isolated from intact cells
(8), intact cells exposed to 100 j.g/mL trypsin for 30 min. at 37 C (0) or unsealed, eryth-
rocyte membranes exposed to 100 j.g/mL trypsin for 30 min. at 37
). 
Curves drawn
through intact cell data (80) were computed by nonlinear regression assuming simple sat-
urable binding. Computed binding constants are: Control (8), Kd(app) = 83 :t 
12 nM,
max = 3.9 pmol/j.g membrane protein; Trypsin 
(0), Kd(app) = 126:t 21 nM, Bmax = 6,
:t 0.3 pmol/j.g membrane protein. Each data point represents the mean :t SEM of at least 4
separate measurements made in duplicate, The membrane protein content of intact cells
(0,6 :t 0.04 pg per cell is not significantly altered by trypsin exposure. The protein content
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of unsealed erythrocyte membranes is depleted by trypsin exposure. Here (T), binding
measurements were made using an equivalent number of cell unit membranes.
Effect of trypsin on maltose-inhibition of cytochalasin B binding to erythrocytes.
Intact cells (8) and trypsin (1 mg/mL for 30 min at 37 C) treated cells (0) were exposed
to saline containing 100 nM cytochalasin B and varying (0 to 33 mM) maltose concentra-
tions osmotically balanced using sucrose. Cytochalasin B binding was measured at 4
Each data point represents the mean :tSEM of nine separate measurements. Curves drawn
through the points were computed by nonlinear regression assuming binding is described
by the relationship (Helgerson & Carruthers , 1987)
(CCB
( CCB b
(CCB J + + (MaltoseJ 1
J (X J 1 K + (MaltoseJ J
where CCBf and CCBb are free and bound cytochalasin B respectively, Xt is glucose
transporter, Ki and Ko are the dissociation constants for cytochalasin B and maltose
(respectively) binding to Xt and a is the negative cooperativity factor. For control cells,
the computed best fit (R2 = 0.972) is obtained using the following constants: Xt = 1.8 11,
Ki = 0. 1 11, Ko = 3.6 mM and a = 2.0. For trypsin-treated cells , the computed best fit (R2
= 0.992) is obtained using the following constants: Xt = 4.3 11, Ki = 0.33 11, Ko = 40.
mM and a )- 2 x 1014
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peptide (fraction of total cpm/fraction of total immunodetectable protein) is 1.75 :t 0.25 (la-
beled after proteolysis; n = 4) versus 0.43 :t 0.23 (labeled before proteolysis; n = 4). Label
incorporation per unit intact GLUT 1 averages O,39:t 0. 13 (n = 5) and is unchanged by ex-
posure to trypsin. This latter finding substantially confirms the central assumption of this
analysis (immunostaining is directly proportional to intact GLUTI and 25 kDa GLUTI
peptide levels) since 25 kDa peptide and intact GLUTI derived from cells that were pho-
tolabelled before proteolysis should be characterized by identical label incorporation effi-
clencles.
Effects of trypsin on equilbrium cytochalasin B binding
If increased cytochalasin B photolabellng of the 25 kDa peptide reflects increased
binding of ligand (rather than increased photolabellng efficiency) this should be observ-
able at the level of steady-state cytochalasin B binding to red cells. We therefore examined
the effects of GLUT 1 trypsinization on equilbrium cytochalasin B binding. Trypsin treated
RBCs are characterized by significantly increased capacity to bind cytochalasin B (Table
IV). Binding shows simple saturation kietics in both control and trypsin treated cells but
maximum cytochalasin B binding (Bmax) and the apparent dissociation constant Kd(app)
for cytochalasin B binding are approximately doubled in trypsin-treated cells relative to
control cells.
Cytochalasin B binding to intact cells is complicated by nonspecific ligand binding
to intracellular hemoglobin (Jung & Rampal, 1977, Helgerson & Carruthers , 1987). We
prepared erythrocyte membranes from control and trypsin-treated cells and measured bind-
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ing to these nominally hemoglobin-free membranes. Bmax and Kd(app) for binding to con-
trol membranes are significantly (almost 2-fold) lower than the corresponding parameters
for cytochalasin B binding to membranes prepared from trypsinized red cells (Table V; Fig-
ure 20B). These effects on Bmax and Kd(app) do not reflect trypsin-induced changes in
erythrocyte membrane protein content since red cell membrane protein content (0.6:t 0,
pg per erythrocyte) is unchanged following erythrocyte exposure to extracellular trypsin.
Trypsinization of unsealed erythrocyte membranes results in the loss of saturable cytocha-
lasin B binding (Figure 19B; Table IV) while trypsin treatment of GLUT 1 proteoliposomes
doubles Kd(app) for cytochalasin B binding to purified GLUTI (Table IV).
Because exofacial proteolysis doubles both Bmax and Kd(app) for cytochalasin B
binding to intact cells, the ratio Bmax/Kd(app) for cytochalasin B binding to erythrocyte-res-
ident GLUTI is unchanged by trypsin-treatment. Since saturable cytochalasin B binding at
low ligand concentrations is described by (cytochalasin BJ-k where k = Bmax/Kd(app), this
suggests that trypsin treatment should not affect ligand binding at limitingly low ligand
concentrations. This was confirmed in experiments where the effects of trypsin treatment
on erythrocyte cytochalasin B binding (at low (cytochalasin BJ) and 30MG uptake were
measured. Neither sugar uptake nor ligand binding are affected (Table V) in spite of exten-
sive GLUTI proteolysis (Fig, 15B , lane 2). In contrast, exposure of control and trypsin-
treated cells to 2 mM DTT (a treatment causing transporter dissociation into dimeric
GLUTl) inhibits protein-mediated sugar uptake 2-fold (Table V),
,; 
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Effects of trypsin on availability of exo- and endofacialligand binding sites
In the absence of maltose, cytochalasin B binding to control and trypsin-treated red
cells are not distinguishable (Fig. 19C). However, the manner by which maltose inhibits cy-
tochalasin B binding to GLUTI is modified significantly following red cell exposure to
trypsin. The nature of the antagonistic relationship between exofacial maltose and endofa-
cial cytochalasin B binding sites is revealed (Helgerson & Carruthers , 1987) by expressing
the ratio free (cytochalasin BJ:bound (cytochalasin BJ as a function of maltose concentra-
tion (Fig. 19C). If cytochalasin B and maltose binding sites cannot co-exist, the relationship
is linear with positive slope. If cytochalasin B and maltose binding sites co-exist but inter-
act with negative cooperativity, the relationship is positively curvilinear. Figure 19C shows
that prior to exofacial proteolysis, exofacial maltose and endofacial cytochalasin B binding
sites interact with negative cooperativity. Following proteolysis, however, cytochalasin B
and maltose binding sites are mutually exclusive, The effect of trypsin on maltose-inhibi-
tion of cytochalasin B binding to red cell GLUTI is not further modified by subsequent cel-
lular exposure to 2 mM DTT (37 C for 30 min; n=3).
Effects of trypsin on 3-0-methyl- glucose transport
Neither Vmax nor Km(app) for net 30MG uptake by erythrocytes are affected sig-
nificantly by trypsin treatment (Table VI). Net 30MG uptake by both control and
trypsinized erythrocytes is inhibited significantly by 2 mM dithiothreitol (Table V). Cy-
tochalasin B inhibition of net 30MG uptake is unaffected in trypsin-treated cells (Table
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VI). Prior trypsin treatment is without effect on subsequent tracer (60 11) 30MG efflux
from erythrocytes at ice temperature (rate constant for exit from control and trypsin-
treated
cells == (0. 18:t 0.
03) and (0.20:t 0.02) min l respectively; n==3). Basal cell membrane per-
meability is unchanged by trypsin treatment as 30MG uptake in the presence of 10 
IJ cy-
tochalasin B is unaffected by prior cell-exposure 
to trypsin (Table VI). It is unlikely,
therefore, that trypsin penetrates cells to alter GLUTI structure/function when the
monosaccharide, 30MG, is excluded by the membrane bilayer.
Km(app) for protein-mediated D-glucose transport by reconstituted GLUTI proteo-
liposomes is reduced 2-fold by exofacial trypsin-treatment but V max for uptake is reduced
by only 20% (Fig. 20 and Table V). The fall in reconstituted transport activity (20%) upon
trypsin treatment of proteoliposomes is close to the expected decline of 37%. Under the
conditions of these experiments, trypsin treatment of GLUTI proteoliposomes results in
the loss of detectable protein (Figure 15C, lane 2) as judged by Coomassie staining of con-
trol and trypsin-treated proteoliposomes resolved by SDS PAGE. Protein-mediated sugar
transport activity is undetectable in proteoliposomes containing GLUTI exposed to trypsin
prior to reconstitution (Fig. 20).
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Figure 20. Effect of trypsin on GLUTI mediated D-glucose uptake by reconstituted
proteoliposomes.
Ordinate: rate of D-glucose uptake from saline containing 100 mM D-glucose in mmol D-
glucose per L intra-proteoliposomal water per min. Abscissa: intra-proteoliposomal (D-
glucoseJ in mM. Key: . control proteoliposomes; Ll , trypsin-treated proteoliposomes (see
Fig 15C for details); (straight line indicating no measurable transport), uptake by pro-
teoliposomes exposed to 100 IJ phloretin plus 50 IJ cytochalasin B or by proteolipo-
somes formed from GLUTI that was trypsin-treated prior to reconstitution by cholate
dialysis. The rate of sugar uptake at each (D-glucoseh was computed as the first order
derivative of the time-course of D-glucose uptake. The curves drawn through the points
were computed by nonlinear regression assuming Michaelis-Menten kinetics and have the
following parameters: Control , V = 56:t 1.9, Km(app) = 9.2:t 0.5; Trypsin , V = 47. 2:t 1.6
m(app) = 4.6 :t 0.2. V has units of mM per min. and corresponds to the rate of D-glucose
uptake when intravesicular D-glucose is absent. Km(app) has units of mM and corresponds
to that concentration of intravesicular D-glucose that reduces sugar uptake to one-half V.
These data summarize 5 separate experiments.
Figure 20
:: 
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Table IV: Effect of Extracellular Trypsin on Ligand Binding to Red Cell 
GLUTI
Controla Trypsin
CCB bindin
Intact Cell? Kd(app) nM
102 :I 40 324 :I 66
max (sites/cell)C 262, 000 :I 23
000 508 700 :I 48, 000
Membranes from intact cellP
Kd(app) nM 86 :I 17
155 :I 31
max (sites/cell) 169 200 :I 14,
400 271 440:1 32, 572
Membranes from leaky cells
Kd(app) nM 103 :I 32
Not detected
max
120 240 :I 21, 960
Not detected
proteoliposome Kd(app) nM
140 :I 15 353 :I 28
Bmax (% quench)9 6.4 :I 0.
0:1 0.
elucose 
bindin to proteoliposomes
Kd(low) 
10:1 0. 07 :I 0.
Bmax(low) (% quench)91. 37:! 0.
95 :I 0.
Kd(high) 
17.45:1 3. 8:11.
max(high) 
(% quench)95. 25 :I 0. 4.4 :I 0.
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Table IV Notes:
Indicates that the result is significantly different from the control measurement (p
05,
1 tailed t-test).
aAll experiments are paired experiments (control versus trypsin treatment). The number of
paired determination made in duplicate is 3 or greater.
bCytochalasi B binding was measured in intact erythrocytes following either control or
trypsin (100 g trypsin/l x 10
9 cells; 30 min. at 37 C) treatment.
max for cytochalasi B binding in molecules Cytochalasi
B bound per unit cell mem-
brane (each cell membrane contains 0.6 pg protein).
dCytochalasin B binding was measured in erythrocyte membranes isolated from either con-
trol or trypsin-treated erythrocytes (100 g trypsin/l x 10
9 cells; 30 min. at 37 C).
eCytochalasi B binding was measured in erythrocyte membranes obtained following ei-
ther control or trypsin- treatment (100 g trypsin/l x 10
9 cells; 30 min. at 37 C) of unsealed
erythrocyte membranes.
fCytochalasi B binding was measured in reconstituted GLUTI 
proteoliposomes following
either control or trypsin-treatment (5 g trypsin/20 jl 
GLUTl).
gBinding was measured by analysis of ligand-induced quenching of GLUTI intrinsic flu-
orescence. Maximum binding is represented by maximum quench (% of original fluores-
cence) induced by the ligand.
glucose binding to GLUTI is characterized by high and low affinity components. Bind-
ing was measured at 24 C following control and trypsin (5
g/20 g GLUTl; 30 min, at
120
C) treatments.
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Table V: Effect of Trypsin on Sugar Transport and Ligand Binding at Limiting
Substrate Levels.
Controla
Saline
b30MG uptake
Control 152. 1 :t 0.4
plus CCB 8 :t 0.
dCCB binding
+DTT
75.6:t 1.2
4.4 :t 0.
Control 10.01 :t 0.36 7.43:t 0.
e plus phloretin 1.9 :t 0. 1.8 :t 0.
Trypsin
Saline
132.9 :t 2.
5.4 :t 0.3
51 :t 0.
1.7 :t 0.
+DTT
78.6 :t 0.
7 :t 0.
97 :t 0.33
1.8 :t 0.
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e V eee
a All experiments are paired experiments (control versus 1 hr. trypsin treatment at 1 mg
trypsin per 1010 cells:t 2 mM dithiothreitol, pH 7.4). The number of paired determinations
made in triplicate is 3 or more.
b3-0-methylglucose uptake (at 100 IJ) was measured at C and is expressed as lJol
sugar transported per L cell water per min.
CUptake was measured in the presence of the sugar transport inhibitor cytochalasin B (50
IJ; Ki(app) for transport inhibition = 350 nM).
dCytochalasin B binding is expressed as the ratio bound (Cytochalasin BJ : free (cytocha-
lasin B J. The concentration of free cytochalasin B at equilibrium was approximately 30 nM.
eCytochalasin B binding was also measured in the presence of 100 IJ phloretin - a cytoch-
alasin B binding antagonist.
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Table VI: Effect of Extracellular Trypsin on GLUTI-Mediated Sugar Transport.
Controla sin
Proteoliposome D-Glucose uptake b
V (mM/min. 58. 8 :t 2. 47. 2:t 1.
m mM 6 :t 0. 6 :t 0.
Red cell 30MG uptake M/min. 241 :t 17 212:t10
m mM 7:t0. 2:t 0.
CCB inhbition of red cell 30MG uptake
("!)
86 :t 11 87 :t 1 6
Kj(app) nM 419:t113 359:t 101
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Table VI Notes:
Indicates that the result is significantly different from the control measurement (po:O,05,
1 tailed t-test).
aAll experiments are paired experiments (control versus trypsin treatment). The number of
paired determination made in duplicate is 3 or greater.
bD-Glucose (100 mM) uptake by proteoliposomes was measured at 24 C. Proteoliposomes
(20 Ilg GLUTl) were exposed to trypsin-free saline or to saline containing 51lg trypsin for
30 min.
Cv is the computed, maximum rate of 3-0-methylglucose uptake while Km is that concen-
tration of intra-liposomaI3-0-methylglucose that produces one-half V.
d3-0-methylglucose uptake by erythrocytes was measured at 0- C. Cells (10 ) were ex-
posed to saline, or to saline containing 0.3 mg.mL-
l trypsin for 30 min, at 37
eCytochalasin B inhibition of red cell 3-0-methylglucose uptake from medium containing
2 mM 3-0-methylglucose was analyzed by nonlinear regression assuming simple satura-
tion kinetics. 1m is the maximum inhibition (%) produced by cytochalasin B while 
Ki(app)
is that concentration of cytochalasin B that produces one-half 1
, Cells (10 ) were
exposed to saline, or to saline containing 0.3 mg.mL-
l trypsin for 30 min. at 37
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Discussion
This study demonstrates that the backbone of the erythrocyte glucose transport pro-
tein can be broken at two extracellular sites without ablating protein-mediated sugar trans-
port. In the process, however, the glucose transporter is converted from a multi-site
transporter (Carruthers & Helgerson, 1991) to a simple carrier (Widdas, 1952), Previous
studies have shown that trypsin cleaves GLUTI at multiple intracellular sites and that the
resulting transporter is non-functional (Baldwin et aI. , 1980, Cairns et aI. , 1987, Carruthers
& Melchior, 1983, Holman & Rees, 1987, Masaik & LeFevre, 1977, Mueckler et aI., 1985).
These studies also concluded that GLUTI was not cleaved at extracellular sites since trans-
port function was unchanged by exofacial trypsin. We show here that GLUTI is indeed
cleaved at the exofacial surface, not once but twice. Proteolysis abolishes cooperative in-
teractions between substrate binding sites but leaves transport activity and transporter oli-
gomeric structure unchanged.
The time course of extracellular tryptic digestion of GLUTI suggests that a rapid
initial cleavage is followed by a second cleavage. The first cut releases a low abundance,
terminal peptide of estimated M 38,000. Within 30 minutes, this intermediate disap-
pears yielding a 25 kDa peptide. It is possible that the initial cleavage is necessary to pro-
vide access to the second cleavage site resulting in the appearance of the 25 kDa peptide.
Assuming this model is correct, our calculations suggest rate constants for the first and sec-
ond cleavage reactions of 0. 1 and 0.75 min l respectively (see Fig. 16B). An alternative
explanation is that the red cell exposes two populations of GLUT 1. The smaller population
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(10% of total GLUTl) is hydrolyzed slowly 
(k = 0. 1 min l) to release a 38 kDa fragment
which is then rapidly degraded (k = 0.5 min ). The larger populatio
(;: 90% of total
GLUTl) is cleaved slowly (rate constant = 0.1 min ) to release the 25 kDa fragment. The
available data do not allow us to distinguish between these possibilties.
The 25 kDa GLUTI tryptic fragment contains an intact C-terminus since this pep-
tide is detected on Western blot analysis using anti-GLUT 1 C-
terminal peptide antiserum,
The electrophoretic mobilities of intact GLUTI and both immuno-
detectable, C-terminal
GLUTI tryptic fragments on 18% acrylamide gels are consistent with molecular weights
of 64.2 :t 1.3, 38.3 :t 0,9 and 25.2 :t 1.2 kDa respectively (n = 7). Assuming this analysis is
correct, potential tryptic cleavage sites are arginine153 (M = 37.7 kDa) and argini 264
= 25. 1 kDa). However, hydropathy and glycosylatio scanning mutagenesis analyses
(Mueckler et aI. , 1985; Hresko et aI., 1994a) suggest that these sites lie inside the cell and
antipeptide antibody binding studies indicate that a GLUTI region immediately N-
terminal
to argini 264 (residues 218 to 232) is cytoplasmic (Andersson & Lundahl
, 1988). GLUTI
and other membrane proteins that bind sodium dodecyl sulfate more avidly than do more
hydrophilc proteins can show anomalous electrophoretic behavior upon SDS-
P AGE. For
example, intact GLUTI and the smaller C-terminal , GLUTI tryptic fragment are resolved
as 56.4:t 0.7 and 17.5:t 1.8 kDa peptides in 10% acrylamide gels (n = 4; Figure 15B). Sim-
ilarly, RhD (Band 7 protein with deduced molecular mass, 45.2 kDa) is resolved as a 33
kDa peptide upon electrophoresis in 10% acrylamide gels (Chapter III or Zottola et ai
1995). It is not possible, therefore, to make precise assignments of sites of GLUTI proteol-
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ysis based upon analysis of peptide maps alone. N-
terminal sequence of the 25 kDa frag-
ment is required. If we assume the proposed membrane topography of GLUTI is correct,
hydrolysi at exofacial residues lysi 183 and lysine300 would produce peptides of M
34.4 and 20.8 kDa respectively with theoretical relative mobilities of 0.
6: 1 (compare with
experimental of (0.65:t 0.05) : 1).
GLUTI-mediated sugar transport in reconstituted 
GLUT 1 proteoliposomes is resis-
essential, noncovalent GLUTI structure are maintained when the proteolyzed transporter
tant to trypsin-inhibiti while reconstitution of trypsin-
treated GLUTI by detergent dial-
ysis fails to reconstitute glucose 
transport. This suggests that GLUTI function and
is embedded in the membrane bilayer but are lost during the reconstitution process.
Red-cell resident GLUTI oligomeric structure was examined by two methods -
size-exclusion chromatography and by analysis of 
Ab binding. The former method pro-
vides information on the hydrodynamic radius of particles released from the red cell mem-
brane upon detergent-solubilzation (Hebert and Carruthers, 1991). The latter method
provides information on the surface accessibility of tetrameric GLUTI-specific epitopes
(Hebert and Carruthers, 1992).
Size-exclusion analysis of cholate-solubilized red cell membranes indicates that
prior cell exposure to trypsin does not change the Stokes radius (8 nm) of lipid/detergent
micelles containing GLUTI and GLUTI-carboxyl terminal peptides. While these particles
may contain non-GLUTI protein species, they also co-elute with authentic tetrameric
GLUTI (Stokes radius = 8 nm), d-Ab-reactive epitopes are lost in reductant-
treated but not
lL,O
in trypsin-treated cells, Our analyses demonstrate that 
Ab reacts with membrane-resi-
dent, tetrameric GLUTI and with SDS-denatured, reduced GLUTI but not with reduced,
membrane-resident (dimeric) GLUTI (see Fig. 18 and Hebert 
& Carruthers, 1992). The re-
suIts of our current analyses, therefore, support the conclusion that exofacial, tryptic diges-
tion of GLUTI does not cause dissociation of the multisubunit 
transporter complex.
Exposure to extracellular reductant, however
, promotes a significant GLUTI conforma-
Steady-state cytochalasin B binding to glucose transporter present in trypsin-
treated
tional change resulting transporter dissociation and occlusion of cell surface (d-
Ab-reac-
tive) epitope(s). While it is formally possible that d-
Ab-reactive epitopes could be lost
under circumstances where GLUTI tetrameric structure is maintained or that 
Ab binding
could be retained under conditions where GLUTI dissociates into dimers, neither of these
possibiliti has been observed experimentally (see here and Hebert & Carruthers, 1992).
cells is almost twice that measured in untreated cells. This increased ligand binding capac-
ity is also seen in erythrocyte ghosts prepared from trypsin-
treated red cells. The increase
in red cell cytochalasi B binding promoted by trypsin is not explained by a trivial loss of
membrane protein because exposure to exofacial trypsin does not alter erythrocyte mem-
brane protei content significantly. Furthermore, our analyses suggest that the 25 
kDa
GLUTI C-terminal peptide is photolabelled by CCB (4:t 1.3)-
fold more efficiently than is
intact GLUT1. This analysis assumes that intact GLUTI and the 25 kDa peptide share
equal blotting affinity for C-Ab. This increased binding accounts quantitatively for the in-
crease in steady-state ligand binding capacity of red cell membranes and confirms previous
demonstrations of suppressed, erythrocyte-resident GLUT 1 CCB 
binding potential (Hebert
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& Carruthers, 1991 , Hebert & Carruthers, 1992).
The photolabelled, intact transporter is proteolyzed more efficiently than non-Ia-
beled GLUTI or the CCB-GLUTI equilbrium complex. Because equilbrium CCB bind-
ing does not enhance GLUTI exofacial proteolysis, this suggests that the covalently (CCB)
liganded transporter is conformationally distinct from its noncovalently (CCB) liganded
and unliganded counterparts. These conclusions are consistent with those of other studies
(Holman & Rees, 1987, Karim et aI., 1987). While the CCB binding capacity of membranes
isolated from trypsin-treated red cell is doubled, the affinity of the membranes for CCB is
halved (Kd(app) is approximately doubled). This result (which is consistent with un-
changed CCB binding at low ligand concentrations (see here and Baldwin et al. 1980) is
equivalent to the loss of 1 van der Waal' s bond between cytochalasin B and its binding site.
In contrast, Kd(app) for D-glucose binding to the sugar influx site and Km(app) for 30MG
uptake are unchanged while Kd(app) for D-glucose binding to the sugar efflux site and
m(app) for D-glucose exit from proteoliposomes are reduced 2 to 4-fold by trypsin-treat-
ment. Although interpretation of the latter effect is complicated by the random orientation
of GLUT 1 in reconstituted proteoliposomes , the evidence suggests that GLUT 1 proteolysis
exerts contrasting actions on the binding of two distinct ligands at the sugar efflux site.
The transported substrates (D-glucose and 30MG) bind with increased affinity to
proteolyzed GLUTI while the nontransported, inhibitory ligand cytochalasin B binds with
reduced affinity. These observations are consistent with the action of intra- plus extracel-
lular trypsin on ligand binding to purified GLUTI (Cairns et aI. , 1984) and support the view
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that cytochalasin B and intracellular sugar binding to the transporter, although mutually ex-
clusive, are not mediated by identical chemistries (Cairns et aI. , 1987, Carruthers & Helg-
erson , 1991 , Holman & Rees, 1987). Transported and nontransported (but reactive) ligands
have previously been shown to promote different actions at GLUTI substrate binding sites.
Binding of nontransported species imparts negative cooperativity between import and ex-
port sites while binding of transported species does not (Helgerson & Carruthers, 1987).
How is it possible that sugar transport in control and trypsinized cells are indistin-
guishable while cytochalasin B binding to trypsinized cells is doubled? The simplest expla-
nation is that the increase in cytochalasin B binding is not associated with the glucose
transporter. Trypsinization reveals cryptic , non-GLUT 1 sites with reduced affinity for
ligand (relative to GLUTl). This seems unlikely since extracellular maltose inhibits the in-
crease in binding produced by trypsin. In addition , photoaffinity labeling experiments in-
dicate that the increased binding is associated with the 25 kDa GLUTI carboxyl-terminal
peptide.
An alternative explanation is that cooperative interactions between subunits of the
oligomeric transporter complex are relaxed upon exofacial proteolysis of GLUT1. The
erythrocyte sugar transporter is a GLUTI tetramer (Hebert & Carruthers , 1991 , Hebert &
Carruthers, 1992). Each subunit (GLUTI protein) contributes a single sugar transport site
to the transporter complex and at any time can expose either a sugar import or a sugar ex-
port site (but not both) to available substrate. It has been proposed that cooperative interac-
tions between subunits produce an antiparallel arrangement of subunit transport sites (two
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uptake and two efflux sites) at all times (Hebert & Carruthers, 1992), Thus if one subunit
exposes a sugar export site , the adjacent subunit must expose a sugar import site and vice
versa. Since cytochalasin B binds at or very close to the sugar efflux site and each subunit
can expose only a sugar uptake or a sugar efflux site (but not both) at any instant, each
GLUTI tetramer can bind only two molecules of CCB. Tetrameric GLUTI dissociates into
GLUTI dimers when exposed to reductant (see here and Hebert & Carruthers (1991) and
Hebert & Carruthers (1992)). Cooperative interactions between subunits are relaxed in
dimeric GLUTI and the antiparallel arrangement of binding sites is lost. The CCB binding
capacity of dimeric GLUTI is thus twice that of the native, tetrameric transporter. The pro-
teolyzed glucose transport may, therefore , functionally resemble the reduced, dimeric
transporter.
This hypothesis does not require that relaxation of catalytic cooperativity between
subunits is accompanied by dissociation of tetrameric GLUTI into GLUTI dimers (al-
though the reverse would be required). However , the theory does predict that loss of coop-
erativity between subunits inhibits GLUT I-mediated sugar transport and abolishes
negative cooperativity between CCB (sugar efflux) and exofacial maltose (sugar influx)
binding sites (Hebert & Carruthers, 1992), Our experiments show that proteolyzed GLUTI
retains structural features unique to tetrameric GLUTI suggesting that the transporter does
not dissociate into GLUTI dimers. Our experiments also show that V max for 30MG up-
take is unaffected by trypsin-treatment of red cells. But, trypsin releases exofacial maltose
and endofacial CCB binding sites from obligate, negative, cooperative interaction and ren-
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ders these sites mutually exclusive, This is a methodologically independent replication of
the action of reductant on ligand binding to the glucose transporter (Hebert & Carruthers,
1991 , Hebert & Carruthers , 1992), In this instance , however, cooperativity between trans-
porter subunits is lost under circumstances where structurally cohesive interactions be-
tween subunits appear to be maintained.
Red cell exposure to reductant mimics the ability of trypsin to inhibit cooperative
interactions between substrate binding sites (Chapter IV or Zottola et ai , 1995) but also
causes inhibition of sugar import and subunit dissociation (as judged by the loss of tetram-
er-specific GLUTI epitopes and the reduced Stoke s radius of the detergent-solubilzed
transporter). This suggests that maintenance of tetrameric structure but not cooperativity
between subunit binding sites is required for efficient catalytic turnover. Provided GLUTI
proteolysis does not introduce as yet uncharacterized compensatory changes in subunit cat-
alytic turnover , the hypothesized antiparallel arrangement of substrate binding sites cannot
contribute directly to catalytic efficiency as was originally proposed (Hebert & Carruthers
1992).
In conclusion , our studies demonstrate that GLUTI is vulnerable to proteolysis by
trypsin in at least one extracellular site. This disruption of glucose transporter covalent
structure is not accompanied by detectable changes in transporter oligomeric structure nor
does it abrogate sugar transport function. Exofacial proteolysis does , however, destroy co-
operative interactions between subunits allowing each subunit to behave as a simple carrier,
This relaxation of obligate, antiparallel, catalytic conformations in adjacent subunits ren-
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ders sugar import and s gar export sites mutually exclusive, reveals the full cytochalasin B
binding potential of GLUTI (1 mol CCB per mol GLUTl) and indicates that cooperative
substrate binding is not necessary for high catalytic turnover. At this time, it is uncertain
whether the loss of catalytic cooperativity results from direct proteolysis of a critical inter-
facial domain between subunits or indirectly from proteolysis-induced disorder in crucial
interfacial domains distal to the site(s) of covalent rupture.
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Chapter VI
Analysis of Net Sugar Uptake
Is human erythrocyte net sugar transport is limited by intracellular sugar binding/
complexation?
Erythrocyte sugar transport is characterized by a degree of kinetic complexity that
is not easily explained by models that consider the process of net transport to reflect
protein-mediated transmembrane sugar movements alone (Baker & Naftalin, 1979,
Carruthers, 1991 , Helgerson & Carruthers, 1989, Naftalin & Holman , 1977 , Naftalin &
1977). If correct, this means that the observable steady state kinetics of erythrocyte sugar
Rist, 1991 , Naftalin et aI. , 1985), This has lead to the hypothesis that transported sugars
become reversibly complexed with intracellular macromolecules (Naftalin & Holman
transport describe the sum of two processes (protein mediated transport and intracellular
The most strikng ilustrations of this problem are found in discussions of methods
sugar complexation) and that kietic models for sugar transport that fail to recognize this
may require significant re-evaluation.
for sugar transport determination. When the time-course of net sugar exit from
erythrocytes is analyzed using appropriate integrated Michaelis-Menten equations or by
using the first derivative of the exit progress curve, relatively high Km(app) for exit are
obtained (Baker & Naftalin, 1979, Carruthers, 1990, Carruthers & Melchior, 1983 , Hankn
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et aI. , 1972). however, an initial rate approach is employed to measure exit, relatively
low Km(app) are obtained (Lowe & Walmsley, 1986, Miler, 1971). Measurement of net
sugar uptake by initial and integrated rate approaches seems not to suffer this problem
(Baker & Naftalin , 1979, Ginsburg & Stein, 1975; but see Wheeler & Whelan, 1988).
These approaches (initial and integrated rate analyses) exploit different expressions for the
same kinetic process and should produce the same answer. Whereas initial rate analysis
successfully predicts the early points of the exit progress curve but fails to predict later
portions of the reaction (Carruthers, 1990 , Lowe & Walmsley, 1986, Naftalin et aI. , 1985),
integrated rate analysis successfully describes the entire course of the exit progress curve
(Carruthers, 1986, Hankn et aI., 1972, Miler, 1968 , Sen & Widdas, 1962).
What is significant in these studies is that the integrated rate analysis follows sugar
exit over prolonged intervals whereas the initial rate analysis monitors only the earliest
period of the exit progress curve. If intracellular sugar binding reduces the amount of free
sugar available for exit, the time-course of exit is prolonged and the measured K
m(app) for
net exit overestimates the actual constant for protein-mediated effux. Similarly, if sugar
uptake is rate-limited by sugar binding to a complex in close proximity to the transporter
and newly imported sugar first enters a compartment of restricted water content, sugar
levels just below the membrane may rise extremely rapidly. This would promote
significant sugar exit and thereby reduce net uptake. Considerations such as these
stimulated Naftalin to propose that erythrocyte sugar transport is an intrinsically
symmetric process whose operational characteristics result from factors extrinsic to the
transport process per se (Baker & Naftalin, 1979, Naftalin & Holman, 1977 , Naftalin et
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aI., 1985). Naftalin has since demonstrated that the glucose transporter of various GLUTI
expressing cells is in reversible functional and/or structural association or proximity with
cytosolic hexokinase (Faik et aI., 1989, Naftalin & Rist, 1990, Pedley et aI., 1993) and that
this association exerts a profound influence on the operational characteristics of cellular
sugar transport.
In this study we ask whether human erythrocyte net sugar transport is limited by
intracellular sugar binding/complexation, We surmised that if such were the case, net
sugar uptake at limiting substrate levels would not be a simple exponential process.
Rather, slow and rapid components of uptake may be discernible. We confirm this for
uptake but not for exit. This and other findings lead us to conclude that newly transported
sugar binds to an intracellular complex that is structurally associated with the sugar
transporter. Sugar dissociation from this complex rate-limits further net sugar uptake or
exit. Our observations substantially confirm Naftalin s hypothesis that red cell net sugar
transport is rate-limited by events extrinsic to the transport process. These observations
show that steady-state red cell transport data represent two serial processes - transport and
sugar binding - and thus cannot be used to model the translocation process directly. They
also suggest a means for net sugar transport regulation via transporter association with
sugar binding macromolecules,
Results
Is erythrocyte sugar transport diffusion-limited?
If sugar transport is a diffusion-limited process, reducing the self-diffusion
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coefficient of the transported sugar by increasing the viscosity of the external or internal
environments wil reduce the rate of sugar transport. The strategy we adopted was that
described by Blacklow et al. (1988) in which the "microviscosity" of the medium is
increased by use of monomeric polyhydroxylated visco genic species such as glycerol or
sucrose. If the rate of sugar transport is limited by the frequency of collsion between
reactants (glucose transporter and transported sugar) and manipulation of medium
viscosity exerts no additional effect on transport, relative medium viscosity and the
relative second-order rate constant for transport are inversely related.
The second-order rate constant for transport (k lKnJ is directly proportional to
V max (V m = kcat (GLUTIJ) which is obtained as the rate constant for transport at
limitingly low sugar concentrations (Carruthers , 1991). Figure 21 shows that human
erythrocyte import of 50 IJ 30MG is reduced by increasing extracellular glycerol levels.
This effect is also seen in resealed erythrocyte ghosts containing glycerol at levels
identical to those applied externally and cannot thus be ascribed to extracellular glycerol-
induced cell shrinkng. The sugar analog 6-NBD glucosamine (NBDG) is transported
some 3,300-fold more slowly than is 30MG (Fig. 21) suggesting that transport of this
sugar is limited by events other than sugar/transporter encounter rate. Because of this
NBDG transport is expected to be less sensitive to altered medium viscosity. Cytochalasin
inhibitable and cytochalasin B-insensitive NBDG uptakes are unaffected by addition of
extracellular glycerol (Fig. 21).
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Figure 21. Effect of increasing medium viscosity on erythrocyte sugar transport.
Effect of medium glycerol content on 30MG uptake by red cells (8) and by red
cell ghosts (0). Red cell ghosts contain glycerol at the same concentration as that in the
external medium, Ordinate: rate constant for 30MG uptake relative to that measured in the
absence of glycerol. Abscissa: medium (GlycerolJ (% wt:vol) and relative medium
viscosity (from Blacklow et aI. , 1988). Data are shown as mean :t SEM of at least 3
separate determinations in duplicate or triplicate. Lines drawn through the points were
computed by the method of least squares and correspond to: Red cells, relative k = 1.0 -
025 (Glycerol), R = 0.997; ghosts, relative k = 0.979 - 0.024 (GlyceroIJ, R = 0.994. First
order rate constants (V maxlK ) for red cell and ghost 30MG uptake are 2.76 :t 0.54 and
30:t 0.06 min- l respectively.
Effect of glycerol on NBDG uptake by red cells. Rate constants (per hour) for
protein-mediated (cytochalasin B inhibitable, 8) and leakage-mediated (cytochalasin B-
insensitive 0) uptakes are shown relative to medium (GlycerolJ and viscosity. Data are
shown as mean :t SEM of at least 3 separate determinations in duplicate or triplicate. Lines
drawn through the points were computed by the method of least squares.
Figure 21
139
Relative viscosity
1.2 1.6 2.4
0.4 0.4
(Glycerol) %
Relative viscosity
1.2 1.6 2.4
0.15
(Glycerol) %
140
Is erythrocyte sugar uptake a multi-component process?
We surmised that if net sugar uptake were limited in some way by diffusion across
an intracellular permeability barrier (e.g. an unstirred sugar layer) or by 
slow
complexatio with an intracellular species (e.g. binding to hemoglobin), this might be
revealed over a complete time course of sugar uptake as multiple kinetic components of
sugar equilibratio between cytosol and interstitium. Figure 22 shows that the time course
of 30MG uptake by erythrocytes at 4 C is consistent with an overall process described by
a rapid fillng of a small compartment plus a slow fillng of a larger cellular compartment.
Figure 22 also shows that when sugar uptake is inhibited using 50 
cytochalasin 
leakage-mediated sugar import (at 37 C) is consistent with a single component of sugar
uptake. This latter observation rules out the possibilty (see Discussion) that 
multi-
component sugar uptake results from sugar import into multiple cell 
populations of
differing volumes.
Is erythrocyte sugar exit a multicomponent process?
If multicomponent sugar uptake results from sugar import by two populatio
cells (e.g. old and young) with differing transporter content or catalytic turnover
, then
sugar exit at limiting intracellular sugar concentrations must also display the 
same
multicomponent kinetics. The reason for this is that red cell sugar transport is passive and
this requires that V rJKm for entry = V rJKm for exit (Krupka, 1989). Fig. 22 shows that
exit of 50 30MG from human erythrocytes is consistent with a single (slow) efflux
process. This suggests (see Discussion) that sugar uptake and exit occur within a uniform
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Figure 22. Time course of 30MG (50 jlM) uptake and exit by red blood cells.
Uptake (D) and exit (T) were measured in the absence of CCB at 4 C. Uptake was
also measured in the presence of 50 IJ cytochalasin B at 37 C (0). A, Raw uptake data.
Ordinate: cpm ( HJ-30MG associated with cells. Abscissa: time in minutes. Curves drawn
through the points were computed by nonlinear regression and have the following
constants: uptake (D), k1 = 5.4:t 2.5 min , C = 5905:t 987 cpm , k2 = 0.0755:t 0,0063
min l, C = 19968 :t 1489 cpm , R = 0.96; CCB-insensitive uptake (0), k1 = 0. 13:t 0.
min , C1 = 28761:t 3621 cpm , R = 0.99; exit (T), k1 = 0. 114:t 0.016 min , C1 = 12750
:t 428 cpm , R = 0.98. Measurements were made in duplicate at each time point.
The data of A replotted as log (I-fractional equilibration) versus time. The curves
drawn through the points are based on the constants computed in A.
Figure 22
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populatio of cells that contain two intracellular sugar compartments characterized by
distinct sizes and kinetics.
Does multicomponent sugar uptake require protein-mediated import?
Cytochalasin B inhibition of sugar uptake also inhibits multi-component sugar
import (Fig. 22). This result is consistent with several hypotheses which include: 1) Only
sugar import via the glucose transporter conveys sugar to bulk cell water via the small,
rate-limiting compartment within the cell. 2) Cytochalasin B inhibited, net uptake is no
longer rate-limited by the series barrier because the rate-limiting diffusion/binding step
within the cell occurs more rapidly than does transbilayer sugar diffusion. 3) The barrier is
lost at higher temperatures.
If a series barrier lies between the plasma membrane and bulk cytosol
, then
bypassing the glucose transporter by membrane permeabilzatio wil not bypass 
the
series barrier. We therefore treated erythrocytes with a-toxin (20 
g/mL) and monitored
30MG and L-glucose uptake by control and treated cells. Figure 23 shows that 30MG
and L-glucose immediately (within 5 sec) equilbrate with cell water in a-toxin-treated
cells. The extracellular medium used in these experiments is K-substituted saline in which
2+ levels are buffered to 0( 0. IJ using EGTA. This medium does not ablate multi-
component 30MG uptake in the absence of a-toxin (Fig. 23). This suggests either that the
series barrier between membrane and bulk cytosol is disrupted by a-
toxin or that the
barrier exists only between the glucose transporter and cytosol.
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Figure 23. Effect of a-toxin on Sugar Transport
Effect of a-toxin on 30MG (0,.) and L- glucose (0, T) uptake by red cells. Cells were
treated with 
(., 
0) or without (0, T) 20 /mL a-toxin. Uptake is shown as fractional
penetratio of red cell total water space versus time in seconds. Lines drawn through L-
glucose (control and a-toxin-cells) and 30MG (a-toxin cells) uptake data were computed
by the method of least squares. The curve drawn through the control red cell data was
computed by nonlinear regression and has the following constants: k1 = 0. 18:t 0.04 sec
Cl = 0. 16 :t 0. , k2 = 0.004:t 0.0001 sec , C2 = 0.285:t 0,036; dead space = 0.282:t
029, R = 0.97. This figure summarizes 5 separate experiments made in triplicate.
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Is the glucose transporter laterally segregated in erythrocyte membranes?
Assuming that other cell membrane structure remains unperturbed upon a-toxin
treatment, the rapid cellular equilbration promoted by a-toxin suggests that the rate-
limiting series barrier does not extend along the entire margin of the membrane. Rather
the barrier is associated with glucose transporter but not with bulk plasma membrane.
Does this mean that the glucose transporter and the series barrier are anisotropically
dispersed in the cell membrane? We examined this possibility by comparing the patterns
of cell-surface staining obtained for GLUTI (the erythroid glucose transport protein) and
the anion transporter. We also compared GLUTI staining patterns obtained with living and
fixed cells using different staining reagents (primary antisera) with and without cell-
attachment to polylysine coverslip. Figure 24 demonstrates that in living cells, GLUTI is
anisotropically distributed across the erythrocyte cell surface (Fig. 24d-i) while the anion
transporter is more uniformly dispersed (Fig, 24j, k, I). Similar, punctate staining patterns
are obtained with paraformaldehyde-fixed, detergent permeabilized cells using exofacial-
(Fig. 24b) or endofacial- (Fig. 24a, c) GLUTI epitope-reactive antisera (d-Ab and C-
antisera respectively). Erythrocyte pretreatment with a-toxin does not alter the pattern of
GLUTI staining (Fig, 24c). Cell attachment to polylysine-coated coverslips does not
promote lateral segregation of GLUTI because similar staining patterns are observed in
free-floating cells.
What is the nature of the series barrier?
It has been suggested that transported sugars interact slowly and nonspecific ally
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Figure 24. Immunofluorescence micrographs.
Fluorescence micrographs of human erythrocyte GLUTI (panels a - i, m), anion
transporter (panels j, k, I) and hexokinase I (panel n) content. GLUTI cell-surface
distribution was obtained using rabbit antiserum that reacts with exofacial GLUTI
epitopes (d- panels band d - h), using anti-GLUT 1 C-terminal peptide antiserum (C-
Ab, panels a and c) or using sheep antiserum that reacts with exofacial GLUTI epitopes
(sd- panel m). Anion transporter was stained using FITC. Hexokiase I was detected
using anti-rat hexokinase I antiserum. The secondary antibodies were fluorescein-
conjugated goat anti-rabbit IgGs and rhodamine conjugated rabbit anti-sheep IgGs, Panels
a, band c were obtained using fixed, permeabilized cells. Cells in panel c were treated
with a-toxin prior to fixation, Panels d, e and f were obtained using living (nonfixed) cells
attached to polylysine coated coverslips. Panels g, h , i , j, k, and I were obtained using free-
floating, living cells. Panels m and n are images obtained at lower magnification from
erythrocyte ghosts double stained for GLUTI (m) and hexokinase I (n).
Figure 24
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with hemoglobin in red cells to form an Hb-sugar complex and that this interaction could
affect the apparent kinetics of net sugar uptake by erythrocytes (Baker & Naftalin, 1979).
We examined this in two ways. First we monitored the kinetics of sugar 
uptake by
resealed, human erythrocyte ghosts. Our results show that 30MG uptake is 
stil
characterized by multi-component uptake kinetics in substantially hemoglobin-
free
erythrocyte ghosts (Fig. 25). Second, we compared the kinetics of sugar uptake by control
human K562 leukemic cells and by K562 cells induced to synthesize hemoglobin by
prolonged exposure to hemin. Both control and Hb-synthesizing K562 cells display two
component, 30MG uptake kinetics (Fig. 25). The results obtained using erythrocyte
ghosts demonstrate that if Hb impacts uptake kietics, it must be membrane bound Hb that
is responsible. The K562 studies demonstrate multicomponent sugar uptake in nucleated
Even so, the erythrocyte ghost data suggest that transport (in particular the slow
cells independent of cellular levels of Hb,
component of uptake) is slow relative to uptake by intact cells. Helgerson and Carruthers
(1989) have shown previously that normal uptake is restored upon inclusion of MgeATP
during ghost resealing. We confirm this in the current study (Table VII). We also examined
the effects of cytoskeletal disruption of erythrocyte sugar 
uptake kinetics. Table VII
summarizes our findings. Neither cytochalasin D nor the ionophore A 23187 plus Ca
impact multi-component nature of sugar import by erythrocytes, although treatment with
A 23187 plus Ca2+ slows the kinetics of uptake. This may be related to 
the ATP-depletion
promoted upon Ca-loading red cells using ionophore (Jacquez, 1983).
If multi-component sugar uptake results from a diffusion-
limiting process, this
150
Condition
Intact Red Cells 7.4:t 1.7 29 :t 6
56:t 0. 71:t6
cytochalasin D 9:t 3.4 29:t 13
1.0:t 0. 71:t 18
dA23187 + Ca 9 :t 0. 32:t 7 054:t 0.016 68:t 14
eErythrocyte Ghosts 5:t 1.4 17:t5 027 :t 0.013 83 :t 5
fGhosts + ATP 6:t 0. 25 :t 6 72:t 0. 75 :t 7
Table VII: Effect of Various Agents on Kinetics of Biphasic 
30MG Uptake.
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Table vn Notes:
and k are the pseudo first-order rate constants for 30MG uptake at limiting (30MGJ
(see methods) and have units of per min.
and C are the cell volumes (% of total cell volume) equilibrated by processes 1 and 2
respectively of eqn 1 (page 40).
cCells were incubated with 50 IJ cytochalasin D at 37 C for 30 min prior to uptake
determinations at ice-temperature in the presence of cytochalasin D.
dCells were incubated with 5 IJ A 23187 plus 100 IJ Ca
2+ at 37 C for 30 min prior to
uptake determinations at ice-temperature in the presence ionophore plus calcium.
Red cells were hypotonically lysed then resealed in the absence or the fpresence of 4 mM
MgeATP (pH 7.4) prior to washing in saline and uptake measurements.
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Figure 25. Time Course of 3- Metbyl- Glucose Uptake.
Time course of 30MG uptake by control (V) and hemin induced (A.) K562 cells and by
resealed human erythrocyte ghosts (0). Uptake is expressed as 10g(l-
fractiona
equilbratio ) versus time. Curves drawn through the data points were 
computed by
nonlinear regression as described in Fig. 22. The computed constants are: control K562
cells and ghosts (solid line), kl = 6.6 min- l, Cl = 0,0787, kz = 0.
0567 min l, Cz = 0.893;
duplicate.
hemin-induced K562 cells (dashed line), kl = 7. 1 min , Cl = 0.
0627, kz = 0.0567 min
Cz = 0.921. These data summarize 3 separate experiments for each condition made in
Figure 25
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Figure 26. Is there a sugar binding complex inside the red cell?
Time-course of equilibrium 30MG uptake by intact red cells. Exchange transport
((30MGJi = (30MGJ ) was measured at 0. 1 ( ), 1 (0), 10 (-), 30 (0) and 60 (8) mM
30MG. Uptake data are expressed as 10g(1-fractional equilbration) versus time (min).
The straight lines drawn through the data points were computed by the method of least
squares and correspond to rate constants of O, 100:t 0.004 , 0. 158 :t 0.006, 0,332 :t 0.033
and 0.549 :t 0.046 min l for exchange uptake of 60, 30, 10 and 1 mM 30MG respectively.
The curve drawn through the 0. 1 mM 30MG data was computed by nonlinear regression
as in Fig. 2B and is characterized by the constants: kl = 6.36:t 1.41 min , Cl = 0.261 :t
037, k2 = 0.066 :t 0.005 min , C2 = 0.738 :t 0.063. This Figure summarizes 8 separate
experiments made in duplicate. If the 0. 1 mM 30MG data are ignored, these data
correspond to Vrnax and Krn(app) for exchange uptake of 7,0 :t 0.5 mmol 30MG/L cell
water/min and 12. 1 :t 2.7 mM respectively (R = 0.99).
Measurement of 30MG binding to cells by equilbrium 30MG space analysis.
ordinate: red cell 30MG space in fL (8) and concentration of 30MG binding sites in 
(0). Abscissa: extracellular (30MGJ in mM. Data represent mean :t SEM of three
separate experiments made in triplicate. Curves drawn through the points were computed
by nonlinear regression assuming simple Michaelis- Menten equilbrium binding kinetics
and have the following constants: displaced red cell volume = 14.5 :t 2.4 fL , Kd(app) = 205
:t 130 IJ 30MG; maximum 30MG binding = 31.1 :t 2.61J, Kd(app) = 446:t 138 
30MG,
Figure 26
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effect should be independent of diffusant (sugar) concentration. Previous studies fail to
show multi-component sugar uptake under equilibrium exchange conditions (intracellular
(sugarJ = extracellular (sugarJ). We confirm this here (Fig. 26) for 30MG concentrations
of 1 mM or greater. However, at lower sugar concentrations , multicomponent equilbrium
exchange sugar uptake is demonstrable, This suggests that the physical basis of this
kinetic phenomenon derives from saturable sugar binding within the celL
Equilibrium uptake experiments can be used to quantitate 30MG "binding sites
within the erythrocyte. Cells were equilibrated with various levels (0 to 50 mM) of
unlabeled 30MG then tracer quantities of labelled 30MG were added to the equilibrated
suspension. If 30MG is bound by intracellular components in a saturable manner, the
labelled 30MG space of the cell wil fall with increasing unlabeled 30MG. Table VIII
summarizes the results of 3 experiments which demonstrate saturable 30MG binding with
Kd(app) 450 IJ and B max = 31 ol per L cell water (1.2 x 106 sites per cell).
What cellular components form the sugar transportbinding complex?
Glyceraldehyde phosphate dehydrogenase and phosphoglycerate kinase are
reported to associate with the red cell membrane (Kliman & Steck, 1980, Lachaal et aL,
1990 , Mercer & Dunham , 1981). Immunoblot analysis of intact erythrocytes and of red
cell membranes indicates that 28.8 :t 1.7% (n = 3) of total cellular hexokinase I is retained
by erythrocyte ghosts. While 30MG is not expected to interact with hexokinase, this
enzyme could form one component of a glycolytic particle that interacts with glucose
following sugar transport into the celL We therefore stained erythrocytes for GLUTI and
157
hexokinase I to determine whether both 
cellular components co-localize. Hexokinase
staining patterns also reveal an anisotropic distribution within the cell (Fig. 24n) however
this distribution does not co-localize with that obtained simultaneously for GLUTI within
the same cell (Fig. 24m).
Discussion
The results of this chapter demonstrate that 30MG uptake by human erythrocytes
is a diffusion controlled process and that net sugar uptake and exit are limited by saturable
sugar binding to a small, intracellular compartment that lies 
between the glucose
transporter and the bulk cell sol.
A general criterion for assessing the catalytic efficiency of an enzyme is the kca
ratio which estimates the second-order rate constant for an enzyme-catalyzed reaction.
Theoretical approaches predict that the second-order rate constant for a diffusion-
limited,
enzyme-mediated reaction is in the range of 10
l s-l (Blacklow et aI., 1988, Solc
& Stockmayer, 1973). However, very few of the fastest enzyme-mediated reactions ever
achieve this range of k m (Hammes & Schimmel
, 1970). Several reasons have been
suggested for this apparent discrepancy. Unlike the diffusion of two small 
unsolvated
species in solution , the binding of a substrate to the active site of an enzyme involves more
than a simple encounter. Binding may involve changes in ion pairing, in hydrogen bonding
partners and in local solvent structure both for 
substrate and the active site. These
exchanges wil produce an enthalpic contribution to what for a small unsolvated species is
normally considered to be a purely entropic 
diffusion phenomenon. An enthalpic
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contribution to activation energy of the docking process wil reduce the 
rate of association.
Lower values of second-order rate constants for enzyme-substrate association are also
expected if the substrate binds only to a rare conformational or solvation state of the active
site.
If an enzyme-catalyzed reaction is limited by the rate 
of substrate enzyme
association , then reducing the rate of substrate diffusion in solution is expected to reduce
the frequency of substrate-enzyme encounters. For small molecules such as glucose, this
requires use of monomeric polyhydroxylated species such as sucrose or 
glycerol
(Blacklow et aL, 1988), Polymeric species such as poly (ethylene glycol) or
polyacrylamid while effective in reducing the self diffusion of larger molecules such as
proteins, have little effect on the diffusion of smaller molecules (Stokes & Weeks, 1964).
Since most enzymes are larger than the substrates upon which they act, the 
overall
encounter rate between enzyme and substrate wil be governed by the rate at 
which
substrate diffuses.
Blacklow et aL (1988) have developed simple criteria for determining whether the
rate of an enzyme-mediated reaction is affected directly by altered rates of substrate
diffusion. First, the rate of the reaction should be reduced by 
increased solution
(micro)viscosity. Second, if a "good substrate" reacts at or near the diffusion limit and this
reaction is sensitive to solution viscosity, the use of a "
poor substrate" (for which some
other non-diffusive step is rate-limiting) provides an internal check for 
whether the
visco genic agent exerts additional (nonspecific) effects on the reaction. Third, where
possible a "poor enzyme" (a mutant form of the enzyme with reduced catalytic efficiency)
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should be used to determine whether the visco genic agent affects the enzyme directly,
Glucose and 30MG transport by human red cells are characterized by kca m of
at both ice and room temperatures (Carruthers, 1990). At C, this value
approaches 10 M-1. 1 (Lowe & Walmsley, 1986). While these second order rate constants
are significantly lower than those expected of diffusion-limited enzymes, protein-mediated
erythrocyte sugar transport is reduced by increasing medium viscosity. For an n-fold
increase in solution viscosity, the second-order rate constant for 30MG transport by cells
and erythrocyte ghosts falls n-fold, Transport of the poorly transported sugar 6-NBD
glucosamine (which occurs 3 300-fold more slowly than does transport of 30MG) is
unaffected by medium viscosity. Transbilayer diffusion of sugar (a process limited by the
mobility of sugar within the hydrocarbon core of the bilayer (Lieb & Stein, 1986)) is also
unaffected by aqueous solvent viscosity. These findings suggest very strongly that
GLUT I-mediated sugar transport is a diffusion-limited process, This supports the
hypothesis of Naftalin and co-workers (Baker & Naftalin, 1979, Naftalin & Holman
1977, Naftalin & Rist, 1991 , Naftalin et aI., 1985) that the observed kinetics of erythrocyte
sugar transport - being influenced by environmental factors - do not reflect the intrinsic
properties of the transporter.
The observations presented in the current study, however, suggest that an
intracellular sugar binding compartment complicates accurate determination of sugar
transport rates. This study describes sugar uptake by human erythrocytes and by human
K562 leukemic cells at low sugar concentrations as a bi-exponential process. 
In red cells
the first process rapidly fills a small cellular compartment (k = 7.4 :t 1.7 min ; vol = 29 :t
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6%) while the second process slowly fills the bulk of the cytosol (k = 0.56 :t 0. 11 min
vol = 71 :t 6%). The transported sugar (30MG) is nonmetabolizable thus subsequent
metabolic transformation cannot account for the phenomenon. Several explanations could
account for bi-exponential sugar uptake.
Were the transporter to contain a high affinity, negative-feedback sugar binding site
within a cytosolic GLUTI domain, sugar uptake would be rapid during initial phases but
would slow as intracellular sugar rises and the regulatory site becomes saturated. We
modelled this possibility in two ways. The first model assumes that occupancy of the
regulatory site locks the transporter in a dysfunctional state (the competitive model). The
second assumes that occupancy of the site does not prevent sugar binding at catalytic sites
but rather slows translocational steps significantly (the allosteric model), Both models
predict that sugar uptake shows biphasic kinetics. However, both models also predict that
exit is accelerated as the regulatory site desaturates (Km(app) for exit falls with fallng
intracellular sugar) and this results in a hysteresis in the exit progress curve that is not
observed experimentally. We therefore reject the kinetic explanation for biphasic sugar
uptake.
more simple explanation describes uptake of sugar into two parallel
compartments (i.e. two populations of cell sizes are present in the cell suspension). This
seems unlikely, however, since it can be shown that the first-order rate constant for sugar
uptake (protein-mediated or leakage) into a sphere of volume v, is given by:
= constant. va 1
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Thus for particles of volume v and vl2.5, k would vary by only 1.3-fold, The observed
difference is 13-fold. Moreover, it can also be shown that for any body, the ratio of
GLUTI-mediated sugar uptake (transport) to transbilayer diffusion (leakage) is
independent of volume and is given by:
(GLUTIJ kcat
where (GLUTlJ is surface glucose transporter density, P is the permeability coefficient of
the membrane bilayer to sugar, Km is the Michaelis constant for GLUTI-mediated sugar
uptake and N is Avagadro s constant. Thus, if two populations of cell sizes give rise to fast
and slow components of protein-mediated sugar uptake, sugar leakage should also show
fast and slow components. This was not observed and we thereby reject this hypothesis,
However, were a second population of cells to exist with lower volume and higher
sugar transporter cell-surface density, this population would transport sugars more rapidly
than the larger cells. Our calculations show that such a population of spherical cells would
be characterized by a diameter of 75% of that of the larger cells and would present cell-
surface GLUTI at a density lO-fold higher than that of the larger cells, More importantly,
this population of cells would also display elevated rates of sugar exit relative to the larger
cells at limiting sugar concentrations and this was not observed. We therefore reject the
hypothesis of multiple cell populations of differing GLUTI content.
If small and large cellular compartments do not exist in parallel, they must be
present in series. Since the smaller compartment fills more rapidly than the larger, we
conclude that this compartment lies between the glucose transport and the bulk cell
r'I'IIIIII
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cytosol. The questions Wf: now address are: 1) Does the compartment extend uniformly
across the cytoplasmic surface of the erythrocyte membrane? 2) Why is sugar exit a single
exponential process?
We approached the first question by permeabilizing the red cell membrane using
toxin of Staphylococcus aureus. Our rationale was to bypass the glucose transporter as
the major portal for sugar import but in a way as to enable uptake rates that would stil be
limited by a slower intracellular process. a-Toxin monomers interact at the cell surface to
form hexameric pores of 2 to 3 nm diameter. These pores limit the passage of
macromolecules but allow smaller molecular species (-=1000 daltons) to move freely
across the membrane (Almert-Hilger et aI., 1985, Bader et aI., 1986, Fussle et aI. , 1981,
Hildebrand et aI. , 1991). The large mass of the a-toxin monomer (:;28 kDa) thus limits its
distribution to the cell surface.
Our studies show that permeabilzed erythrocytes fill within 5 seconds of exposure
to extracellular sugar. This suggests that the series barrier does not extend uniformly
across the endofacial surface of the membrane. Rather, it must be limited (structurally or
functionally) to locations coincident with glucose transporter-mediated sugar entry. While
our studies cannot eliminate the possibilty that toxin-treated red cells lose the series
barrier below the cell membrane, these same studies demonstrate that the
characteristically anisotropic GLUTI cell surface distribution is maintained suggesting
that at least major structural elements remain in position in permeabilized erythrocytes,
When examined in other cell types, a-toxin permeabilizatio neither disrupts membrane
cycling processes nor depletes cellular enzyme activities (Baldini et aI., 1991 , Bauldry et
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aI., 1992 , Klarlund et aI. , 1993) indicating that fundamental cellular structure and function
are retained by permeabilized cells. If the series barrier were an unstirred sugar layer
acting to reduce the rate of cytosolic sugar diffusion, bypassing the glucose transporter by
cell membrane permeabilzation is not expected to impact this phenomenon.
Because of the very high glucose transporter content of human red cells (6% of
total erythrocyte surface area is occupied by GLUTI (Hebert & Carruthers, 1992)), we
expected to observe uniform surface staining when erythrocytes were stained for GLUT1.
Contrary to expectations, the GLUTI staining patterns obtained suggest that GLUTI
distribution is restricted to surface domains of very high local transporter density. This
contrasts with the uniform cell-surface distribution of the anion transporter. It is probable,
therefore, that the series barrier is also restricted to these locations of high GLUTI density.
Occasionally, GLUTI staining intensity coincides with red cell crenations. However
, this
is an unusual rather than a normal occurrence. If GLUTI were restricted to crenations
resulting from echinocytosis (Lin et aI. , 1994), the sugar binding complex must also co-
localize within these structures.
The series barrier is not formed from macromolecules that are lost upon cellular
lysis because multicomponent sugar uptake is stil observed in erythrocyte ghosts which
lack more than 95% cellular hemoglobin, Human K562 leukemic cells (a pre-erythroid
cell line) also shows multi-component sugar uptake which is unaffected by subsequent
cell-induction to synthesize hemoglobin. This suggests that sugar binding to hemoglobin
(whether free in bulk cytosol or anchored to the membrane) is not responsible for this
phenomenon. While hypotonically lysed and washed erythrocytes
retain
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disproportionate amount of Hexokinase I suggesting a membrane association (28% based
upon immunoblot analysis), the distribution of this enzyme does not coincide with that of
GLUTI. Other enzymes of glycolysis are suggested to associate strongly with the
erythrocyte membrane, These include glyceraldehyde phosphate 
dehydrogenase and
phosphoglycerate kinase (Kliman & Steck, 1980, Mercer & Dunham, 
1981). Indeed,
GAPDH has been shown to associate in a nucleotide-
dependent fashion with erythrocyte
GLUTI in vitro (Lachaal et aI., 1990). At this time, the molecules that associate with
erythrocyte GLUTI remain uncertain. Equilbrium 30MG space 
analysis indicates that
erythrocytes contain some 1.2 x 10 30MG binding sites per cell (30
; GLUTl:binding
site molar ratio = 1:4) with Kd(app) for 30MG binding at 4 C of 450 
. This apparent
binding constant is close to Km(app) for 30MG net uptake at this temperature (Helgerson et
aI. , 1989), It is interesting that ATP-depletion (e.g. ghost-formati
) reversibly slows the
rapid (presumed translocation) step somewhat and the slower (presumed sugar desorption)
step considerably. If transported sugar were to bind to a hypothetical glycolytic complex
via a substrate tunneling-lie phenomenon
, slower sugar dissociation from the complex
may favor more efficient metabolic processing,
We conclude that net sugar transport by human erythrocytes and by human K562
cells is the sum of two sequential processes - sugar translocation and reversible sugar
binding to a complex in very close association with the glucose transporter, Because of
this, steady-state sugar transport measurements report both translocation and binding steps
and cannot be used directly to model the translocation process in isolation. This process
also ilustrates the potential for control of net sugar 
transport by reversible recruitment of
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sugar biudiug complexes to the 
trsportr - a process known to occur iu thymocytes
CRG cell and iu macrophag
(Faik et al., 1989, Nafin & Rist, 1989, Naftain & Rist,
1990, Pedley et aI., 1993).
- - - -
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Chapter VII
Significance and Future Directions
In the body of work presented in this thesis, we tested aspects of the model
hypothesized by Hebert and Carruthers (1992), Specifically, we wanted 1) to understand
why the native, noncovalent, homotetrameric GLUTI complex is sensitive to reductant, 2)
to determine whether the tetramer is more catalytically efficient than the dimer in vivo, and
3) to test the hypothesis that it is the antiparallel arrangement of substrate binding sites
between subunits that provides the transporter with its catalytic advantage. We used
biochemical and molecular biological approaches to isolate specific determinants of
transporter oligomeric structure and/or transport function in purified isolated transporter
preparations, in intact red cells and in CHO cells. We also examined the hypothesis that
net sugar transport in the human erythrocyte is rate limited by reduced cytosolic diffusion
of sugars and/or by reversible sugar association with intracellular macromolecules.
We have shown that serine substitution at cysteines 347 and 421 significantly
reduces Ab binding to GLUT1. Ab binds to epitopes presented by the GLUTI tetramer.
The magnitude of this effect suggests that remaining Ab binding is accounted for by
binding to parental GLUT1. While these results do not discount the possibility that serine
substitution at cysteine 347 and 421 induces subtle conformational changes that mask the
Ab epitopes, they are consistent with the view that these cysteine residues are important
for GLUTI oligomeric structure. When reviewed in the context of the peptide mapping/
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alkylation studies, these fi!1ding strongly suggest that the internal, GLUTI disulfide bridge
is formed between cysteine residues 347 and 421.
Hydrodynamic analyses using GLUTI/GLUT4 chimeras indicate that GLUTI
residues 463-492 make a negligible (isoform-specific) contribution to GLUTI oligomeric
structure. This is consistent with the observation that anti-GLUT 1 carboxyl terminal
peptide antiserum (C-Ab) binding to GLUTI is insensitive to GLUTI oligomeric structure.
A portion (25%) of the expressed GLUTln-4 chimera (GLUTI residues 1 through 199 plus
GLUT4 residues 216 to 509) does resolve as a tetramer. Specific immunoprecipitation of
GLUTln-4 from CHO cells using anti-GLUT4 carboxyl terminal peptide antiserum
quantitatively precipitates parental GLUTI (Pes sino et aI., 1991), Almost all parental
GLUTI from GLUTln-4 chimera-expressing cells co-resolves with authentic tetrameric
GLUT1. However, most of the chimera co-resolves with authentic dimeric GLUTl. While
our studies cannot rule out the possibility that GLUTln-4-containing micelles contain
molecular species other than lipid, detergent, GLUTln-4 and GLUTl , these data are
consistent with the hypothesis that GLUTln-4 /wild-type GLUTI complexes are
heterotetramers while the remaining GLUTln-4 forms only homodimeric structures. If
correct, this would mean that wild-type GLUTI is dominant positive over GLUTln-
4 with
regard to transporter oligomeric structure.
These data further suggest that the GLUTI N-terminal half provides dimerization
motifs/contact surfaces while the carboxyl-terminal half contains the tetramerization motif
(cys 347 and 421) and contact surfaces (Fig. 27). These contact surfaces for tetramerization
presumably also include domains that are well conserved in GLUT 1 and GLUT4 carboxyl-
- - . - - -
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Figure 27. 2D Structure of GLUTl.
This is our modified model for the 2D structure of GLUT1. The location of the cysteines is
denoted by the dark circles. We propose that the N-terminal half (residues 1- 199) provides
the dimerization domain or contact surfaces for dimerization. The structure is stabilzed by
an intramolecular disulfide bridge between cysteine residues 347 and 421. The C-terminal
half of the protein has been hypothesized to contain the catalytic domain. Thus the loca-
tion of the disulfide bond is well suited to impact transport function.
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terminal halves. GLUTl residues 200 - 463 and GLUT4 residues 216 - 479 share 78%
sequence homology.
Our studies show that in situ disulfide disruption by cell impermeant reductants
results in the loss of cooperative subunit interactions and a 3 to 15-fold reduction the
intrinsic efficiency of the transporter. 3-0-methyl- glucose uptake is noncompetitively
inhibited following red cell exposure to reductant. The import inhibition is rapidly reversed
upon removal of extracellular reductant. Transport inhibition increases in the order
dithiothreitol c: B-mercaptoethanol c: reduced glutathione, Transport inhibition is not
observed in resealed erythrocyte ghosts that contain 2 mM DTT but are washed free of
extracellular reductant. These findings indicate that the site of action is most liely
extracellular and that inhibition is unrelated to the closed ring structure of oxidized
dithiothreitoL
Weare currently initiating studies to determine which regions of GLUTI mediate
oligomerization. Our plan is to utilize a co-immunoprecipitation strategy using GLUTlI
GLUT4 chimeric transporters to broadly map the dimerization and tetramerization
domains. This wil be done by swapping transmembrane domains between GLUTI and
GLUT4 and assessing the effect on oligomerization. In this way, we can begin to
understand the role of defined subsequences in GLUT 1 oligomerization. GLUTI does
contain two motifs which may form contact regions between subunits in the transporter
complex. A leucine zipper motif (L- L; residues 64 - 85) is present in all
glucose transporters. The role of leucine zipper motifs in membrane protein
oligomerization is without precedent. GLUT also contains the glycophorin A
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dimerization motif (L- G; residues 159 - 167). The role of the glycophorin A
dimerization motif in glycophorin A oligomerization is well established but this protein
spans the bilayer only once and thus may not serve as a useful paradigm for understanding
membrane proteins the bilayer many times. It wil be interesting to see if these domains
have any role in GLUTI oligomerization. We may also be able to exploit chimeric
transporters to map GLUTI domains required for rapid transport function and/or
cooperative ligand binding domains. Such an approach may assist in determining whether
domains that establish transporter catalytic properties are distinct from or inseparable from
domains that establish oligomeric structure.
We have shown that GLUTI is vulnerable to proteolysis by trypsin at least one ex-
tracellular site. This disruption of glucose transporter covalent structure is not accompanied
by detectable changes in transporter oligomeric structure nor does it abrogate sugar trans-
port function. Exofacial proteolysis does, however, destroy cooperative interactions be-
tween subunits allowing each subunit to behave as a simple carrier. This relaxation of
obligate , antiparallel , catalytic conformations in adjacent subunits renders sugar import and
sugar export sites mutually exclusive, reveals the full cytochalasin B binding potential of
GLUTI (1 mol CCB per mol GLUTl) and indicates that cooperative substrate binding is
not necessary for high catalytic turnover. At this time, it is uncertain whether the loss of
catalytic cooperativity results from direct proteolysis of a critical interfacial domain be-
tween subunits or indirectly from proteolysis-induced disorder in crucial interfacial do-
mains distal to the site(s) of covalent rupture. It is our hope that more detailed studies of
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cooperative ligand binding and transport function in chimeric transporters wil allow us 
define domains which regulate catalytic activity independently of oligomeric structure and
VIce versa.
We have shown that net sugar transport by human erythrocytes and by human
K562 cells is the sum of two sequential processes - sugar translocation and reversible
sugar binding to a complex in very close association with the glucose transporter. Because
of this, steady-state sugar transport measurements report both translocation and binding
steps and cannot be used directly to model the translocation process in isolation. This
process also ilustrates the potential for control of net sugar transport by reversible
recruitment of sugar binding complexes to the transporter.
We are currently initiating experiments to determine the nature of the barrier.
These experiments may involve nondenaturing chromatographic separation of membrane
constituents in conjunction with sugar binding assays to determine whether sugar binding
complexes have been isolated.
Based on the results presented in this thesis, we propose a model (Fig. 28) for the
native transporter is a GLUT 1 tetramer. This structure is stabilzed by a single, extracellular
disulfide bridge within each subunit. Contacts between subunits are of two types.
Dimerization surfaces are provided by the N-terminal 199 residues of GLUTl.
Tetramerization and cooperativity contacts are provided by GLUTI carboxyl-terminal
residues 200 - 463, The disulfide bridge between cysteine residues 347 and 421 spans the
proposed ligand binding/catalytic domain of GLUT 1 (Clark & Holman , 1990, Deziel et aI.,
1984 , Holman et aI., 1988, Holman & Rees, 1987, Karim et aI., 1987, Oka et aI., 1991) and
.- - - -
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Figure 28. Proposed Model for GL UTI 
Structure.
A hypothetical glocose transportr is 
showo looking into the plane of the biayer. The
section is across two of the four subunits that fono the transportcr. The complcx fonos a
water-filed cavity that almost extends across the entire bilayer. Dimensions arc based in
par upon measured hydrodynaic 
radii and detergentlpidJprotein 
ratios of GLUTI
micelles (Hebert and 
Carthcrs, 1992). The catayti domain is at the center of the water-
filled cavity. Each subunit contrbute 1 
transport site to the complex (these domains and
their coufonoational changcs arc shown in expanded-
at the bottom of thc figure).
Subuuit 1 is shown in an e1 state (exposing an intracellular sugar binding site and shaded
for clarity) while subunit 2 i, in an e2 state (binding 
extracllular sugar). 
When subunit 2
translocates its bound sugar across the 
membrane (an 02..el coufonoationa 
change),
subunit 1 must undergo the antipatalel (01.-02) conformational 
change and vice 
versa. 
this way, thc tranporter complex always exposes two sugar 
infux site and two sugar
effux sites. The strcmre of 
each subuuit is stabilzed by an extrcellular, internal 
diulfde
between cysteine residues 347 and 421. Reduction of this 
bridge results in 
tetrer
dissociation into dimers. Reduced subunits adopt an altered confonoatio
that causes the
loss of functional coupling bctween adjacent cataytic sitos. Each sitc can now 
isomeri
between 01 and 02 states without 
affectig (and indcpcndently of) 
the state of its neighbo
Figure 28
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is thus well positioned to impact the ligand binding and catalytic properties of each subunit.
Like the potassium-channel of the endoplasmic reticulum (Miler, 1982) and the
erythrocyte water channel (Smith & Agre, 1991), we suggest that the catalytic domain of
GLUTI does not span the entire membrane but, rather, is formed from a limited structure
that bridges a larger, water-filed cavity. This is consistent with the very high (;: 80%)
solvent accessibility ofthe GLUTI polypeptide backbone (Alvarez et aI., 1987, Jung et aI.,
1986) and the amphipathic nature of a number of proposed membrane spanning domains
(Mueckler et aI., 1985). This hypothesis is also consistent with the observation that
GLUTI-mediated sugar transport is a diffusion-limited process and allows for disulfide
bridge formation within protein domains hypothesized previously to be buried within the
lipid bilayer and thus inaccessible to extracellular solvent.
The hypothesis of Hebert and Carruthers (1992) cannot explain our observation that
GLUTI cytochalasin B binding capacity is doubled but sugar transport capacity remains
unchanged following exofacial trypsin-treatment of in situ GLUT1. We are now
considering the possibilty that each subunit of the glucose transporter is indeed a simple
carrier (i.e. contains a single catalytic site at any instant) but additionally contains endo- and
exofacial ligand binding sites that serve as noncatalytic, regulatory allosteric sites. The
cytochalasin B binding site of the transporter may be the endofacial allosteric site which
when occupied by its ligand blocks access to the catalytic El (exit) site. This would explain
why cytochalasin B competitively inhibits sugar exit. Thus each subunit contains one
catalytic site (El or E2) but two allosteric (1 endo- and 1 exofacial) sites that interact
cooperatively to modify El 0(-;: E2 transition rates. Subunit packing in the tetramer may
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occlude 1 of every 2 endofacial allosteric sites and thereby halve the cytochalasin B binding
capacity of tetrameric GLUT1. Exofacial proteolysis or reduction of the tetramer may
subsequently disocclude these sites. This model allows for the observed multi-site sugar
binding and sugar transport kinetics yet may permit apparent uncoupling of sugar binding
and sugar transport function. Future studies must address this possibility.
We also propose a model for net erythrocyte sugar transport as a three compartment
process (Fig. 29). Sugar transporters are laterally segregated into domains of very high
local transporter density. Below these domains lie the sugar binding species which form a
complex with cytoplasmic domains of GLUTI in order that sugar released at the exit site
is rapidly bound by the complex. Sugar association with the complex and sugar transport
are more rapid than sugar dissociation from the complex. Some leakage is permitted
between transporter and bulk cytosol. When sugar levels are low, net sugar uptake is rate-
limited by sugar dissociation from the complex into cytosol. At higher sugar levels, binding
sites are saturated and leakage between bulk cytosolic and peri-transporter water spaces
dominates, Sugar exit is rate limited by sugar dissociation from the complex into the sugar
exit cleft. Exit is slow and monoexponential because the amount of free sugar in the
transporter/sugar binding particle complex is extremely low (the free water content of the
complex is 0(0( cell water) and slow desorption from the complex limits hexose availability
to the transporter. Uptake appears bi-exponential because the locally high concentration of
binding sites on the sugar binding particle must fil (rapidly) before slow dissociation into
cytosol can proceed.
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Figure 29. A model for net sugar transport by human erythrocytes.
The upper diagram shows clusters of 
transportr dcliverng 
extracellular sugar (So) to a
sub-membranouS comparent of 
liited free water content. This sugar (S", 
can exit
rapidly via transport, can leak slowly iuto 
bul cytosol to form S, or can biud rapidly to a
sugar binding complex to form bound sugar (Sb
)' Sb then dissociates slowly back to Sm or
to bulk cytosoli sugar Si' The lower diagram is a schematic representati
of this model.
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